
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7128F89B720F31C128F002F2D7789.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="acsomega">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332615/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="ACS Omega">
<meta name="citation_title" content="Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain">
<meta name="citation_author" content="Jennifer S Katz">
<meta name="citation_author_institution" content="Hunterian Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 United States">
<meta name="citation_author" content="Hasan Slika">
<meta name="citation_author_institution" content="Hunterian Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 United States">
<meta name="citation_author" content="Shahab Aldin Sattari">
<meta name="citation_author_institution" content="Hunterian Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 United States">
<meta name="citation_author" content="Adarsha P Malla">
<meta name="citation_author_institution" content="Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland 21201 United States">
<meta name="citation_author" content="Yuanxuan Xia">
<meta name="citation_author_institution" content="Hunterian Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 United States">
<meta name="citation_author" content="Albert Antar">
<meta name="citation_author_institution" content="Hunterian Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 United States">
<meta name="citation_author" content="Kathleen Ran">
<meta name="citation_author_institution" content="Hunterian Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 United States">
<meta name="citation_author" content="Betty Tyler">
<meta name="citation_publication_date" content="2025 Jul 22">
<meta name="citation_volume" content="10">
<meta name="citation_issue" content="30">
<meta name="citation_firstpage" content="32544">
<meta name="citation_doi" content="10.1021/acsomega.5c00364">
<meta name="citation_pmid" content="40787406">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332615/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332615/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332615/pdf/ao5c00364.pdf">
<meta name="description" content="The blood-brain barrier (BBB) greatly hinders the delivery of therapeutic agents to the brain. Vast efforts have been dedicated to exploring novel strategies and developing technologies to enhance the delivery of drugs, nucleic acids, antibodies, ...">
<meta name="og:title" content="Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The blood-brain barrier (BBB) greatly hinders the delivery of therapeutic agents to the brain. Vast efforts have been dedicated to exploring novel strategies and developing technologies to enhance the delivery of drugs, nucleic acids, antibodies, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332615/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12332615">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1021/acsomega.5c00364"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ao5c00364.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332615%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12332615/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12332615/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332615/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-acsomega.png" alt="ACS Omega logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to ACS Omega" title="Link to ACS Omega" shape="default" href="https://pubs.acs.org/journal/acsodf" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">ACS Omega</button></div>. 2025 Jul 22;10(30):32544–32563. doi: <a href="https://doi.org/10.1021/acsomega.5c00364" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1021/acsomega.5c00364</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS%20Omega%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS%20Omega%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Overcoming the
Blood-Brain Barrier for Drug Delivery
to the Brain</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katz%20JS%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jennifer S Katz</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jennifer S Katz</span></h3>
<div class="p">
<sup>†</sup>
Hunterian
Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
21231
United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katz%20JS%22%5BAuthor%5D" class="usa-link"><span class="name western">Jennifer S Katz</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Slika%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Hasan Slika</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Hasan Slika</span></h3>
<div class="p">
<sup>†</sup>
Hunterian
Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
21231
United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Slika%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hasan Slika</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sattari%20SA%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Shahab Aldin Sattari</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Shahab Aldin Sattari</span></h3>
<div class="p">
<sup>†</sup>
Hunterian
Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
21231
United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sattari%20SA%22%5BAuthor%5D" class="usa-link"><span class="name western">Shahab Aldin Sattari</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Malla%20AP%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Adarsha P Malla</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Adarsha P Malla</span></h3>
<div class="p">
<sup>§</sup>
Department
of Neurosurgery, University of Maryland
School of Medicine, Baltimore, Maryland
21201
United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Malla%20AP%22%5BAuthor%5D" class="usa-link"><span class="name western">Adarsha P Malla</span></a>
</div>
</div>
<sup>§</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xia%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yuanxuan Xia</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yuanxuan Xia</span></h3>
<div class="p">
<sup>†</sup>
Hunterian
Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
21231
United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xia%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuanxuan Xia</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Antar%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Albert Antar</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Albert Antar</span></h3>
<div class="p">
<sup>†</sup>
Hunterian
Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
21231
United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Antar%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Albert Antar</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ran%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Kathleen Ran</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Kathleen Ran</span></h3>
<div class="p">
<sup>†</sup>
Hunterian
Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
21231
United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ran%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kathleen Ran</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tyler%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Betty Tyler</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Betty Tyler</span></h3>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tyler%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Betty Tyler</span></a>
</div>
</div>
<sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>†</sup>
Hunterian
Neurosurgical Research Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
21231
United States
</div>
<div id="aff2">
<sup>§</sup>
Department
of Neurosurgery, University of Maryland
School of Medicine, Baltimore, Maryland
21201
United States
</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">
Email: <span>btyler@jhmi.edu</span>. Tel.: 410-502-8197. Fax: 410-614-0478.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jan 13; Accepted 2025 Jun 27; Revised 2025 Jun 20; Collection date 2025 Aug 5.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Authors. Published by American Chemical Society</div>
<p>This article is licensed under CC-BY-NC-ND 4.0</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12332615  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40787406/" class="usa-link">40787406</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The blood-brain barrier (BBB) greatly hinders the delivery
of therapeutic
agents to the brain. Vast efforts have been dedicated to exploring
novel strategies and developing technologies to enhance the delivery
of drugs, nucleic acids, antibodies, etc., effectively in the context
of brain tumors, neurodegenerative diseases, and other brain pathologies.
These strategies aim to guarantee impactful and targeted accumulation
of the delivered agents within the brain or within specific areas
or niches through either localized sustained delivery (convection-enhanced
delivery and implantable biodegradable polymer-based systems), encapsulation
of the agents within vectors that can enhance their ability to penetrate
the BBB and achieve proper interstitial distribution (viral vectors,
exosomes, and nanoparticles), or modulation of the BBB to facilitate
the crossing of the delivered cargo (focused ultrasound and receptor/transporter-mediated
delivery). Indeed, exploring these innovative strategies and how they
may work synergistically with conventional treatments is crucial to
advancing the management of brain pathologies.</p></section><section class="abstract" id="abstract2"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c525/12332615/99e0492dd6cc/ao5c00364_0008.jpg" loading="lazy" height="340" width="666" alt="graphic file with name ao5c00364_0008.jpg"></p></section><section class="abstract" id="abstract3"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c525/12332615/99e0492dd6cc/ao5c00364_0006.jpg" loading="lazy" id="tgr1" height="340" width="666" alt="graphic file with name ao5c00364_0006.jpg"></p></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>The blood-brain barrier
(BBB) selectively regulates the transport
of circulating substances into the brain. While this structure is crucial for maintaining brain homeostasis
and protecting the brain against pathogens and toxic metabolites,
simultaneously, it limits the optimal distribution of &gt;98% of potential
therapeutic agents to the brain. In particular, only highly lipophilic
molecules with few hydrogen bonds and a molecular weight of less than
400 Da have the ability to cross the BBB. Hence, all large drugs and a great proportion of small-molecule
drugs lack the ability to penetrate the BBB and act in the brain.</p>
<p>Structurally, the BBB is composed of a neurovascular unit (NVU)
formed by tightly sealed endothelial cells joined together with tight
junctions and surrounding supporting cells. The barrier blocks paracellular
transport and limits transcytosis. Functionally, the BBB utilizes
selective mechanisms, such as receptor-mediated and carrier-mediated
transport, to regulate the movement of molecules entering and exiting
the brain parenchyma <sup>1,2.</sup>
</p>
<p>To overcome the BBB for
the purpose of drug delivery, many novel
strategies have been investigated, which can be broadly characterized
into categories. Local delivery techniques,
including convection-enhanced delivery (CED) and local biodegradable
polymer-based drug release, bypass the BBB by delivering therapeutics
directly into the targeted site. BBB-penetrant strategies, such as
nanoparticles, exosomes, and vectors, cross the BBB by utilizing the
brain’s endogenous transport pathways. BBB-disrupting strategies,
including focused ultrasound (FUS), transiently increase the barrier’s
permeability to enhance drug biodistribution. Intranasal delivery
offers a noninvasive and direct route, while receptor-mediated transport
leverages existing transport mechanisms. This paper seeks to review
evolving strategies for therapeutic purposes.</p></section><section id="sec2"><h2 class="pmc_sec_title">2. Local Delivery Techniques</h2>
<section id="sec2.1"><h3 class="pmc_sec_title">2.1. Convection-Enhanced Delivery</h3>
<section id="sec2.1.1"><h4 class="pmc_sec_title">2.1.1. Overview</h4>
<p>Convection-enhanced delivery
(CED) is a direct drug delivery method that can bypass the BBB by
allowing the delivery of high volumes of therapeutics while limiting
systemic toxicities. CED functions through
placing small catheters into the targeted region while an infusion
pump generates a pressure gradient using a bulk flow technique, leading
to the direct infusion of therapeutics into the tumor and the surrounding
areas. Interest in CED has grown since
a wide range of compounds can be homogeneously delivered, achieving
a greater area of local drug distribution as compared to conventional
diffusion-based techniques. Various studies
investigated the utility of CED, and the outcomes are dependent on
multiple variables including (1) catheter characteristics (e.g., couple-controlled
catheter movements with constant pressure infusion provides higher
infusion volume versus stationary catheters), (2) infusion frequency (e.g., better outcomes with single versus
serial infusions of Serclutamab talirine in glioblastoma), (3) CED flow rate (e.g., Hamilton syringes versus
catheters), and (4) tumor heterogeneity
(e.g., the heterogeneity in cell density and vascularization can lead
to differences in drug distribution, diffusion, and clearance). Therefore, all of these variables need to be
considered to achieve an optimal outcome for the particular disease
treated. These challenges and obstacles still need to be tackled to
optimize the use of CED, such as backflow from the catheters and changes
in the tumoral landscape after procedures.</p></section><section id="sec2.1.2"><h4 class="pmc_sec_title">2.1.2. CED in Brain Tumors</h4>
<p>Diffuse intrinsic
pontine glioma (DIPG) is one of the most aggressive central nervous
system (CNS) cancers in the pediatric population, with a median overall
survival of lower than 1 year. Souweidane et al. reported the findings
from a phase 1 clinical trial which investigated the safety and efficacy
of CED of the antibody I-8H9, targeting
the glioma-associated B7–H3 antigen, in 28 children with DIPG
who have been treated with radiation therapy previously. Apart from
one case of transient hemiparesis and skin infection, no other complications
occurred and dose-limiting toxicities were not observed. These findings
show that CED may be an efficient strategy for drug delivery to brain
stem tumors, which should be further investigated in future trials. Glioblastoma multiforme (GBM) is the most commonly
occurring primary malignant brain tumor, which is locally invasive
and exhibits high recurrence rates with a poor prognosis despite surgery
and chemoradiation. Several trials have
been conducted to assess the safety and efficacy of CED of therapeutic
agents in recurrent GBM.<em>
−

</em> In a phase 1 trial by van Putten
et al., 19 patients with recurrent GBM underwent CED of the oncolytic
Delta24-RGD virus (DNX-2401), inducing a local inflammatory response
against the tumor. Eight patients showed
survival or radiographic response to the administered treatment; however,
nine cases sustained serious adverse events, mainly attributed to
increased intracranial pressure. Interestingly, one case showed complete
response without any sign of tumor recurrence or requirement for further
treatment. In a parallel fashion, topotecan
is an effective chemotherapeutic agent against glioma cells, but the
BBB has limited its application in the clinical setting. To address
this obstacle, Spinazzi et al. conducted a phase 1 trial, in which
five patients with recurrent GBM, who had already received surgery
and chemoradiation, underwent subcutaneous implantation of a catheter-pump
system capable of CED of topotecan into the brain. Their trial has
demonstrated that topotecan significantly decreased tumor growth in
all patients, though one case developed treatment-related intraoperative
supplemental motor area syndrome. Similarly,
Bos et al. conducted a phase 1 trial in which 15 patients with recurrent
GBM received peritumoral and intertumoral CED of human recombinant
bone morphogenic protein 4 (hrBMP4). Areas
that received hrBMP4 showed tumor growth inhibition. Additionally,
hrBMP4 infusion was safe and well-tolerated, and no dose-limiting
toxicities were detected. Despite the
limited sample size, the short follow-up period, and the absence of
a control group, these findings are promising and merit further investigation
(clinical trials investigating CED are summarized in <a href="#tbl1" class="usa-link">Table 
</a>).</p>
<section class="tw xbox font-sm" id="tbl1"><h5 class="obj_head">1. Clinical trials for local delivery
techniques (source: clinicaltrials.gov). IL, interleukin; PE, pseudomonas
exotoxin; AAV, adeno-associated virus; GDNF, glial cell line-derived
neurotrophic factor; hBMP, human bone morphogenic protein; MTX, methotrexate;
IT, immunotoxin; HSV, herpes simplex virus; BCNU, carmustine.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">clinical
trial identifier</th>
<th align="center" colspan="1" rowspan="1">condition</th>
<th align="center" colspan="1" rowspan="1">intervention</th>
<th align="center" colspan="1" rowspan="1">phase</th>
<th align="center" colspan="1" rowspan="1">status</th>
</tr></thead>
<tbody>
<tr><td colspan="5" align="left" rowspan="1">Convection-Enhanced Delivery (CED)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00024570" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00024570</a></td>
<td align="left" colspan="1" rowspan="1">malignant glioma</td>
<td align="left" colspan="1" rowspan="1">IL13-PE38QQR</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00089427" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00089427</a></td>
<td align="left" colspan="1" rowspan="1">newly diagnosed malignant
glioma</td>
<td align="left" colspan="1" rowspan="1">IL13-PE38QQR</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00431561" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00431561</a></td>
<td align="left" colspan="1" rowspan="1">high-grade glioma</td>
<td align="left" colspan="1" rowspan="1">AP 12009</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01502917" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01502917</a></td>
<td align="left" colspan="1" rowspan="1">diffuse intrinsic pontine
glioma</td>
<td align="left" colspan="1" rowspan="1">124I-omburtamab</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01582516" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01582516</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">delta24-RGD</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01621581" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01621581</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">AAV2-GDNF</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01644955" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01644955</a></td>
<td align="left" colspan="1" rowspan="1">high-grade glial neoplasms</td>
<td align="left" colspan="1" rowspan="1">carboplatin</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02022644" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02022644</a></td>
<td align="left" colspan="1" rowspan="1">high-grade glioma</td>
<td align="left" colspan="1" rowspan="1">nanoliposomal irinotecan</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02278510" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02278510</a></td>
<td align="left" colspan="1" rowspan="1">high-grade glioma</td>
<td align="left" colspan="1" rowspan="1">topotecan</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02858895" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02858895</a></td>
<td align="left" colspan="1" rowspan="1">newly diagnosed glioblastoma
or recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">MDNA55</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02869243" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02869243</a></td>
<td align="left" colspan="1" rowspan="1">glioblastoma</td>
<td align="left" colspan="1" rowspan="1">hBMP4</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03043391" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03043391</a></td>
<td align="left" colspan="1" rowspan="1">pediatric malignant glioma</td>
<td align="left" colspan="1" rowspan="1">lerapolturev (oncolytic
recombinant polio virus vaccine)</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03086616" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03086616</a></td>
<td align="left" colspan="1" rowspan="1">diffuse intrinsic pontine
glioma</td>
<td align="left" colspan="1" rowspan="1">nanoliposomal
irinotecan</td>
<td align="left" colspan="1" rowspan="1">phase
I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03154996" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03154996</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">topotecan</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03566199" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03566199</a></td>
<td align="left" colspan="1" rowspan="1">diffuse intrinsic pontine
glioma</td>
<td align="left" colspan="1" rowspan="1">panobinostat</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03652363" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03652363</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">GDNF</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04160494" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04160494</a></td>
<td align="left" colspan="1" rowspan="1">malignant glioma</td>
<td align="left" colspan="1" rowspan="1">atezolizumab + D2C7-IT</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">active, not recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04264143" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04264143</a></td>
<td align="left" colspan="1" rowspan="1">diffuse midline gliomas</td>
<td align="left" colspan="1" rowspan="1">panobinostat</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04479241" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04479241</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">lerapolturev (oncolytic
recombinant polio virus vaccine)</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT05734560" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05734560</a></td>
<td align="left" colspan="1" rowspan="1">newly diagnosed glioblastoma</td>
<td align="left" colspan="1" rowspan="1">D2C7-IT + 2141-V11</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06126744" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06126744</a></td>
<td align="left" colspan="1" rowspan="1">High-grade glioma</td>
<td align="left" colspan="1" rowspan="1">MVR-C5252 (oncolytic HSV)</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06177964" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06177964</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">lerapolturev (oncolytic
recombinant polio virus vaccine)</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06455605" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06455605</a></td>
<td align="left" colspan="1" rowspan="1">resected recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">D2C7-IT + 2141-V11</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06468605" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06468605</a></td>
<td align="left" colspan="1" rowspan="1">high-grade glioma</td>
<td align="left" colspan="1" rowspan="1">JCXH-211</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">not yet recruiting</td>
</tr>
<tr><td colspan="5" align="left" rowspan="1">Implantable Polymeric Systems</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00003876" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00003876</a></td>
<td align="left" colspan="1" rowspan="1">malignant glioma</td>
<td align="left" colspan="1" rowspan="1">BCNU-polymer wafers</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00003878" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00003878</a></td>
<td align="left" colspan="1" rowspan="1">supratentorial brain metastases</td>
<td align="left" colspan="1" rowspan="1">BCNU-polymer wafers</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00479765" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00479765</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">paclitaxel-loaded thermos-responsive
gel</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">terminated (Funding issues)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00984438" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00984438</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">BCNU-polymer wafers</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT05083754" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05083754</a></td>
<td align="left" colspan="1" rowspan="1">newly diagnosed glioblastoma</td>
<td align="left" colspan="1" rowspan="1">BCNU-polymer wafers combined
with retifanlimab</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="sec2.2"><h3 class="pmc_sec_title">2.2. Implantable Polymer-Based Drug Delivery</h3>
<section id="sec2.2.1"><h4 class="pmc_sec_title">2.2.1. Overview</h4>
<p>Polymer-based local delivery
has emerged as a pivotal avenue for bypassing the BBB in the management
of GBM and other brain tumors. In fact, chemotherapeutics, particularly
carmustine (BCNU), became standard care in the 1990s.<em>
,
</em> However, their effectiveness is constrained by structural factors.
Specifically, BCNU has a low molecular weight that permits only partial
BBB crossing. Chemotherapeutic drugs in general are hindered by their
short serum half-life and severe systemic toxicities. To maintain a high therapeutic concentration, high level
doses of chemotherapeutics are needed; however, this high dosing increases
the risk of systemic toxicity and adverse events.</p>
<p>Polymer-based
local delivery offers several advantages in comparison to other delivery
methods. By enabling direct interstitial delivery of a chemotherapeutic
drug or drugs into the resection cavity, polymer-based delivery achieves
prolonged drug action with reduced systemic side effects. This controlled and sustained release of the
drugs from polymers, specifically polymeric wafers, achieves consistent
and effective drug concentrations, thus optimizing treatment outcomes.
</p></section><section id="sec2.2.2"><h4 class="pmc_sec_title">2.2.2. Nonbiodegradable and Biodegradable Polymers</h4>
<p>The first polymer that was used for locally controlled release
of drugs was ethylene vinyl acetate copolymer (EVAc), which utilized
first-order diffusion kinetics, releasing over 90% of the encapsulated
drug. EVAc’s diffusion percentage
was determined by molecular weight, charge, and solubility of the
drug loaded. However, a critical limitation of EVAc-based systems
is their nonbiodegradability. Therefore, an additional surgery for
polymer removal would be a necessity to remove the nondegraded remnants
from the brain parenchyma. Despite the
significant drawbacks, nonbiodegradable polymers have certain advantages,
such as extended stability to provide a sustained release. Polyethylene
glycol (PEG) (molecular weight &gt; 20,000) is another example of
a nonbiodegradable
polymer utilized in clinical trials for its conjugation with nanoparticles
to improve drug solubility. While there
are benefits observed when it comes to drug stability and release,
the long-term implantation of the polymer can provoke chronic inflammation,
since the polymer is recognized as a foreign body to the host tissue.
</p>
<p>To circumvent the need for additional
surgery, biodegradable polymers were developed. Two of the most widely
established biodegradable polymers are poly­(lactic-<em>co</em>-glycolic acid) (PLGA) and polyanhydrides. PLGA is a synthetic carrier
that is favored for its biocompatibility and biodegradability. The
monomeric components in PLGA, lactic acid and glycolic acid, naturally
metabolize in the body, achieving sustained drug delivery with minimal
systemic toxicity.<em>
,
</em> Owing to these properties, PLGA
gained vast popularity within the realm of localized biodegradable
delivery and remains one of the most versatile polymers used in biomaterial
design and development.<em>
−

</em>
</p>
<p>The second commonly used
polymer is a polyanhydride matrix poly­[1,3-bis­(carboxyphenoxy)­propane-<em>co</em>-sebacic acid] (PCPP:SA). PCPP polymers degrade through
a spontaneous reaction with water to form carboxylic acid and nontoxic
byproducts that are naturally eliminated. The hydrophobic anhydride
linkage in PCPP creates a stable backbone with biodegradability, a
greater half-life for the drugs, controlled delivery, and drug protection. The major advantage of biodegradable polymers
lies in their ability to degrade in situ, eliminating the need for
a second invasive procedure for removal. Additionally, the polymeric
matrix allows for controlled drug release and enhanced drug stability,
even after polymer degradation. Further, the degradation rate can
be tuned based on the polymer’s monomer component constitution
and concentration.
</p></section><section id="sec2.2.3"><h4 class="pmc_sec_title">2.2.3. Biodegradable BCNU-Loaded Polymers</h4>
<p>The development of PCPP:SA as a local platform for the delivery of
chemotherapeutics in treating brain tumors altered the manner in which
brain tumor therapy was approached. Gliadel is a PCPP:SA-based wafer
loaded with BCNU that has demonstrated significant efficacy in clinical
trials.<em>
−


</em> BCNU is embedded within a hydrophobic copolymer matrix, which facilitates
localized drug release in the resection cavity. While studies have
shown that the majority of BCNU is liberated from the wafer matrix
within the first week of polymer implantation, the effect of local chemotherapy is significant.<em>
,,
</em> BCNU wafers utilize surface erosion
for degradation, which degrades layer by layer for controlled diffusion.
For the treatment of brain tumor patients, local delivery through
wafers reduces systemic toxicities, which is notable in comparison
to systemic BCNU delivery.
</p>
<p>Clinical
trials (phases I and II) have confirmed the safety of Gliadel wafers.
The initial BCNU loading dose was determined to be 3.85%. These studies demonstrated a 50% increase in
the 6-month survival of patients receiving Gliadel compared to those
receiving placebo wafers. Subsequent
phase III trials further validated these findings. A 29% reduction
in mortality risk and a survival advantage at 2 and 3 years was documented,
further emphasizing the safety and efficacy of BCNU wafers.<em>
,
</em> Later, an increase in the BCNU loading dose within the polymer was
tested. The standard tolerated dose of BCNU for Gliadel was 3.85%;
however, higher doses (6.5, 10,14.5, or 20%) were tested without encountering
dose-limiting toxicities.<em>
,
</em>
</p>
<p>The combination
of BCNU-loaded polymers with TMZ, radiation, and
other treatment methods may enhance the overall survival. TMZ is an
orally administered alkylating agent, typically given daily over several
weeks. In this context, Brem et al. have
shown that loading TMZ into polyanhydride CPP:SA polymers allowed
for higher localized dose concentrations in the rodent brain, in contrast
to orally administered TMZ treatment. Over the past two decades, many retrospective and prospective trials
have evaluated the coupling of TMZ and BCNU polymers. Wait et al.
summarized the observations from 10 studies, concluding that the combination
of both modalities is safe and effective. Clinically, BCNU wafers
are implanted into the resection cavity postsurgery, followed by TMZ
and/or radiation beginning on day 4. This combination has been associated
with a 76% 1 year survival rate compared to the 59.2% survival rate
of BCNU-only treatment. These results suggest that the integration
of BCNU polymers with oral TMZ with/without radiotherapy may extend
survival by several months. Recently,
Champeaux-Depond analyzed a French national database of patients with
high-grade glioma who received Gliadel implantation following surgical
resection from 2008 to 2019. The median overall survival was 17.04
months, and a multivariable logistic regression model showed that
the concomitant use of Gliadel wafers with radiation and oral TMZ
was significantly associated with enhanced overall survival. The Japan Clinical Oncology Group Study (MACS
study) is currently conducting a randomized phase III trial assessing
the efficiency of combining maximal GBM resection with BCNU wafer
implantation, followed by TMZ chemoradiotherapy (3 weeks post-resection).
Preliminary data suggest that the expected 2-year survival rate for
resection + BCNU wafers + TMZ is 12% greater than resection + TMZ
alone.
</p></section><section id="sec2.2.4"><h4 class="pmc_sec_title">2.2.4. Other Implantable Polymer Formulations</h4>
<p>In addition to BCNU, the pCPP:SA copolymer was used to locally
deliver the hypoxia-inducible factor 1 (HIF1) inhibitor acriflavine
(ACF) in a 9L rat model. This delivery
of ACF showed a substantial improvement in overall survival of the
rats receiving this therapy as compared to untreated controls and
those receiving systemic ACF. Additionally, the implantation of ACF
wafers resulted in total tumor clearance in &gt;90% of the rats. Besides pCPP:SA, other polymeric formulations
have been used to synthesize implantable compressed wafers that can
achieve sustained drug delivery. For instance, the copolymer of fatty
acid dimer and sebacic acid (FAD:SA) that loads hydrophilic drugs
has also shown promising results in rodent models, though its efficiency
in human trials remains unexplored.<em>
,
</em>
</p>
<p>Polymeric
wafers are highly favored for versatility and efficiency in localized
delivery; however, an emerging technique of electrospinning polymers
into nanofibers offers advantages, such as a lower impact on intracranial
pressure and a high surface area to volume ratio. In vitro, these nanofibers induce high rates of cell apoptosis
in GBM compared to free drug delivery.<em>
−

</em> Additionally, the delivery
of BCNU using electrospun NanoMesh fibers has shown favorable release
kinetics and promising efficacy in a rat model of GBM. Hydrogels, which are another formulation mechanism,
consist of a three-dimensional hydrophilic polymer that can be generated
in situ to conform to accommodate the shape of the resection area
and achieve maximal contact along the boundaries of the cavity. For instance, the OncoGel formulation (hydrogel
of PLGA and PEG loaded with paclitaxel) was shown to provide a controlled
localized release of paclitaxel in 9L gliosarcoma rats, resulting
in tumor shrinkage and increased survival (clinical trials investigating local implantable biodegradable polymeric
systems are summarized in <a href="#tbl1" class="usa-link">Table 
</a>).</p></section></section></section><section id="sec3"><h2 class="pmc_sec_title">3. BBB-Penetrant Strategies</h2>
<section id="sec3.1"><h3 class="pmc_sec_title">3.1. Exosomes</h3>
<section id="sec3.1.1"><h4 class="pmc_sec_title">3.1.1. Overview</h4>
<p>Extracellular vesicles
(EVs) are nanomicroscale membrane-bound vesicles secreted by almost
all types of cells. EVs can carry biologically active cargo, including
lipids, proteins, and nucleic acids, and have been found to mediate
long-distance communication among various cell types. In the context
of drug delivery, EVs are comparable to liposomes, given that both
are phospholipid-based. However, EVs can be composed of a mixture
of lipids and surface proteins, some of which can facilitate tissue
targeting or mitigate nonspecific interactions. Two major subtype classifications of EVs exist: ectosomes
and exosomes. Given that exosomes have excellent drug-carrying capacity
and can accommodate hydrophilic and hydrophobic drugs, they will be
the focus of this section. In fact, exosomes offer numerous advantages
as a delivery strategy, owing to their biocompatibility, versatility,
and effective transport. Currently, exosomes are being investigated
in clinical trials for different uses, including depression (<a href="https://clinicaltrials.gov/ct2/show/NCT04202770" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04202770</a>)
and ischemic stroke (<a href="https://clinicaltrials.gov/ct2/show/NCT06138210" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06138210</a>). However, their clinical translation
as a drug delivery vehicle still faces multiple challenges related
to the scalability of production, maintaining consistency in characteristics,
maximizing drug loading capabilities, and ensuring their stability
and safety when delivered exogenously to patients.<em>
,
</em>
</p></section><section id="sec3.1.2"><h4 class="pmc_sec_title">3.1.2. Neurodegenerative Diseases</h4>
<p>Exosome-based
therapeutic applications have received considerable attention, given
their extended blood circulation half-life, BBB permeability, and
low toxicity and immunogenicity. Exosomes have shown promise in a
number of non-neoplastic and neoplastic brain pathologies (<a href="#fig1" class="usa-link">Figure 
</a>). In Alzheimer’s
disease (AD), exosomes have been utilized for delivering therapeutic
cargo to ameliorate cognitive deficits in murine models. Cui et al.
created brain-targeting exosomes derived from mesenchymal stem cells
by modifying the exosomes with the CNS-specific rabies viral glycoprotein
(RVG) peptide to enhance the efficacy and delivery of exosomes in
the brains of transgenic Alzheimer’s mice. Two other studies have successfully delivered exosome-encapsulated
natural compounds across the BBB to alleviate neurodegenerative phenotypes
in murine models.<em>
,
</em> Additionally, Perets et al. established
a neuroimaging method for longitudinally and quantitatively tracking
exosomes derived from mesenchymal stem cells based on gold nanoparticle
labeling agents and X-ray computed tomography. These studies found that the exosomes accumulated in neurodegenerative
and neurodevelopmental murine model brain regions for as long as 96
h, while they showed a diffuse distribution pattern and clearance
within 24 h in healthy controls. Additionally, the exosome accumulation
and homing mechanism appeared to be neuroinflammation-driven, as the
neuroinflammatory signals in diseased brains were correlated with
the exosome accumulation. Finally, these studies show that the exosomes
primarily accumulate within neuronal cells in the diseased regions
but not in glial cells.</p>
<figure class="fig xbox font-sm" id="fig1"><h5 class="obj_head">1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c525/12332615/11e2c8ab09c3/ao5c00364_0001.jpg" loading="lazy" id="gr1" height="662" width="625" alt="1"></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Engineered exosomes for CNS disease. Number
of studies generated
brain-targeting exosomes by engineering the surface of exosomes with
the CNS-specific rabies viral glycoprotein (RVG) peptide to improve
the efficacy and delivery of exosomes carrying microRNAs in the brains
of transgenic Alzheimer’s mice. In the context of brain tumors,
studies have engineered the surface of exomes with a variety of proteins
to better target brain tumor cells for the delivery of small interfering
RNAs (siRNAs) and superparamagnetic iron oxide nanoparticles (SPIONs).
Created with <a href="http://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">BioRender.com</a>.</p></figcaption></figure><p>In the context of Parkinson’s disease (PD),
exosomes have
been found to both facilitate and mitigate disease progression. Guo
et al. observed that microglia-derived exosomes treated with human
α-synuclein fibrils can induce protein aggregation in recipient
neurons. They found that the combination
of these exosomes with microglia-derived proinflammatory cytokines
augmented protein aggregation in neurons. When injected stereotactically
into the brain, these exosomes resulted in nigrostriatal degeneration
in a time-dependent manner, while irradiating microglia in these animals
significantly decreased the accumulation of α-synuclein. Finally,
they observed that CD11b+ exosomes from cerebrospinal fluid patients
with PD contained α-synuclein oligomers, which could induce α-synuclein
aggregation in neurons. Additionally, Jiang et al. observed that microRNA-137
found in serum exosomes plays a role in inducing oxidative stress
in neurons and that down-regulation of miR-137 derived from exosomes
lessens oxidative stress injury in murine models of PD. Two studies
have utilized the RVG peptide targeting approach mentioned above to
target and deliver exosomes containing vector-based therapies to reduce
neuropathological and behavioral deficits in mouse models of PD.<em>
,
</em> In other non-neoplastic brain pathologies, exosomes have been observed
to improve pathological processes in demyelinating disorder,<em>
,
</em> stroke, perimenopausal depression, and CNS tuberculosis.
</p></section><section id="sec3.1.3"><h4 class="pmc_sec_title">3.1.3. Brain Tumors</h4>
<p>Exosomes have recently
become a key player in neoplastic brain diseases and are being investigated
as therapeutic platforms in brain tumor therapy. These therapeutic
approaches center on engineering exosomes with highly decorated surfaces
to enhance their targeting and functional capabilities. In two papers,
Lee et al. engineered exosomes and nanovesicles with the T7 peptide
on the surface, which is the transferrin receptor binding peptide.<em>
,
</em> Given that GBM tumor cells are known to overexpress the transferrin
receptor, these studies found that T7 peptide-decorated exosomes were
more efficient at delivering cargo into the brain and inducing the
expression of tumor suppressor genes than unmodified or rabies viral
glycoprotein (RVG)-modified exosomes. Liu et al. used this same T7
peptide approach to deliver exosomes containing siRNA targeting the
YY1 protein to demonstrate that this therapy synergizes with chemotherapy
and radiation therapy to significantly improve survival time in GBM-bearing
mice. Wu and Li et al., similarly, modified
exosomes with angiopep-2 on their surface with the aim of altering
the protein corona such that these particles would have increased
targeting and uptake into GBM cells and show less absorption of serum
proteins and phagocytosis by macrophages. The angiopep-2 expressing exosomes showed enhanced BBB penetration
and targeting to GBM cells and augmented the delivery of docetaxel
to the tumor tissue. Additionally, the angiopep-2-modified exosomes
significantly attenuated tumor progression in an orthotopic GBM model.
Using a similar approach, Liang et al. conjugated angiopep-2 and CD133
aptamers onto the surface of exosomes loaded with Temozolomide. These dual-receptor-specific exosomes achieved
in vitro inhibition of U87MG human glioma and glioma stem cell proliferation
as well as extension of the median survival time of U87MG tumor-bearing
mice. Two studies have created platforms combining magnetic nanoparticles
with exosomes to improve the targeting of the exosomes as well as
enable imaging of the exosomes in vivo. Li et al. developed a composite
therapeutic platform, combining magnetic nanoparticle targeting and
drug delivery properties, with engineered exosome BBB penetration
and siRNA encapsulation abilities. They
demonstrated the effectiveness of ferroptosis therapy through the
breakdown of the ferroptosis defense axis with the aid of Fe3O4 nanoparticles,
which facilitated Fe<sup>2+</sup> release. Jia et al. developed neuropilin-1-targeted
peptide-targeted and superparamagnetic iron oxide nanoparticles (SPIONs)
loaded exosomes. In orthotopic GBM models,
these exosomes crossed the BBB and allowed for targeted imaging and
therapy. Rehman et al. decorated mesenchymal stem cell-derived exosomes
with heme oxygenase-1 (Hmox1) specific short peptide (HSSP) for specifically
targeting TMZ-resistant glioma cells. These targeted exosomes were loaded with STAT3-targeted siRNA and
were found to inhibit tumor cell proliferation, decrease the level
of MGMT expression in TMZ-resistant GBM cells, and synergize with
TMZ-loaded exosomes in vivo. Additionally, a few studies have utilized
exosomes to augment immune responses to brain tumors. One example
is that by Cui et al., who designed immune exosomes, which are serum
micelles decorated with CpG oligonucleotides and agonists of TLR9. These immune exosomes were then used to coat
the pure drug nanomicelles. These studies demonstrated that immune
exosome-coated micelles can bind transferrin, prolong blood circulation,
remain intact while crossing the BBB, and target GBM cells. These
particles induced apoptosis in GBM cells, stimulated dendritic cell
maturation, and polarized tumor-associated macrophages, generating
anti-GBM immune responses in the GBM microenvironment (Clinical trials investigating exosome-based delivery are
summarized in <a href="#tbl2" class="usa-link">Table 
</a>).</p>
<section class="tw xbox font-sm" id="tbl2"><h5 class="obj_head">2. Clinical Trials for BBB-Penetrant
Strategies (Source: clinicaltrials.gov)<sup></sup>
.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">clinical
trial identifier</th>
<th align="center" colspan="1" rowspan="1">condition</th>
<th align="center" colspan="1" rowspan="1">intervention</th>
<th align="center" colspan="1" rowspan="1">phase</th>
<th align="center" colspan="1" rowspan="1">status</th>
</tr></thead>
<tbody>
<tr><td colspan="5" align="left" rowspan="1">Exosomes</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04202770" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04202770</a></td>
<td align="left" colspan="1" rowspan="1">depression, anxiety, and
dementia</td>
<td align="left" colspan="1" rowspan="1">exosomes
derived from healthy,
full-term cesarean section amniotic fluid with focused ultrasound</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">suspended</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06138210" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06138210</a></td>
<td align="left" colspan="1" rowspan="1">acute ischemic stroke</td>
<td align="left" colspan="1" rowspan="1">GD-iExo-003 exosomes</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr><td colspan="5" align="left" rowspan="1">Vectors</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00087789" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00087789</a></td>
<td align="left" colspan="1" rowspan="1">Alzheimer’s
disease</td>
<td align="left" colspan="1" rowspan="1">CERE-110
vector</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00229736" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00229736</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">AAV-hAADC-2</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01621581" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01621581</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">AAV2-GDNF</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01973543" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01973543</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">VY-AADC-01</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01985256" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01985256</a></td>
<td align="left" colspan="1" rowspan="1">grade III or grade IV gliomas</td>
<td align="left" colspan="1" rowspan="1">Toca 511 vector</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02026271" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02026271</a></td>
<td align="left" colspan="1" rowspan="1">glioblastoma or malignant
glioma</td>
<td align="left" colspan="1" rowspan="1">Ad-RTS-hIL-12</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03065192" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03065192</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">VY-AADC-01</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03152318" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03152318</a></td>
<td align="left" colspan="1" rowspan="1">recurrent malignant glioma</td>
<td align="left" colspan="1" rowspan="1">rQNestin34.5v.2</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03634007" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03634007</a></td>
<td align="left" colspan="1" rowspan="1">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1">AAVrh.10hAPOE2</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT05040217" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05040217</a></td>
<td align="left" colspan="1" rowspan="1">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1">AAV2-BDNF</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06264388" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06264388</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma and
anaplastic astrocytoma</td>
<td align="left" colspan="1" rowspan="1">DB107-retroviral replicating
vector combined with DB107-flucytosine</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr><td colspan="5" align="left" rowspan="1">Nanoparticles</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02820454" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02820454</a></td>
<td align="left" colspan="1" rowspan="1">nrain metastases</td>
<td align="left" colspan="1" rowspan="1">AGuIX gadolinium-based nanoparticles</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03020017" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03020017</a></td>
<td align="left" colspan="1" rowspan="1">glioblastoma</td>
<td align="left" colspan="1" rowspan="1">NU-0129 nanoparticles</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03566199" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03566199</a></td>
<td align="left" colspan="1" rowspan="1">diffuse intrinsic pontine
glioma</td>
<td align="left" colspan="1" rowspan="1">MTX110 nanoparticle</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03818386" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03818386</a></td>
<td align="left" colspan="1" rowspan="1">brain metastases</td>
<td align="left" colspan="1" rowspan="1">AGuIX gadolinium-based nanoparticles</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">active, not recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04881032" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04881032</a></td>
<td align="left" colspan="1" rowspan="1">glioblastoma</td>
<td align="left" colspan="1" rowspan="1">AGuIX nanoparticles</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">active, not recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04899908" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04899908</a></td>
<td align="left" colspan="1" rowspan="1">brain metastases</td>
<td align="left" colspan="1" rowspan="1">AGuIX gadolinium-based nanoparticles</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t2fn1">
<sup>a</sup><p class="display-inline">IL, interleukin; AAV, adeno-associated
virus; BDNF, brain-derived neurotrophic factor; GDNF, glial cell line-derived
neurotrophic factor</p>
</div></div></section></section></section><section id="sec3.2"><h3 class="pmc_sec_title">3.2. Vectors</h3>
<section id="sec3.2.1"><h4 class="pmc_sec_title">3.2.1. Overview</h4>
<p>In its simplest form,
gene therapy revolves around the utilization of viral or nonviral
carriers to introduce genetic cargo into target cells with the aim
of preventing or curing diseases by altering certain genes of interest.</p></section><section id="sec3.2.2"><h4 class="pmc_sec_title">3.2.2. Viral Vectors</h4>
<p>In its simplest form,
gene therapy revolves around the utilization of viral or nonviral
carriers to introduce genetic cargo into target cells with the aim
of preventing or curing diseases by altering certain genes of interest.
While a number of gene editing technologies exist, some of the viral
vectors that have shown the greatest promise in preclinical and clinical
investigations are adeno-associated virus (AAV) vectors, recombinant
AAVs, short regulatory DNA sequences, and peptides.<em>
−


</em> AAV vectors are nonpathogenic
single-stranded DNA parvoviruses that can transduce cells via endocytosis
and trafficking into the nucleus, at which point the AAV genome is
converted to double-stranded DNA for transcription and translation.
Importantly, a very small portion of the AAV genome plays an essential
role in vector production and ensuring persistent cell transduction, leaving almost 96% of the AAV genome to be re-engineered
for gene therapy. A limitation of AAV vectors is their ability to
package a maximum of ∼5.0 kb of DNA. Additionally, while versatile
in gene editing capacity, high systemic doses are generally required
to achieve CNS transgene expression due to the BBB. A considerable
amount of the administered vector is taken up by other tissues, resulting
in varying degrees of adverse effects.</p>
<p>While it has been appreciated
that parental serotypes have differing abilities to cross the BBB,<em>
−

</em> only recently have some of the structural features that facilitate
the BBB penetration of AAVs been characterized. Albright et al. used
rational design and screening to identify key clusters of residues
on the AAVrh.10 capsid that augment its ability to cross the BBB and
achieve successful transduction of neurons in mice. This work identified a minimal footprint from AAVrh.10
for crossing the BBB, which, when grafted onto AAV1, generated a neurotropic,
liver-detargeted vector for global CNS gene transfer. More recently,
Huang et al. engineered peptide-modified AAV capsids that enhanced
brain transduction by introducing de novo interactions with LY6A and
LY6C1, proteins expressed on the BBB of mice. This work demonstrated
that directly targeting AAV capsids to defined cell surface proteins
expressed on the BBB can efficiently result in robust gene delivery
vectors with predictable in vivo tropisms. As was noted in the original
paper, these findings cannot be translated to primates, given that
these proteins do not have homologues in primates. To address this
challenge of the translation of BBB-penetrating-AAVs, Chuapoco et
al. describe AAV.CAP-Mac, an engineered AAV9 variant observed to have
improved efficiency for brain-wide transgene expression in multiple
nonhuman primate species. Using this
platform, they showed successful delivery of a cocktail for three
fluorescent reporters and GCaMP8s for the optical evaluation of ex
vivo neuronal activity. Another group attempted to address the translatability
of AAVs from murine models to humans by employing an in vitro model
of the human BBB consisting of human cerebral microvasculature endothelial
cells (hCMEC/D3) cocultured with primary astrocytes in a transwell
system. Using this model, Song et al.
isolated a catalog of capsids with enhanced BBB permeability and transduction
of hiPSC-derived cortical neurons and primary astrocytes.
</p></section><section id="sec3.2.3"><h4 class="pmc_sec_title">3.2.3. CNS Applications</h4>
<p>In addition to
understanding the mechanism of gene therapy, BBB permeability, and
tropism, preclinical studies have also highlighted the efficacy of
these therapeutic approaches in CNS pathologies, including AD, PD,
and brain tumors. Two recent studies have utilized vector conjugate
nanodelivery platforms for gene delivery to the CNS for AD. Israel
et al. conjugated 6 different peptide vectors, each with specificity
for different transcytosis receptors, to a 50 kDa poly­(β-l-malic
acid)-trileucine polymer, forming P/LLL(40%)/vector conjugate. They found that BBB permeability was significantly
increased using the vector conjugates of P/LLL(40%) due to the copolymer
group binding at the endothelial membrane and subsequently making
the sites needed for vector–receptor complex formation more
accessible. As an extension of this work and to design a platform
with cell-type specificity, Israel et al. conjugated a D-configured-peptide
vector for improved targeting and delivery of microRNA and antisense
RNA specifically to neurons or amyloid plaques compared to astrocytes
and other glia in a mouse model of AD. Finally, Marino et al. leveraged the BBB crossing properties of
AAVs to deliver a single domain antibody (VHHs), also known as nanobodies,
to inhibit BACE1, a well-characterized target in AD. This AAV-mediated approach of a VHH resulted in whole-brain,
persistent anti-BACE1 VHH (B9) production in an AD mouse model for
up to 12 months after administration. The resulting sustained VHH-B9
expression also resulted in greater than 12 months of positive effects
on cognitive function, neuroinflammation, amyloid load, and synaptic
function. In brain tumor research, but also employing a nanocomplex
approach, Neves et al. designed a cell-penetrating peptide, WRAP5,
with a transferrin sequence to contain plasmid DNA encoding tumor
suppressor p53. These complexes were
internalized by GBM cells and trafficked to the nucleus. In the same
work described above by Israel et al., they show that the P/LLL/A2
copolymer showed the highest penetrance into the tumor microenvironment
of the GL261 syngeneic GBM mouse model (clinical trials investigating vector-based delivery are summarized
in <a href="#tbl2" class="usa-link">Table 
</a>).</p></section></section><section id="sec3.3"><h3 class="pmc_sec_title">3.3. Nanoparticles</h3>
<section id="sec3.3.1"><h4 class="pmc_sec_title">3.3.1. Overview</h4>
<p>Nanoparticles, microscopic
entities with diameters ranging from 1 to 100 nm, have revolutionized
our approach to addressing the BBB and facilitated groundbreaking
innovations in drug delivery to the CNS. Various nanoparticles are explored, including Cu<sub>2–<em>x</em>
</sub>Se particles, gold nanoparticles, solid lipid nanoparticles,
PEGylated polyester nanoparticles, and albumin-bound nanoparticles.</p></section><section id="sec3.3.2"><h4 class="pmc_sec_title">3.3.2. Imaging and Therapeutics for BBB Exploration</h4>
<p>Recent technological advancements have made it feasible to develop
highly specialized nanoparticles such as ultrasmall Cu<sub>2–<em>x</em>
</sub>Se particles with a 3.0 nm diameter (<a href="#fig4" class="usa-link">Figure 
</a>). These have been pivotal
in advancing noninvasive imaging techniques. Photoacoustic imaging,
made possible through these nanoparticles, has given researchers unprecedented
visibility into the workings of the BBB. Zhang et al. combined focused ultrasound and Cu<sub>2–<em>x</em>
</sub>Se nanoparticles in murine models to produce high-resolution
images of nanoparticle distribution in deep-seated brain regions.
This advancement has profound implications for targeted drug delivery
and disease mapping. Additionally, a
key study by Ohta et al. explored the optimal size of gold nanoparticles
(AuNPs) for BBB penetration. Their work underscored the significance
of balancing nanoparticle size against effective excretion, concluding
that medium-sized AuNPs (15 nm) offered an optimal trade-off.
</p>
<figure class="fig xbox font-sm" id="fig4"><h5 class="obj_head">4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c525/12332615/8f1e13a9abaa/ao5c00364_0004.jpg" loading="lazy" id="gr4" height="560" width="555" alt="4"></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Three anatomic
regions of the nasal cavity are the vestibular,
respiratory, and olfactory regions. In humans, the respiratory region
comprises the majority of the cavity’s surface area. The main
pathways for trafficking biomolecules from the nose to the brain are
through the olfactory pathway (via the olfactory nerve) and the trigeminal
pathway (via V1 ophthalmic division and V2 maxillary division nerves).</p></figcaption></figure></section><section id="sec3.3.3"><h4 class="pmc_sec_title">3.3.3. Strategies to Augment BBB Permeability</h4>
<p>Li et al. applied a groundbreaking combination of AuNPs with transcranial
picosecond laser pulses, inducing temporary and reversible permeability
changes in the BBB. This resulted in
the successful delivery of bioactive substances, such as human IgG
antibodies and adeno-associated virus particles, into the CNS. Furthermore,
the picosecond laser-induced nanoscale pressure waves had the added
advantage of loosening tight junctions without damaging surrounding
cellular structures.
</p>
<p>Another noteworthy
study by Lilius et al. demonstrated the utility of intracisterna magna
administration to deliver medium-sized, 111In-radiolabeled AuNPs to
deep brain tissues. Their research found
that hypertonic saline coadministration dramatically elevated nanoparticle
uptake, enhancing the effectiveness of the delivery mechanism and
opening new doors for therapeutic intervention.
</p></section><section id="sec3.3.4"><h4 class="pmc_sec_title">3.3.4. Design and Biochemical Optimization</h4>
<p>While manipulating external conditions to aid in nanoparticle delivery
is invaluable, the intrinsic design of nanoparticles also offers a
plethora of opportunities for optimization. Wünsch et al. employed
lecithin-stabilized nanoparticles coated with ApoE. These particles exhibited an unprecedented ability to traverse
an in vitro BBB model of primary porcine brain capillary endothelial
cells via ApoE-mediated transcytosis. This approach essentially mimics
the body’s natural lipid trafficking mechanisms, thereby broadening
the scope of substances that could be effectively delivered to the
CNS. Rabanel et al. investigated how varying surface properties and
sizes of PEGylated polyester nanoparticles influence their uptake.
Interestingly, while these variations affected the endocytosis rates,
they had minimal influence on the particles’ ability to cross
the cell barrier. This counterintuitive finding suggested that other
intrinsic factors may be involved, indicating an avenue for further
exploration.
</p></section><section id="sec3.3.5"><h4 class="pmc_sec_title">3.3.5. Non-Neoplastic Diseases</h4>
<p>The versatility
of nanoparticles makes them highly applicable for treating a wide
range of neurological pathologies beyond neurodegenerative diseases.
For example, traumatic brain injury (TBI) and ALS represent feasible
targets. Bharadwaj et al. provided a nuanced understanding of how
varying types of TBI could affect BBB permeability differently, setting
the stage for more personalized therapeutic approaches. Moreover, Han et al. designed lipid-covered
nanoparticles that act as radical scavengers. These nanoparticles
were remarkably successful in reducing calcium influx and neuroinflammation
following TBI. However, as Violatto et
al. demonstrated, not all nanoparticles are equal in their effectiveness;
some failed to cross the BBB or release their pharmaceutical payloads,
emphasizing the critical need for more sophisticated drug-tethering
techniques.
</p></section><section id="sec3.3.6"><h4 class="pmc_sec_title">3.3.6. Neoplastic Diseases</h4>
<p>Nanoparticles
have emerged as a crucial tool in addressing the challenging treatment
landscape of CNS malignancies, which have historically been resistant
to conventional therapies due to the BBB. Liang et al. employed nanoparticles
covalently bonded to albumin, exploiting a protein secreted protein
acidic and rich in cysteine, or SPARC-dependent, uptake mechanism
to effectively bypass the BBB. Similarly,
Ha et al. used albumin nanoparticles in conjunction with ultrasound
to transiently penetrate the BBB in a U87MG orthotopic mouse model. Rizzuto et al. took a different approach, using
human apoferritin (HFn) as a nanovector for delivering monoclonal
antibodies (mAbs) through an in vitro BBB model. The cellular uptake of these HFn-mAb complexes by human
cerebral microvascular endothelial cells was confirmed, maintaining
the biological activity of the antibodies. Wu et al. explored the optimization of nanoparticles for BBB crossing
and glioma targeting, emphasizing the promise of dual ligand modifications
while acknowledging inherent challenges such as stability and toxicity. He et al. utilized solid lipid nanoparticles
(SLN) to encapsulate β-elemene, a traditional Chinese medicine
with antitumor properties but poor solubility and bioavailability. The SLN-encapsulated form not only inhibited
cell growth more effectively but also showed enhanced pharmacokinetic
properties compared with its traditional form. Finally, Gkountas et
al. highlighted the potential of magnetism in enhancing the number
of nanoparticles, particularly larger ones around 100 nm, that could
successfully bypass the BBB. Despite
the promise that magnetism provides due to its safety and efficacy
in driving brain permeation, there are some challenges that remain
to be tackled. The most important is the current inability to form
a localized magnetic field of acceptable intensity without the use
of highly invasive techniques.
</p></section><section id="sec3.3.7"><h4 class="pmc_sec_title">3.3.7. Current Challenges and Future Directions</h4>
<p>While the promise of nanoparticle-mediated drug delivery to the
CNS is clear, several challenges remain. Specificity in drug delivery
is a key concern; unintended interactions could compromise treatment
effectiveness or induce adverse effects. Additionally, issues related
to nanoparticle stability and the scalability of production methods
must be addressed. Complex pharmacokinetics further complicates the
picture, requiring a deeper understanding of systemic absorption,
metabolism, and excretion. Overcoming these challenges is crucial
for the successful translation of lab-based findings into viable clinical
treatments for neurological disorders (Clinical trials investigating
nanoparticle-based delivery are summarized in <a href="#tbl2" class="usa-link">Table 
</a>).</p></section></section></section><section id="sec4"><h2 class="pmc_sec_title">4. BBB-Disrupting Strategies</h2>
<section id="sec4.1"><h3 class="pmc_sec_title">4.1. Focused Ultrasound</h3>
<section id="sec4.1.1"><h4 class="pmc_sec_title">4.1.1. Overview</h4>
<p>Focused ultrasound (FUS)
relies on the use of a concave transducer or an array of transducers
that can effectively deliver targeted ultrasound waves to a determined
area. Therapeutic FUS has been investigated for many decades. In the 1950s, initial trials of therapeutic
FUS for treating psychiatric diseases, movement disorders, and brain
tumors were conducted.<em>
−

</em> At the present time, FUS has
been approved for the treatment of many diseases, including uterine
fibroids and lesions of the breast, prostate, and liver. Another major application that has attracted
considerable interest is the ability of low-intensity FUS to transiently
disrupt the BBB and allow the delivery of therapeutic agents or nucleic
acids for gene therapy. The mechanical
force carried by the FUS waves induces temporary alterations in tight
junctions, decreases P-glycoprotein, and increases caveolae formation.
Additionally, the coupling of FUS with intravascularly circulating
microbubbles promotes the cavitation of these microbubbles, which
in its turn augments the structural disruption of the BBB. Herein, we review recent FUS applications for
the purpose of BBB opening (<a href="#fig2" class="usa-link">Figure 
</a>).</p>
<figure class="fig xbox font-sm" id="fig2"><h5 class="obj_head">2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c525/12332615/8af97c88752c/ao5c00364_0002.jpg" loading="lazy" id="gr2" height="413" width="541" alt="2"></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Reprinted (adapted) with permission from {Zhang H, Wang
T, Qiu
W, et al. Monitoring the Opening and Recovery of the Blood-Brain Barrier
with Noninvasive Molecular Imaging by Biodegradable Ultrasmall Cu<sub>2–<em>x</em>
</sub>Se Nanoparticles. Nano Lett. 2018;18(8):4985–4992.
doi:10.1021/acs.nanolett.8b01818}. Copyright {2018} American Chemical
Society. PA, photoacoustic imaging; SPECT/CT, single-photonemission
computed tomograph; green circles represent 99 mTc-labeled and unlabeled
ultrasmall Cu<sub>2–<em>x</em>
</sub>Se nanoparticles;
and blue rectangles represent mice BBB layer.</p></figcaption></figure></section><section id="sec4.1.2"><h4 class="pmc_sec_title">4.1.2. Alzheimer’s Disease</h4>
<p>AD is
the most commonly encountered neurodegenerative disorder, with an
estimated prevalence of triple by 2050. Therefore, experimental and clinical research studies have investigated
various disease-modifying treatments and explored potential avenues
to facilitate their delivery, including the use of FUS.<em>
−










</em> In mouse models of AD, it was shown that FUS-assisted BBB opening
upregulated brain-derived neurotrophic factor (BDNF), EGR1, and acetylcholinesterase
in the hippocampus, which increased hippocampal neurogenesis and improved
spatial memory and cognition. Interestingly,
Kong et al. found that this improved cognition lasted up to 7 weeks. Continued intraneuronal inflammation-driven
stress and pro-apoptosis are some of the underlying pathogeneses that
have been targeted by some studies.<em>
,
</em> In a healthy
situation, nerve growth factor (NGF) augments nerve survival, growth,
and synaptic plasticity through the tropomyosin receptor kinase A
(TrkA) pathway. However, in AD (and hence the defective TrkA pathway),
endogenous NGF predominantly binds to the p75 neurotrophin receptor
(p75NTR), yielding neuronal inflammation and apoptosis. By using a
mouse model of AD, Xhima et al. showed that MRI-guided FUS-mediated
delivery of the selective TrkA agonist D3 (a peptidomimetic agonist
of TrkA) to the forebrain region augmented neurotrophin signaling
and cholinergic function. Utilizing
a similar model, Liu et al. investigated the FUS-assisted delivery
of quercetin-modified sulfur nanoparticles (Qc@SNPs). They showed that upon Qc@SNPs accumulation
in the brain parenchyma, it offsets endoplasmic reticulum stress,
optimizing calcium homeostasis and oxidative stress, hence ameliorating
neuronal inflammation and apoptosis. Furthermore, the Morris water
maze experiment has shown improved learning and memory abilities in
these mice. Using the 5XFAD model of AD in mice, Antoniou et al. demonstrated
the successful FUS-mediated delivery of an antibody against amyloid
β (i.e., the main component of amyloid plaque). However, the
efficacy of this method needs to be further investigated. In line with preclinical investigations, clinical
studies have also demonstrated the efficacy of FUS-mediated transient
BBB opening in patients with AD without cognitive disturbances or
other adverse events.<em>
−





</em> In addition, Park et al. and Rezai et al. have proven the ability
of FUS to reduce amyloid plaque burden,<em>
,
</em> though the possible subsequent effects on AD symptoms need to be
established by future studies.</p></section><section id="sec4.1.3"><h4 class="pmc_sec_title">4.1.3. Parkinson’s Disease</h4>
<p>PD is
the second most abundant neurodegenerative disease, involving about
3% of individuals older than 80. Medical therapy, ablative surgery,
and deep brain stimulation are conventional treatments. FUS-mediated interventions such as gene delivery,
BBB opening, and ablation have been under investigation.<em>
−






</em> The use of AAV.SIRT3-myc (recombinant AAV serotype overexpressing
myc-tagged Sirtuin 3) for the delivery of gene therapy was investigated
in a PD rat model and exhibited protective and regenerative abilities.
Trinh et al. used a similar model to investigate MRI-guided FUS-assisted
delivery of AAV.SIRT3-myc, following intravenous injection, to the
striatum and substania nigra (SN). Post-mortem
immunohistochemistry revealed SIRT3-myc expression in the striatum
and not in the SN, despite MRI-proven sufficient permeabilization. Given that gene expression in both the striatum
and the SN is required for optimal treatment, Aly et al. investigated
FUS-assisted intranasal delivery of plasmid DNA nanoparticles into
deep brain regions in a rodent model of PD. They showed that this technique yielded an 80 and 40% increase in
gene expression in the SN and dopaminergic neurons of the sonicated
hemisphere, respectively. Along with
preclinical research, clinical studies exhibited the safety, feasibility,
and reversibility of BBB opening in PD patients at the right parietal-occipital-temporal
junction, putamen, and striatum. These findings
were followed by a study by Meng et al., which evaluated MRI-guided
FUS-mediated delivery of intravenous recombinant lysosomal enzyme
glucocerebrosidase (GCase) in four patients with PD due to <em>GBA1</em> mutations. Apart from
two episodes of post-treatment transient dyskinesia, no other adverse
events occurred. At 6 months of follow-up, blinded Movement Disorder
Society-Unified Parkinson’s Disease Rating Scale motor scores
showed a 12% reduction relative to the baseline value in patients
off medication. Although these results
seem promising, future studies need to corroborate these findings
with a larger sample size and a longer follow-up.</p></section><section id="sec4.1.4"><h4 class="pmc_sec_title">4.1.4. Amyotrophic Lateral Sclerosis</h4>
<p>Amyotrophic
lateral sclerosis (ALS) is a rare neurodegenerative disease with a
poor prognosis, with a predicted 2–4 years of survival after
diagnosis. Current medications with moderate benefits include riluzole
and edaravone. To enhance edaravone delivery and using an ALS mouse
model, Shen et al. demonstrated that FUS-mediated edaravone delivery
to the motor cortex resulted in a more remarkable neuromuscular improvement
as compared to mice treated with edaravone only. As the next step, Abrahao et al. applied MRI-guided FUS
to the primary motor cortex of four patients with ALS. This study demonstrated the safety and efficacy
of the FUS-mediated transient BBB opening. Future investigations should
focus on the FUS-assisted delivery of disease-modifying therapeutics
in this patient population.</p></section><section id="sec4.1.5"><h4 class="pmc_sec_title">4.1.5. Malignant Glioma</h4>
<p>Researchers have
investigated FUS’s role in enhancing drug delivery through
the BBB in patients with glioma.<em>
−







</em> In this context, TMZ is an established chemotherapeutic agent for
grade IV glioma. Using a rat model of
GBM, Dong et al. applied FUS following Temozolomide therapy, and found
that the FUS group showed higher glial fibrillary acidic protein (GFAP)
and lower <em>K</em>
<sub>i</sub>-67 versus the control group,
indicating that FUS can augment Temozolomide delivery through the
BBB. Wei et al. investigated the efficacy
of the FUS-mediated delivery of Etoposide to a murine GBM model. In
comparison to the control group, the FUS-assisted treatment decreased
tumor growth by 45% and prolonged survival by 30%. Gambogic acid (GA) is a common chemotherapeutic agent,
although its pharmacodynamic characteristics limit its efficacy in
brain tumors. To increase its efficacy in brain tumors, Wang et al.
formulated GA-loaded poly lactic-<em>co</em>-glycolic acid
(PLGA) nanobubbles conjugated into a cationic microbubble complex
(CMC) (GA-PLGA-CMC). Using a murine
glioma model, they assessed FUS-triggered delivery of GA-PLGA-CMC,
in which the first FUS waves opened the BBB with the help of the CMC
and delivered GA-PLGA into the brain. The second FUS irradiation augmented
GA delivery into the brain tumor, yielding tumor growth inhibition. In a similar context, Panobinostat is a chemotherapeutic
medication that has shown promising in vitro findings against DIPG.
To enhance Panobinostat efficacy, Martinez et al. evaluated FUS-assisted
Panobinostat delivery in a mouse DIPG model. This strategy resulted in a 3-fold increase in intertumoral Panobinostat
concentration, 71% tumor volume reduction, and an increase in survival
of 10 days. In line with the preclinical
studies, clinical trials have been conducted to evaluate the safety
and feasibility of FUS-mediated BBB opening in patients with glioma.<em>
−


</em> In a phase 0 trial by Anastasiadis et al., four patients harboring
infiltrating glioma underwent transcranial FUS for targeted BBB opening. Although this study was limited by its small
sample size, it showed that this technique can be applied safely for
transient targeted BBB opening in glioma patients for the purpose
of drug delivery. Park et al. conducted
a phase 1 trial in which six GBM patients underwent MRI-guided FUS
adjacent to the resection margin on the day of adjuvant Temozolomide
chemotherapy, demonstrating transient BBB openings at the targets.
At the 15-month follow-up, the 1 year survival was 100%; two cases
sustained recurrence, and no FUS-related complication was found.<em>
,
</em> Sonabend et al. reported a phase 1 clinical trial in which 17 patients
with recurrent GBM underwent US device implantation for albumin-bound
paclitaxel delivery.<em>
−


</em> Imaging proved successful BBB opening at the targets, which subsided
over 1 h. The only complications associated with US-mediated BBB opening
were a transient mild headache. Paclitaxel-related complications included
self-resolving encephalopathy associated with the 260 mg/m<sup>2</sup> dose, neutropenia (47%), leukopenia (29%), and hypertension (29%). These studies open a new chapter and augment
the possibility of the application of previously BBB-impermeable therapeutic
agents<em>
−


</em> (clinical trials investigating FUS-mediated BBB opening to assist
delivery are summarized in <a href="#tbl3" class="usa-link">Table 
</a>).</p>
<section class="tw xbox font-sm" id="tbl3"><h5 class="obj_head">3. Clinical Trials for Focused Ultrasound-Mediated
Blood-Brain Barrier Opening to Enhance Therapeutic Delivery.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">clinical
trial identifier</th>
<th align="center" colspan="1" rowspan="1">condition</th>
<th align="center" colspan="1" rowspan="1">intervention</th>
<th align="center" colspan="1" rowspan="1">phase</th>
<th align="center" colspan="1" rowspan="1">status</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02986932" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02986932</a></td>
<td align="left" colspan="1" rowspan="1">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1">ExAblate Neuro system</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03322813" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03322813</a></td>
<td align="left" colspan="1" rowspan="1">infiltrating
glioma</td>
<td align="left" colspan="1" rowspan="1">ExAblate 4000
Type 2 system</td>
<td align="left" colspan="1" rowspan="1">phase
0</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03616860" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03616860</a></td>
<td align="left" colspan="1" rowspan="1">newly diagnosed gliobalstoma</td>
<td align="left" colspan="1" rowspan="1">ExAblate Neuro Model 4000
Type 2 (220 kHz) + Temozolomide</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03626896" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03626896</a></td>
<td align="left" colspan="1" rowspan="1">recurrent
glioblastoma</td>
<td align="left" colspan="1" rowspan="1">NaviFUS
system</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03671889" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03671889</a></td>
<td align="left" colspan="1" rowspan="1">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1">ExAblate Model 4000 Type
2.0 (220 kHz) system</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04417088" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04417088</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">Exablate Model 4000 Type
2 + carboplatin</td>
<td align="left" colspan="1" rowspan="1">phase
I/II</td>
<td align="left" colspan="1" rowspan="1">active, not
recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04440358" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04440358</a></td>
<td align="left" colspan="1" rowspan="1">recurrent
glioblastoma</td>
<td align="left" colspan="1" rowspan="1">Exablate
Model 4000 Type
2 + carboplatin</td>
<td align="left" colspan="1" rowspan="1">phase
I/II</td>
<td align="left" colspan="1" rowspan="1">active, not
recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04528680" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04528680</a></td>
<td align="left" colspan="1" rowspan="1">recurrent
glioblastoma</td>
<td align="left" colspan="1" rowspan="1">SonoCloud-9
+ albumin-bound
paclitaxel or carboplatin</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">active, not recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04804709" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04804709</a></td>
<td align="left" colspan="1" rowspan="1">diffuse midline glioma</td>
<td align="left" colspan="1" rowspan="1">FUS + oral panobinostat</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">active, not recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT05317858" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05317858</a></td>
<td align="left" colspan="1" rowspan="1">nonsmall cell lung carcinoma
brain metastases</td>
<td align="left" colspan="1" rowspan="1">Exablate
Model 4000 Type
2.0/2.1 + pembrolizumab</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT05630209" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05630209</a></td>
<td align="left" colspan="1" rowspan="1">diffuse intrinsic pontine
glioma</td>
<td align="left" colspan="1" rowspan="1">Exablate Model
4000 Type2.0/2.1
+ Doxorubicin</td>
<td align="left" colspan="1" rowspan="1">phase
I/II</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT05902169" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05902169</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">SonoCloud-9 + carboplatin</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06496971" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06496971</a></td>
<td align="left" colspan="1" rowspan="1">recurrent glioblastoma</td>
<td align="left" colspan="1" rowspan="1">NaviFUS + bevacizumab</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section></section><section id="sec5"><h2 class="pmc_sec_title">5. Intranasal Delivery</h2>
<section id="sec5.1"><h3 class="pmc_sec_title">5.1. Overview</h3>
<p>The nasal cavity offers
one of the most direct routes to access the CNS. Considering its unique
anatomy and CNS proximity, the transnasal delivery of compounds has
been studied since the late 1900s. Anatomically,
the cavity can be separated into three regions (<a href="#fig3" class="usa-link">Figure 
</a>): (1) a vestibular region with poor potential
for drug absorption, (2) a respiratory region with the largest surface
area in humans and extensive vascularization, and (3) an olfactory
region with the highest capacity for direct drug delivery. Across
these three sections, the trigeminal and olfactory cranial nerves
facilitate CNS access. The trigeminal
nerve predominates in the respiratory region, where molecular drug
trafficking occurs through the innervating sensory fibers of the nerve’s
ophthalmic (V1) and maxillary (V2) divisions. At the same time, the
olfactory nerve, present only in its designated region, allows for
CNS access along sensory neurons that project to the olfactory bulb.
Of the two, the olfactory system contributes most to CNS drug delivery.<em>
,
</em>
</p>
<figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332615_ao5c00364_0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c525/12332615/9246dc3e42bc/ao5c00364_0003.jpg" loading="lazy" id="gr3" height="403" width="639" alt="3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Summary
of microbubble-enhanced focused ultrasound (MB-FUS) blood-brain
barrier opening applications in the context of Alzheimer’s
disease, brain tumors, Parkinson’s disease, and amyotrophic
lateral sclerosis. Created with <a href="http://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">BioRender.com</a>.</p></figcaption></figure><p>The transnasal approach can be viewed as a local
and direct drug
delivery paradigm. With its anatomical proximity, it benefits from
local delivery and avoids systemic complications like non-CNS adverse
effects, preabsorption metabolism, hepatic first-pass metabolism,
and dilution from plasma protein binding.<em>
,
</em> Its direct access circumvents issues like poor CNS bioavailability
that plague systemic drug formulations and enables significantly lower
dosages, up to 0.01–1% of oral doses. Further, its ease of access makes patient self-administration a
possibility. To this point, minimally invasive nasal depot, or the
MIND technique, was recently described, where a common outpatient
procedure already employed by ear, nose, and throat surgeons to endoscopically
access the nasal cavity was repurposed to successfully deliver oligonucleotide
therapy to increase neurotrophic factors and counter neurodegenerative
processes.
</p>
<p>Despite these advantages of the transnasal approach,
the MIND technique
also illustrates continued challenges in designing transnasal therapeutics.
Though there has been extensive focus on this subject, with innumerable
therapies reported successfully in vitro and in vivo, the technique has largely failed in clinical
trials. Beyond the universal obstacles of drug discovery and therapeutic
design, the approach’s advantage with anatomical proximity
is also one of its greatest drawbacks. The olfactory epithelium, which
is the major conduit for transnasal delivery, makes up only 3–5%
of the human nasal cavity’s total surface area. Further, since nasopharyngeal mucus is constantly
moved into the GI tract by mucociliary action, compounds that reach
the olfactory epithelium only have ∼15–20 min of real
contact time before being swept away, in addition to degradation by
resident proteases and nucleases within the nasopharyngeal mucus. Though there are formidable challenges, efforts
in recent years have continued to substantiate the transnasal approach
as a promising means of CNS drug delivery.</p></section><section id="sec5.2"><h3 class="pmc_sec_title">5.2. Neurodegenerative Disease</h3>
<p>In neurodegeneration,
broad efforts have been reported on AD, PD, and Huntington’s
disease (HD) therapies. For transnasal approaches, nanomedicine-based
delivery systems have been gaining traction as a modular delivery
system. In brief, nanoparticles help
to counter physiological barriers by shielding compounds before they
reach the CNS or augment drug absorption through hydrophobic formulations.
A variety of acetylcholinesterase inhibitors (e.g., galantamine, donepezil,
rivastigmine) and other AD-targeting compounds have been successfully
trialed in nanoparticle formulations in crossing the BBB. Modifying
a nanoparticle coating to better bind both olfactory epithelium and
β-amyloid deposits has been recently reported as a transnasal
method for AD therapy. For HD, a modified
lipid-membrane nanoparticle was proposed as a theoretically ideal
transnasal therapy for administering engeletin, a compound that reduces
mitochondrial dysfunction and blocks deleterious NF-κB signaling.
In AD, a gel-based intranasal delivery system has been evaluated in
vitro and ex vivo for the model drug donepezil, confirming how increasing
the delivery system’s viscosity properties can improve CNS
penetration. Similarly, in PD, a thermosensitive
gel was optimized in mice to change states from liquid to solid in
situ to help maximize drug retention time and CNS delivery. Another paradigm shift in treating neurodegenerative
disorders such as AD and PD has been targeting calcium-permeable amyloid
pores rather than canonical amyloid aggregates. With this focus, an
antipore peptide, AmyP53, was recently developed and shown in animal
models to successfully traffic into the CNS after intranasal administration.
</p>
<p>Nasal delivery has been used for numerous
other CNS pathologies as well, where the common theme has been addressing
the limitations of a drug’s CNS bioavailability by formulating
it into a delivery vehicle, oftentimes utilizing nanomedicine, for
transnasal delivery. Though there have been extensive efforts in this
process, clinical trials are lacking for most. Most reports have focused
on packaging standard medicines for transnasal delivery. For instance,
organophosphate poisoning, which irreversibly binds to and disables
acetylcholinesterases, can be rescued in rat models treated with intranasal
quaternary ammonium antidotes contained in a modified liposomal delivery
system. The antifungal ketoconazole
was similarly trafficked into the CNS through an intranasal lipid
carrier system and reduced disease burden in mice with fungal CNS
infections. In a rat model of AIDS with
neurological complications, administering the anti-HIV dolutegravir
in a nanoemulsion gel intranasally could confine the medicine to the
CNS with minimal systemic levels. For
schizophrenia, the standard antipsychotic olanzapine was loaded in
micelle nanocarriers and given intranasally in an <em>in vivo</em> schizophrenia rat model to reduce symptoms. Oral tizanidine, a common medication for muscular spasms,
has poor CNS bioavailability and was formulated into nanosized “cubosomes”
for transnasal delivery into rats. Other
intranasal studies have trialed novel therapeutics. In epilepsy, the
psychostimulant citicoline has been loaded into niosomes, a form of
nanoparticle, for transnasal delivery and shown to diffuse successfully
in vitro and ex vivo. Finally, gene
editing through microRNA against neuroinflammation was shown in vivo
to improve deficits in mice with intracranial hemorrhage.
</p></section><section id="sec5.3"><h3 class="pmc_sec_title">5.3. Brain Tumors</h3>
<p>Finally, neurooncology
has seen an abundance of transnasal delivery applications. In recent
years, both chemotherapies and novel gene editing techniques have
been applied in transnasal approaches with preclinical success. In
vitro work for nanoemulsions of the chemotherapy lomustine, though
limited without in vivo or ex vivo data, showed increased release
kinetics for intranasal delivery compared to standard lomustine. Taking a step further, nanoparticle packaging
systems for combination chemotherapies of doxorubicin-erlotinib and
paclitaxel-miltefosine have reduced tumor volume and prolonged survival
in rodent GBM models.<em>
,
</em> Further, they have shown reduced
systemic side effects compared to traditional oral therapy, likely
by virtue of their local intranasal delivery. Similarly, a nanomicelle
shell system demonstrated analogous outcomes in delivering antiglioma
siRNA transnasally. Notably, one recent
study in a mouse model of GBM found evidence that photostimulation
of the lymphatic network significantly enhanced the liposomal delivery
into the CNS, highlighting the importance of the lymphatic system
in this route of delivery.
</p>
<p>Across
a variety of CNS pathologies, transnasal delivery continues to be
an area of great pharmaceutical interest. Its ability to bypass the
BBB while providing such a short direct route to the CNS remains a
key element to its therapeutic advantage. Despite the bevy of preclinical
data available on different medications for transnasal administration,
clinical trials are urgently needed to define which options are the
most clinically promising (Clinical trials investigating intranasal
delivery are summarized in <a href="#tbl4" class="usa-link">Table 
</a>).</p>
<section class="tw xbox font-sm" id="tbl4"><h4 class="obj_head">4. Clinical Trials Investigating Intranasal
Delivery to the Brain.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">clinical
trial identifier</th>
<th align="center" colspan="1" rowspan="1">condition</th>
<th align="center" colspan="1" rowspan="1">intervention</th>
<th align="center" colspan="1" rowspan="1">phase</th>
<th align="center" colspan="1" rowspan="1">status</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04091503" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04091503</a></td>
<td align="left" colspan="1" rowspan="1">glioblastoma</td>
<td align="left" colspan="1" rowspan="1">intranasal temozolomide</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06357377" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06357377</a></td>
<td align="left" colspan="1" rowspan="1">pediatric-type diffuse high-grade
gliomas</td>
<td align="left" colspan="1" rowspan="1">intranasal
NEO100</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">not yet recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02704858" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02704858</a></td>
<td align="left" colspan="1" rowspan="1">recurrent or progressive
grade III or grade IV gliomas</td>
<td align="left" colspan="1" rowspan="1">intranasal NEO100</td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
<td align="left" colspan="1" rowspan="1">recruiting</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02064166" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02064166</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">intranasal insulin</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01398748" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01398748</a></td>
<td align="left" colspan="1" rowspan="1">Parkinson's disease</td>
<td align="left" colspan="1" rowspan="1">intranasal glutathione</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00422981" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00422981</a></td>
<td align="left" colspan="1" rowspan="1">mild cognitive impairment</td>
<td align="left" colspan="1" rowspan="1">intranasal AL-108</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
<td align="left" colspan="1" rowspan="1">completed</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="sec6"><h2 class="pmc_sec_title">6. Receptor and Transporter-Mediated Delivery</h2>
<section id="sec6.1"><h3 class="pmc_sec_title">6.1. Overview</h3>
<p>Multiple receptor and transport
systems, which play critical roles in molecular trafficking, may be
utilized to facilitate drug delivery to the CNS (<a href="#fig5" class="usa-link">Figure 
</a>).<em>
,
</em>
</p>
<figure class="fig xbox font-sm" id="fig5"><h4 class="obj_head">5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c525/12332615/6229ff3ae9ae/ao5c00364_0005.jpg" loading="lazy" id="gr5" height="449" width="636" alt="5"></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Receptor
and transporter targets for enhancing drug delivery across
the blood-brain barrier. Created with <a href="http://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">BioRender.com</a>.</p></figcaption></figure></section><section id="sec6.2"><h3 class="pmc_sec_title">6.2. Caveolin-Mediated Transport</h3>
<p>Caveolin-mediated
transcytosis is known to play an important role in transporting large
macromolecule cargoes, such as albumin and lipoproteins, across the
BBB. Caveolins are scaffolding proteins
which are enriched in certain areas of the endothelial cell plasma
membrane and form membrane invaginations with high localized concentrations
of cholesterol, glycosphingolipids, and lipid-anchoring proteins.<em>
,
</em> Specifically, caveolin-1 is the primary caveolin protein expressed
by BBB endothelial cells. During CNS
pathologies in which BBB integrity is compromised, caveolin-1 expression
increases, suggesting that it plays a critical role in BBB permeability.<em>
,
</em> Additionally, an increase in caveolin-mediated transcytosis is believed
to be the physiological mechanism underlying BBB disruption via FUS.
</p></section><section id="sec6.3"><h3 class="pmc_sec_title">6.3. Claudin-5 Modulation</h3>
<p>Claudin-5 (Cldn5)
proteins are the primary constituents of endothelial cell tight junctions
(TJ), which strictly regulate paracellular movement across the BBB.
TJs, comprised of Cldn5, present a significant barrier to the delivery
of hydrophilic compounds and molecules over 400 Da. Thus, TJ modulators that target Cldn5 to increase BBB permeability
are being investigated for their ability to enhance drug delivery
to the brain. For example, enterotoxin’s (CPE) C-terminal claudin binding domain (cCPE)
can enhance paracellular flow of small solutes by removing specific
claudin subtypes from TJs in a tissue-specific manner.<em>
,
</em> Cldn5-binding cCPE-variants have demonstrated potential to safely
increase BBB permeability for drug delivery when applied to in vitro
models. In mouse models, M01 is a compound
that has been found to facilitate paclitaxel delivery via binding
to the extracellular domain of Cldn5. Additionally, Cldn5 modulation via anti-Cldn5 monoclonal antibody
has been found to increase BBB permeability in primates, but a safe
therapeutic window has yet to be established.
</p></section><section id="sec6.4"><h3 class="pmc_sec_title">6.4. Transferrin Receptor-Mediated Transport</h3>
<p>Transferrin receptors (TfR), which are expressed on BBB endothelial
cells as well as brain parenchymal cells, are critical for iron uptake
into the brain. TfR expression is unique
to the endothelial cells of the brain microvasculature, and TfRs are
not found on endothelial cells of the general vasculature. Iron ions complexed with transferrin protein
in the blood are understood to enter the brain via TfR-mediated endocytosis,
although detailed mechanisms of this transport mechanism have yet
to be fully elucidated. Immunofluorescence-based
transcellular transport studies have revealed that TfR conducts the
bidirectional transport of iron, indicating that drug delivery strategies
targeting this pathway must also account for flow in the brain-to-blood
direction. Fusion of anti-TfR monoclonal
antibodies to therapeutic peptides is a promising drug delivery system,
and optimal physiologically based pharmacokinetic modeling is under
current investigation.
</p>
<p>Development
of clinically effective AD treatments requires a simultaneous innovation
in drug delivery mechanisms. Importantly, AD is known to cause BBB
dysfunction and may impair the normal functioning of various receptors
and transport mechanisms. TfR-mediated
transport across endothelial cells remains intact in mouse models
of amyloid beta and tau-protein pathologies, suggesting this pathway
is a promising target for AD drug delivery. Specifically, transferrin-Pep63-liposomes have been demonstrated
to reduce amyloid beta plaque burden in AD mouse models. Synthesis of transporter proteins that may
be coadministered with therapeutic compounds is another avenue of
exploration. Previously, Sarkar et al. synthesized a transporter protein
modeled after the LDLR-binding domain of carrier protein apolipoprotein
E (ApoE) to increase antibody delivery to the brain in a mouse model. Zou et al. similarly synthesized an analogous
transporter protein, K16APoE, which ameliorated AD in a mouse model
when coadministered with the therapeutic HAYED peptide.
</p>
<p>Treatment of neoplastic disease is another
area in which enhanced
drug delivery strategies are urgently needed. TfR-targeting strategies
are currently being explored for their potential to enhance the effects
of drugs against brain neoplasms. Recently, Kang et al. employed docetaxel
liposomes, which were comodified with RI7217 monoclonal antibody against
TfR and muscone, a BBB permeabilizing compound, to treat glioma in
a mouse model. A separate study successfully
utilized 2D-HFn, a compound that binds TfR to traverse the BBB, to
enhance doxorubicin treatment of glioma in a mouse model. Caveolar transport mechanisms have also been
explored in the context of neoplastic disease, and methamphetamine
has been shown to temporarily permeabilize the BBB and enhance doxorubicin
delivery. Enhanced drug delivery strategies
via receptor and transporter-targeted mechanisms are needed to increase
the number of clinically effective treatments.</p></section></section><section id="sec7"><h2 class="pmc_sec_title">7. Conclusions and Future Directions</h2>
<p>In
this review, strategies to bypass or overcome the BBB were summarized
and analyzed. As it was noted, to maximize CED outcomes, numerous
catheter-related variables need to be optimized, and heterogeneous
tumor profiles need to be taken into consideration. As for implantable
biodegradable polymers, the advent of BCNU wafers constituted a great
milestone in this field; however, these wafers have their own set
of limitations. Hence, an investigation into more advanced formulations
that can carry multiple drugs, sustain a longer and more consistent
release, and achieve maximal contact with the resection cavity is
still needed. Exosomes, with their cargo-carrying capacity, can be
made highly tissue-specific via tissue engineering. In addition, exosomes
can be combined with other biomaterials or inorganic components such
as magnetic nanoparticles for improved targeting and tracking. Their
clinical translation will rely on evaluation in clinically relevant
systems and additional insights into the biology of exosomes that
mediate cell infiltration and immune evasion. Recent mechanistic insights
into the transport of AAVs have led to gene delivery systems that
feature more efficient crossing of the BBB and cell-type-specific
targeting within the CNS. Continued efforts toward understanding AAV
biology and the associated therapeutic challenges and successes will
serve as the foundation for future clinical translation of these CNS
delivery platforms. In parallel, translational research has demonstrated
the efficacy of FUS in drug delivery in different animal models and
disease contexts. Clinical studies have further supported the safety
of FUS-mediated BBB opening and amyloid plaque reduction in AD, and
the efficacy of FUS-assisted drug delivery in other neurodegenerative
diseases and brain tumors. However, limited sample sizes, the absence
of control groups, and short-term follow-up periods have limited the
ability of these findings to drive FDA approval. Future randomized
clinical trials are needed to build on and corroborate these promising
findings. Further, transnasal delivery continues to be an area of
pharmaceutical interest in many brain pathologies. The key element
in its therapeutic advantage is the proximity of the nasal cavity
to the brain. Additionally, coupling methods, such as FUS-assisted
intranasal delivery, may enhance outcomes. However, randomized controlled
trials are needed to optimize these strategies and establish their
safety, feasibility, and efficacy. Another field that has attracted
significant interest is nanomedicine and its various applications
in drug delivery. Importantly, the nanoparticle size is a crucial
factor that dictates effective BBB penetration and excretion. Additionally,
various alterations and combinations applied to nanoparticles have
been investigated to augment their capability. Indeed, there is a
need to enhance the specificity of nanoparticles for targeted drug
delivery. Moreover, there is also a lack of deep understanding regarding
the complex pharmacokinetics involved in the systemic absorption,
metabolism, and excretion of nanoparticles. Finally, the proper functioning
of multiple receptors and transporter pathways is essential to the
BBB's integrity. Strategies targeting these pathways are being
investigated
for their ability to enhance drug delivery across the BBB. Effective
methods that augment the delivery of drugs through these pathways
are critical to the clinical application and success of treatments
for neurodegenerative diseases and brain tumors.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The Table of Contents graphic and <a href="#fig1" class="usa-link">Figures 
</a>, , and  were created using <a href="http://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">BioRender.com</a>.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Glossary</h2>
<h3>Abbreviations</h3>
<dl class="def-list" id="dl1">
<dt>AAV</dt>
<dd><p>adeno-associated
virus</p></dd>
<dt>ACF</dt>
<dd><p>acriflavine</p></dd>
<dt>AD</dt>
<dd><p>Alzheimer’s
disease</p></dd>
<dt>ALS</dt>
<dd><p>amyotrophic
lateral
sclerosis</p></dd>
<dt>BBB</dt>
<dd><p>blood-brain
barrier</p></dd>
<dt>BCNU</dt>
<dd><p>carmustine</p></dd>
<dt>BDNF</dt>
<dd><p>brain-derived
neurotrophic factor</p></dd>
<dt>CED</dt>
<dd><p>convection-enhanced delivery</p></dd>
<dt>CNS</dt>
<dd><p>central nervous system</p></dd>
<dt>Cldn5</dt>
<dd><p>claudin-5</p></dd>
<dt>DIPG</dt>
<dd><p>diffuse intrinsic pontine glioma</p></dd>
<dt>EV</dt>
<dd><p>extracellular vesicles</p></dd>
<dt>EVAc</dt>
<dd><p>ethylene vinyl
acetate copolymer</p></dd>
<dt>FAD</dt>
<dd><p>fatty acid dimer</p></dd>
<dt>FUS</dt>
<dd><p>focused ultrasound</p></dd>
<dt>GBM</dt>
<dd><p>glioblastoma</p></dd>
<dt>GDNF</dt>
<dd><p>glial cell line-derived neurotrophic</p></dd>
<dt>HD</dt>
<dd><p>Huntington’s disease</p></dd>
<dt>HIF</dt>
<dd><p>hypoxia-inducible factor</p></dd>
<dt>hrBMP4</dt>
<dd><p>human recombinant
bone morphogenic protein 4</p></dd>
<dt>HSV</dt>
<dd><p>herpes simplex virus</p></dd>
<dt>IL</dt>
<dd><p>interleukin</p></dd>
<dt>MTX</dt>
<dd><p>methotrexate</p></dd>
<dt>NP</dt>
<dd><p>nanoparticle</p></dd>
<dt>PCPP:SA</dt>
<dd><p>poly­[1,3-bis­(carboxyphenoxy)­propane-<em>co</em>-sebacic acid]</p></dd>
<dt>PD</dt>
<dd><p>Parkinson's
disease</p></dd>
<dt>PEG</dt>
<dd><p>polyethylene
glycol</p></dd>
<dt>PLGA</dt>
<dd><p>poly­(lactic-<em>co</em>-glycolic acid)</p></dd>
<dt>RVG</dt>
<dd><p>rabies viral glycoprotein</p></dd>
<dt>SN</dt>
<dd><p>substania nigra</p></dd>
<dt>SLN</dt>
<dd><p>solid lipid nanoparticles</p></dd>
<dt>TBI</dt>
<dd><p>traumatic brain injury</p></dd>
<dt>TfR</dt>
<dd><p>transferrin receptors</p></dd>
<dt>TMZ</dt>
<dd><p>temozolomide</p></dd>
</dl></section><section id="notes1"><p>The manuscript
was written through contributions of all authors. All authors have
given approval to the final version of the manuscript.</p></section><section id="notes2"><p>This project
was generously funded by The Khatib Foundation and The Florence D.
and Irving J. Sherman MD Charitable Foundation Trust.</p></section><section id="notes3"><p>The authors
declare the following competing financial interest(s): Betty Tyler
has research funding from NIH. Ashvattha Therapeutics Inc* has licensed
one of her patents and she is a stockholder for Peabody Pharmaceuticals*
(*includes equity or options).</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="ref1">
<cite>Arvanitis C. D., Ferraro G. B., Jain R. K.. The Blood-Brain Barrier and Blood-Tumour
Barrier in Brain Tumours and Metastases. Nat.
Rev. Cancer. 2020;20(1):26–41. doi: 10.1038/s41568-019-0205-x.</cite> [<a href="https://doi.org/10.1038/s41568-019-0205-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8246629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31601988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=The%20Blood-Brain%20Barrier%20and%20Blood-Tumour%20Barrier%20in%20Brain%20Tumours%20and%20Metastases&amp;author=C.%20D.%20Arvanitis&amp;author=G.%20B.%20Ferraro&amp;author=R.%20K.%20Jain&amp;volume=20&amp;issue=1&amp;publication_year=2020&amp;pages=26-41&amp;pmid=31601988&amp;doi=10.1038/s41568-019-0205-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref2">
<cite>Pardridge W. M.. Drug Transport
across the Blood-Brain Barrier. J. Cereb Blood
Flow Metab. 2012;32(11):1959–1972. doi: 10.1038/jcbfm.2012.126.</cite> [<a href="https://doi.org/10.1038/jcbfm.2012.126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3494002/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22929442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cereb%20Blood%20Flow%20Metab&amp;title=Drug%20Transport%20across%20the%20Blood-Brain%20Barrier&amp;author=W.%20M.%20Pardridge&amp;volume=32&amp;issue=11&amp;publication_year=2012&amp;pages=1959-1972&amp;pmid=22929442&amp;doi=10.1038/jcbfm.2012.126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref3">
<cite>Burgess A., Hynynen K.. Drug Delivery across the Blood-Brain Barrier Using
Focused Ultrasound. Expert Opin Drug Deliv. 2014;11(5):711–721. doi: 10.1517/17425247.2014.897693.</cite> [<a href="https://doi.org/10.1517/17425247.2014.897693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4388327/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24650132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Drug%20Deliv&amp;title=Drug%20Delivery%20across%20the%20Blood-Brain%20Barrier%20Using%20Focused%20Ultrasound&amp;author=A.%20Burgess&amp;author=K.%20Hynynen&amp;volume=11&amp;issue=5&amp;publication_year=2014&amp;pages=711-721&amp;pmid=24650132&amp;doi=10.1517/17425247.2014.897693&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref4">
<cite>D’Amico R. S., Aghi M. K., Vogelbaum M. A., Bruce J. N.. Convection-Enhanced
Drug Delivery for Glioblastoma: A Review. J.
Neurooncol. 2021;151(3):415–427. doi: 10.1007/s11060-020-03408-9.</cite> [<a href="https://doi.org/10.1007/s11060-020-03408-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8034832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33611708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurooncol&amp;title=Convection-Enhanced%20Drug%20Delivery%20for%20Glioblastoma:%20A%20Review&amp;author=R.%20S.%20D%E2%80%99Amico&amp;author=M.%20K.%20Aghi&amp;author=M.%20A.%20Vogelbaum&amp;author=J.%20N.%20Bruce&amp;volume=151&amp;issue=3&amp;publication_year=2021&amp;pages=415-427&amp;pmid=33611708&amp;doi=10.1007/s11060-020-03408-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref5">
<cite>Porath K. A., Regan M. S., Griffith J. I., Jain S., Stopka S. A., Burgenske D. M., Bakken K. K., Carlson B. L., Decker P. A., Vaubel R. A., Dragojevic S., Mladek A. C., Connors M. A., Hu Z., He L., Kitange G. J., Gupta S. K., Feldsien T. M., Lefebvre D. R., Agar N. Y. R., Eckel-Passow J. E., Reilly E. B., Elmquist W. F., Sarkaria J. N.. Convection Enhanced
Delivery of EGFR Targeting Antibody-Drug Conjugates Serclutamab Talirine
and Depatux-M in Glioblastoma Patient-Derived Xenografts. Neurooncol Adv. 2022;4(1):vdac130. doi: 10.1093/noajnl/vdac130.</cite> [<a href="https://doi.org/10.1093/noajnl/vdac130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9446689/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36071925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurooncol%20Adv.&amp;title=Convection%20Enhanced%20Delivery%20of%20EGFR%20Targeting%20Antibody-Drug%20Conjugates%20Serclutamab%20Talirine%20and%20Depatux-M%20in%20Glioblastoma%20Patient-Derived%20Xenografts&amp;author=K.%20A.%20Porath&amp;author=M.%20S.%20Regan&amp;author=J.%20I.%20Griffith&amp;author=S.%20Jain&amp;author=S.%20A.%20Stopka&amp;volume=4&amp;issue=1&amp;publication_year=2022&amp;pages=vdac130&amp;pmid=36071925&amp;doi=10.1093/noajnl/vdac130&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref6">
<cite>Mehta J. N., Morales B. E., Hsu F.-C., Rossmeisl J. H., Rylander C. G.. Constant Pressure Convection-Enhanced Delivery Increases
Volume Dispersed With Catheter Movement in Agarose. J. Biomech Eng. 2022;144(11):111003. doi: 10.1115/1.4054729.</cite> [<a href="https://doi.org/10.1115/1.4054729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9254693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35656789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomech%20Eng.&amp;title=Constant%20Pressure%20Convection-Enhanced%20Delivery%20Increases%20Volume%20Dispersed%20With%20Catheter%20Movement%20in%20Agarose&amp;author=J.%20N.%20Mehta&amp;author=B.%20E.%20Morales&amp;author=F.-C.%20Hsu&amp;author=J.%20H.%20Rossmeisl&amp;author=C.%20G.%20Rylander&amp;volume=144&amp;issue=11&amp;publication_year=2022&amp;pages=111003&amp;pmid=35656789&amp;doi=10.1115/1.4054729&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref7">
<cite>O’Leary C., Forte G., Mitchell N. L., Youshani A. S., Dyer A., Wellby M. P., Russell K. N., Murray S. J., Jolinon N., Jones S. A., Stacey K., Davis D. M., Henckaerts E., Palmer D. N., Kamaly-Asl I., Bigger B. W.. Intraparenchymal
Convection Enhanced Delivery of AAV in Sheep to Treat Mucopolysaccharidosis
IIIC. J. Transl Med. 2023;21(1):437. doi: 10.1186/s12967-023-04208-1.</cite> [<a href="https://doi.org/10.1186/s12967-023-04208-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10320977/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37407981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Transl%20Med.&amp;title=Intraparenchymal%20Convection%20Enhanced%20Delivery%20of%20AAV%20in%20Sheep%20to%20Treat%20Mucopolysaccharidosis%20IIIC&amp;author=C.%20O%E2%80%99Leary&amp;author=G.%20Forte&amp;author=N.%20L.%20Mitchell&amp;author=A.%20S.%20Youshani&amp;author=A.%20Dyer&amp;volume=21&amp;issue=1&amp;publication_year=2023&amp;pages=437&amp;pmid=37407981&amp;doi=10.1186/s12967-023-04208-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref8">
<cite>Bhandari A., Jaiswal K., Singh A., Zhan W.. Convection-Enhanced
Delivery of Antiangiogenic Drugs and Liposomal Cytotoxic Drugs to
Heterogeneous Brain Tumor for Combination Therapy. Cancers. 2022;14(17):4177. doi: 10.3390/cancers14174177.</cite> [<a href="https://doi.org/10.3390/cancers14174177" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9454524/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36077714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Convection-Enhanced%20Delivery%20of%20Antiangiogenic%20Drugs%20and%20Liposomal%20Cytotoxic%20Drugs%20to%20Heterogeneous%20Brain%20Tumor%20for%20Combination%20Therapy&amp;author=A.%20Bhandari&amp;author=K.%20Jaiswal&amp;author=A.%20Singh&amp;author=W.%20Zhan&amp;volume=14&amp;issue=17&amp;publication_year=2022&amp;pages=4177&amp;pmid=36077714&amp;doi=10.3390/cancers14174177&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref9">
<cite>Souweidane M. M., Kramer K., Pandit-Taskar N., Zhou Z., Haque S., Zanzonico P., Carrasquillo J. A., Lyashchenko S. K., Thakur S. B., Donzelli M., Turner R. S., Lewis J. S., Cheung N.-K. V, Larson S. M., Dunkel I. J.. Convection-Enhanced
Delivery for Diffuse Intrinsic Pontine Glioma: A Single-Centre, Dose-Escalation,
Phase 1 Trial. Lancet Oncol. 2018;19(8):1040–1050. doi: 10.1016/S1470-2045(18)30322-X.</cite> [<a href="https://doi.org/10.1016/S1470-2045(18)30322-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6692905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29914796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Convection-Enhanced%20Delivery%20for%20Diffuse%20Intrinsic%20Pontine%20Glioma:%20A%20Single-Centre,%20Dose-Escalation,%20Phase%201%20Trial&amp;author=M.%20M.%20Souweidane&amp;author=K.%20Kramer&amp;author=N.%20Pandit-Taskar&amp;author=Z.%20Zhou&amp;author=S.%20Haque&amp;volume=19&amp;issue=8&amp;publication_year=2018&amp;pages=1040-1050&amp;pmid=29914796&amp;doi=10.1016/S1470-2045(18)30322-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref10">
<cite>Stupp R., Mason W. P., van den
Bent M. J., Weller M., Fisher B., Taphoorn M. J. B., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O.. Radiotherapy plus Concomitant and
Adjuvant Temozolomide for Glioblastoma. N Engl
J. Med. 2005;352(10):987–996. doi: 10.1056/NEJMoa043330.</cite> [<a href="https://doi.org/10.1056/NEJMoa043330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15758009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J.%20Med.&amp;title=Radiotherapy%20plus%20Concomitant%20and%20Adjuvant%20Temozolomide%20for%20Glioblastoma&amp;author=R.%20Stupp&amp;author=W.%20P.%20Mason&amp;author=M.%20J.%20van%20den%20Bent&amp;author=M.%20Weller&amp;author=B.%20Fisher&amp;volume=352&amp;issue=10&amp;publication_year=2005&amp;pages=987-996&amp;pmid=15758009&amp;doi=10.1056/NEJMoa043330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref11">
<cite>van
Putten E. H. P., Kleijn A., van Beusechem V. W., Noske D., Lamers C. H. J., de Goede A. L., Idema S., Hoefnagel D., Kloezeman J. J., Fueyo J., Lang F. F., Teunissen C. E., Vernhout R. M., Bakker C., Gerritsen W., Curiel D. T., Vulto A., Lamfers M. L. M., Dirven C. M. F.. Convection
Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients
with Recurrent GBM: A Phase I Clinical Trial Including Correlative
Studies. Clin. Cancer Res. 2022;28(8):1572–1585. doi: 10.1158/1078-0432.CCR-21-3324.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-21-3324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9365362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35176144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=Convection%20Enhanced%20Delivery%20of%20the%20Oncolytic%20Adenovirus%20Delta24-RGD%20in%20Patients%20with%20Recurrent%20GBM:%20A%20Phase%20I%20Clinical%20Trial%20Including%20Correlative%20Studies&amp;author=E.%20H.%20P.%20van%20Putten&amp;author=A.%20Kleijn&amp;author=V.%20W.%20van%20Beusechem&amp;author=D.%20Noske&amp;author=C.%20H.%20J.%20Lamers&amp;volume=28&amp;issue=8&amp;publication_year=2022&amp;pages=1572-1585&amp;pmid=35176144&amp;doi=10.1158/1078-0432.CCR-21-3324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref12">
<cite>Spinazzi E. F., Argenziano M. G., Upadhyayula P. S., Banu M. A., Neira J. A., Higgins D. M. O., Wu P. B., Pereira B., Mahajan A., Humala N., Al-Dalahmah O., Zhao W., Save A. V., Gill B. J. A., Boyett D. M., Marie T., Furnari J. L., Sudhakar T. D., Stopka S. A., Regan M. S., Catania V., Good L., Zacharoulis S., Behl M., Petridis P., Jambawalikar S., Mintz A., Lignelli A., Agar N. Y. R., Sims P. A., Welch M. R., Lassman A. B., Iwamoto F. M., D’Amico R. S., Grinband J., Canoll P., Bruce J. N.. Chronic
Convection-Enhanced Delivery of Topotecan for Patients with Recurrent
Glioblastoma: A First-in-Patient, Single-Centre, Single-Arm, Phase
1b Trial. Lancet Oncol. 2022;23(11):1409–1418. doi: 10.1016/S1470-2045(22)00599-X.</cite> [<a href="https://doi.org/10.1016/S1470-2045(22)00599-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9641975/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36243020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Chronic%20Convection-Enhanced%20Delivery%20of%20Topotecan%20for%20Patients%20with%20Recurrent%20Glioblastoma:%20A%20First-in-Patient,%20Single-Centre,%20Single-Arm,%20Phase%201b%20Trial&amp;author=E.%20F.%20Spinazzi&amp;author=M.%20G.%20Argenziano&amp;author=P.%20S.%20Upadhyayula&amp;author=M.%20A.%20Banu&amp;author=J.%20A.%20Neira&amp;volume=23&amp;issue=11&amp;publication_year=2022&amp;pages=1409-1418&amp;pmid=36243020&amp;doi=10.1016/S1470-2045(22)00599-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref13">
<cite>Bos E. M., Binda E., Verploegh I. S. C., Wembacher E., Hoefnagel D., Balvers R. K., Korporaal A. L., Conidi A., Warnert E. A. H., Trivieri N., Visioli A., Zaccarini P., Caiola L., van Wijck R., van der Spek P., Huylebroeck D., Leenstra S., Lamfers M. L. M., Ram Z., Westphal M., Noske D., Legnani F., DiMeco F., Vescovi A. L., Dirven C. M. F.. Local Delivery
of HrBMP4 as an Anticancer Therapy in Patients with Recurrent Glioblastoma:
A First-in-Human Phase 1 Dose Escalation Trial. Mol. Cancer. 2023:129. doi: 10.1186/s12943-023-01835-6.</cite> [<a href="https://doi.org/10.1186/s12943-023-01835-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10413694/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37563568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cancer&amp;title=Local%20Delivery%20of%20HrBMP4%20as%20an%20Anticancer%20Therapy%20in%20Patients%20with%20Recurrent%20Glioblastoma:%20A%20First-in-Human%20Phase%201%20Dose%20Escalation%20Trial&amp;author=E.%20M.%20Bos&amp;author=E.%20Binda&amp;author=I.%20S.%20C.%20Verploegh&amp;author=E.%20Wembacher&amp;author=D.%20Hoefnagel&amp;publication_year=2023&amp;pages=129&amp;pmid=37563568&amp;doi=10.1186/s12943-023-01835-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref14">
<cite>Woodworth G. F., Dunn G. P., Nance E. A., Hanes J., Brem H.. Emerging Insights
into Barriers to Effective Brain Tumor Therapeutics. Front Oncol. 2014;4:126. doi: 10.3389/fonc.2014.00126.</cite> [<a href="https://doi.org/10.3389/fonc.2014.00126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4104487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25101239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Emerging%20Insights%20into%20Barriers%20to%20Effective%20Brain%20Tumor%20Therapeutics&amp;author=G.%20F.%20Woodworth&amp;author=G.%20P.%20Dunn&amp;author=E.%20A.%20Nance&amp;author=J.%20Hanes&amp;author=H.%20Brem&amp;volume=4&amp;publication_year=2014&amp;pages=126&amp;pmid=25101239&amp;doi=10.3389/fonc.2014.00126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref15">
<cite>Group
GM. Chemotherapy in Adult
High-Grade Glioma: A Systematic Review and Meta-Analysis of Individual
Patient Data from 12 Randomised Trials. Lancet. 2002;359(9311):1011–1018. doi: 10.1016/S0140-6736(02)08091-1.</cite> [<a href="https://doi.org/10.1016/S0140-6736(02)08091-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11937180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Chemotherapy%20in%20Adult%20High-Grade%20Glioma:%20A%20Systematic%20Review%20and%20Meta-Analysis%20of%20Individual%20Patient%20Data%20from%2012%20Randomised%20Trials&amp;volume=359&amp;issue=9311&amp;publication_year=2002&amp;pages=1011-1018&amp;pmid=11937180&amp;doi=10.1016/S0140-6736(02)08091-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref16">
<cite>

Gorelick, N.
; 
Jackson, E.
; 
Tyler, B.
; 
Brem, H.
. 
Chapter
11 - Interstitial Chemotherapy
and Polymer Drug Delivery. In Handbook of
Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
(Second ed.); 
Newton, H. B.
, Ed.; Academic Press, 2018; pp 155–165. 10.1016/B978-0-12-812100-9.00011-5.</cite> [<a href="https://doi.org/10.1016/B978-0-12-812100-9.00011-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Handbook%20of%20Brain%20Tumor%20Chemotherapy,%20Molecular%20Therapeutics,%20and%20Immunotherapy%20(Second%20ed.)&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref17">
<cite>

Domb, A. J.
; 
Khan, W.
. 
Focal Controlled Drug
Delivery
<em>/ Edited by</em>

Abraham J., Domb
; 
Wahid, Khan
, 1st 2014.; Springer US: New York, NY, 2014. 10.1007/978-1-4614-9434-8.</cite> [<a href="https://doi.org/10.1007/978-1-4614-9434-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Focal%20Controlled%20Drug%20Delivery&amp;publication_year=2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref18">
<cite>Langer R., Folkman J.. Polymers for the Sustained
Release of Proteins and
Other Macromolecules. Nature. 1976;263(5580):797–800. doi: 10.1038/263797a0.</cite> [<a href="https://doi.org/10.1038/263797a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/995197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Polymers%20for%20the%20Sustained%20Release%20of%20Proteins%20and%20Other%20Macromolecules&amp;author=R.%20Langer&amp;author=J.%20Folkman&amp;volume=263&amp;issue=5580&amp;publication_year=1976&amp;pages=797-800&amp;pmid=995197&amp;doi=10.1038/263797a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref19">
<cite>Greenwald R. B.. PEG Drugs:
An Overview. J. Controlled Release. 2001;74(1–3):159–171. doi: 10.1016/S0168-3659(01)00331-5.</cite> [<a href="https://doi.org/10.1016/S0168-3659(01)00331-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11489492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=PEG%20Drugs:%20An%20Overview&amp;author=R.%20B.%20Greenwald&amp;volume=74&amp;issue=1%E2%80%933&amp;publication_year=2001&amp;pages=159-171&amp;pmid=11489492&amp;doi=10.1016/S0168-3659(01)00331-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref20">
<cite>Pasut G., Veronese F. M.. PEG Conjugates in Clinical Development or Use as Anticancer
Agents: An Overview. Adv. Drug Deliv Rev. 2009;61(13):1177–1188. doi: 10.1016/j.addr.2009.02.010.</cite> [<a href="https://doi.org/10.1016/j.addr.2009.02.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19671438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Drug%20Deliv%20Rev.&amp;title=PEG%20Conjugates%20in%20Clinical%20Development%20or%20Use%20as%20Anticancer%20Agents:%20An%20Overview&amp;author=G.%20Pasut&amp;author=F.%20M.%20Veronese&amp;volume=61&amp;issue=13&amp;publication_year=2009&amp;pages=1177-1188&amp;pmid=19671438&amp;doi=10.1016/j.addr.2009.02.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref21">
<cite>Makadia H. K., Siegel S. J.. Poly Lactic-Co-Glycolic Acid (PLGA) as Biodegradable
Controlled Drug Delivery Carrier. Polymers (Basel) 2011;3(3):1377–1397. doi: 10.3390/polym3031377.</cite> [<a href="https://doi.org/10.3390/polym3031377" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3347861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22577513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Polymers%20(Basel)&amp;title=Poly%20Lactic-Co-Glycolic%20Acid%20(PLGA)%20as%20Biodegradable%20Controlled%20Drug%20Delivery%20Carrier&amp;author=H.%20K.%20Makadia&amp;author=S.%20J.%20Siegel&amp;volume=3&amp;issue=3&amp;publication_year=2011&amp;pages=1377-1397&amp;pmid=22577513&amp;doi=10.3390/polym3031377&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref22">
<cite>Slika H., Shahani A., Gattu K., Mundrathi V., Solan A. A., Gonzalez B., Haque T. N., Rahman S., Sugandhi V. V., Lee J., Velarde E., Alomari S., Pacis V. L., Brem H., Tyler B., Xin X., Cho H.. Intracranial Nanogel Pellets Carrying Temozolomide and Paclitaxel
for Adjuvant Brain Cancer Therapy. Mol. Pharmaceutics. 2025;22(1):131–141. doi: 10.1021/acs.molpharmaceut.4c00708.</cite> [<a href="https://doi.org/10.1021/acs.molpharmaceut.4c00708" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39666995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmaceutics&amp;title=Intracranial%20Nanogel%20Pellets%20Carrying%20Temozolomide%20and%20Paclitaxel%20for%20Adjuvant%20Brain%20Cancer%20Therapy&amp;author=H.%20Slika&amp;author=A.%20Shahani&amp;author=K.%20Gattu&amp;author=V.%20Mundrathi&amp;author=A.%20A.%20Solan&amp;volume=22&amp;issue=1&amp;publication_year=2025&amp;pages=131-141&amp;pmid=39666995&amp;doi=10.1021/acs.molpharmaceut.4c00708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref23">
<cite>Liu Y., Wang Y., Kulkarni R. A., Wegiel L. A., Lee B., Bedingfield S. K., Weitz D.. Syringable Microcapsules for Sustained,
Localized, and Controllable SiRNA Delivery. ACS Appl. Mater. Interfaces. 2025;17(1):187–196. doi: 10.1021/acsami.4c12805.</cite> [<a href="https://doi.org/10.1021/acsami.4c12805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39705128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Mater.%20Interfaces&amp;title=Syringable%20Microcapsules%20for%20Sustained,%20Localized,%20and%20Controllable%20SiRNA%20Delivery&amp;author=Y.%20Liu&amp;author=Y.%20Wang&amp;author=R.%20A.%20Kulkarni&amp;author=L.%20A.%20Wegiel&amp;author=B.%20Lee&amp;volume=17&amp;issue=1&amp;publication_year=2025&amp;pages=187-196&amp;pmid=39705128&amp;doi=10.1021/acsami.4c12805&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref24">
<cite>Story B. D., Park S., Roszak K., Shim J., Motta M., Ferneding M., Rudeen K. M., Blandino A., Ardon M., Le S., Teixeira L. B. C., Yiu G., Mieler W. F., Thomasy S. M., Kang-Mieler J. J.. Safety and Biocompatibility of a
Novel Biodegradable Aflibercept-Drug Delivery System in Rhesus Macaques. Drug Deliv. 2025;32(1):2460671. doi: 10.1080/10717544.2025.2460671.</cite> [<a href="https://doi.org/10.1080/10717544.2025.2460671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11884103/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40038090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Deliv&amp;title=Safety%20and%20Biocompatibility%20of%20a%20Novel%20Biodegradable%20Aflibercept-Drug%20Delivery%20System%20in%20Rhesus%20Macaques&amp;author=B.%20D.%20Story&amp;author=S.%20Park&amp;author=K.%20Roszak&amp;author=J.%20Shim&amp;author=M.%20Motta&amp;volume=32&amp;issue=1&amp;publication_year=2025&amp;pages=2460671&amp;pmid=40038090&amp;doi=10.1080/10717544.2025.2460671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref25">
<cite>Leong K. W., Brott B. C., Langer R.. Bioerodible Polyanhydrides
as Drug-Carrier
Matrices. I: Characterization, Degradation, and Release Characteristics. J. Biomed Mater. Res. 1985;19(8):941–955. doi: 10.1002/jbm.820190806.</cite> [<a href="https://doi.org/10.1002/jbm.820190806" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3880353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomed%20Mater.%20Res.&amp;title=Bioerodible%20Polyanhydrides%20as%20Drug-Carrier%20Matrices.%20I:%20Characterization,%20Degradation,%20and%20Release%20Characteristics&amp;author=K.%20W.%20Leong&amp;author=B.%20C.%20Brott&amp;author=R.%20Langer&amp;volume=19&amp;issue=8&amp;publication_year=1985&amp;pages=941-955&amp;pmid=3880353&amp;doi=10.1002/jbm.820190806&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref26">
<cite>Danhier F., Ansorena E., Silva J. M., Coco R., Le Breton A., Preat V.. PLGA-Based Nanoparticles:
An Overview of Biomedical Applications. J. Controlled
Release. 2012;161(2):505–522. doi: 10.1016/j.jconrel.2012.01.043.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2012.01.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22353619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=PLGA-Based%20Nanoparticles:%20An%20Overview%20of%20Biomedical%20Applications&amp;author=F.%20Danhier&amp;author=E.%20Ansorena&amp;author=J.%20M.%20Silva&amp;author=R.%20Coco&amp;author=A.%20Le%20Breton&amp;volume=161&amp;issue=2&amp;publication_year=2012&amp;pages=505-522&amp;pmid=22353619&amp;doi=10.1016/j.jconrel.2012.01.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref27">
<cite>Valtonen S., Timonen U., Toivanen P., Kalimo H., Kivipelto L., Heiskanen O., Unsgaard G., Kuurne T.. Interstitial
Chemotherapy
with Carmustine-Loaded Polymers for High-Grade Gliomas: A Randomized
Double-Blind Study. Neurosurgery. 1997;41(1):44–48. doi: 10.1097/00006123-199707000-00011.</cite> [<a href="https://doi.org/10.1097/00006123-199707000-00011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9218294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurosurgery&amp;title=Interstitial%20Chemotherapy%20with%20Carmustine-Loaded%20Polymers%20for%20High-Grade%20Gliomas:%20A%20Randomized%20Double-Blind%20Study&amp;author=S.%20Valtonen&amp;author=U.%20Timonen&amp;author=P.%20Toivanen&amp;author=H.%20Kalimo&amp;author=L.%20Kivipelto&amp;volume=41&amp;issue=1&amp;publication_year=1997&amp;pages=44-48&amp;pmid=9218294&amp;doi=10.1097/00006123-199707000-00011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref28">
<cite>Chowdhary S. A., Ryken T., Newton H. B.. Survival
Outcomes and Safety of Carmustine
Wafers in the Treatment of High-Grade Gliomas: A Meta-Analysis. J. Neurooncol. 2015;122(2):367–382. doi: 10.1007/s11060-015-1724-2.</cite> [<a href="https://doi.org/10.1007/s11060-015-1724-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4368843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25630625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurooncol&amp;title=Survival%20Outcomes%20and%20Safety%20of%20Carmustine%20Wafers%20in%20the%20Treatment%20of%20High-Grade%20Gliomas:%20A%20Meta-Analysis&amp;author=S.%20A.%20Chowdhary&amp;author=T.%20Ryken&amp;author=H.%20B.%20Newton&amp;volume=122&amp;issue=2&amp;publication_year=2015&amp;pages=367-382&amp;pmid=25630625&amp;doi=10.1007/s11060-015-1724-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref29">
<cite>Xing W. K., Shao C., Qi Z. Y., Yang C., Wang Z.. The Role of
Gliadel Wafers in the Treatment of Newly Diagnosed GBM: A Meta-Analysis. Drug Des Devel Ther. 2015;9:3341–3348. doi: 10.2147/DDDT.S85943.</cite> [<a href="https://doi.org/10.2147/DDDT.S85943" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4492653/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26170620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Des%20Devel%20Ther&amp;title=The%20Role%20of%20Gliadel%20Wafers%20in%20the%20Treatment%20of%20Newly%20Diagnosed%20GBM:%20A%20Meta-Analysis&amp;author=W.%20K.%20Xing&amp;author=C.%20Shao&amp;author=Z.%20Y.%20Qi&amp;author=C.%20Yang&amp;author=Z.%20Wang&amp;volume=9&amp;publication_year=2015&amp;pages=3341-3348&amp;pmid=26170620&amp;doi=10.2147/DDDT.S85943&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref30">
<cite>Westphal M., Ram Z., Riddle V., Hilt D., Bortey E.. Gliadel Wafer in Initial
Surgery for Malignant Glioma: Long-Term Follow-up of a Multicenter
Controlled Trial. Acta Neurochir. 2006;148(3):269–275. doi: 10.1007/s00701-005-0707-z.</cite> [<a href="https://doi.org/10.1007/s00701-005-0707-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16482400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neurochir&amp;title=Gliadel%20Wafer%20in%20Initial%20Surgery%20for%20Malignant%20Glioma:%20Long-Term%20Follow-up%20of%20a%20Multicenter%20Controlled%20Trial&amp;author=M.%20Westphal&amp;author=Z.%20Ram&amp;author=V.%20Riddle&amp;author=D.%20Hilt&amp;author=E.%20Bortey&amp;volume=148&amp;issue=3&amp;publication_year=2006&amp;pages=269-275&amp;pmid=16482400&amp;doi=10.1007/s00701-005-0707-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref31">
<cite>Burri S. H., Prabhu R. S., Sumrall A. L., Brick W., Blaker B. D., Heideman B. E. Jr., Boltes P., Kelly R., Symanowski J. T., Wiggins W. F., Ashby L., Norton H. J., Judy K., Asher A. L.. BCNU Wafer Placement with Temozolomide
(TMZ) in the Immediate Postoperative Period after Tumor Resection
Followed by Radiation Therapy with TMZ in Patients with Newly Diagnosed
High Grade Glioma: Final Results of a Prospective, Multi-Institutional,
Phase II Trial. J. Neurooncol. 2015;123(2):259–266. doi: 10.1007/s11060-015-1793-2.</cite> [<a href="https://doi.org/10.1007/s11060-015-1793-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25947286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurooncol&amp;title=BCNU%20Wafer%20Placement%20with%20Temozolomide%20(TMZ)%20in%20the%20Immediate%20Postoperative%20Period%20after%20Tumor%20Resection%20Followed%20by%20Radiation%20Therapy%20with%20TMZ%20in%20Patients%20with%20Newly%20Diagnosed%20High%20Grade%20Glioma:%20Final%20Results%20of%20a%20Prospective,%20Multi-Institutional,%20Phase%20II%20Trial&amp;author=S.%20H.%20Burri&amp;author=R.%20S.%20Prabhu&amp;author=A.%20L.%20Sumrall&amp;author=W.%20Brick&amp;author=B.%20D.%20Blaker&amp;volume=123&amp;issue=2&amp;publication_year=2015&amp;pages=259-266&amp;pmid=25947286&amp;doi=10.1007/s11060-015-1793-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref32">
<cite>Westphal M., Hilt D. C., Bortey E., Delavault P., Olivares R., Warnke P. C., Whittle I. R., Jaaskelainen J., Ram Z.. A Phase 3 Trial of Local Chemotherapy with Biodegradable Carmustine
(BCNU) Wafers (Gliadel Wafers) in Patients with Primary Malignant
Glioma. Neuro Oncol. 2003;5(2):79–88. doi: 10.1093/neuonc/5.2.79.</cite> [<a href="https://doi.org/10.1093/neuonc/5.2.79" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1920672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12672279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=A%20Phase%203%20Trial%20of%20Local%20Chemotherapy%20with%20Biodegradable%20Carmustine%20(BCNU)%20Wafers%20(Gliadel%20Wafers)%20in%20Patients%20with%20Primary%20Malignant%20Glioma&amp;author=M.%20Westphal&amp;author=D.%20C.%20Hilt&amp;author=E.%20Bortey&amp;author=P.%20Delavault&amp;author=R.%20Olivares&amp;volume=5&amp;issue=2&amp;publication_year=2003&amp;pages=79-88&amp;pmid=12672279&amp;doi=10.1093/neuonc/5.2.79&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref33">
<cite>Wait S. D., Prabhu R. S., Burri S. H., Atkins T. G., Asher A. L.. Polymeric
Drug Delivery for the Treatment of Glioblastoma. Neuro. Oncol. 2015;17 Suppl 2(Suppl 2):ii9–ii23. doi: 10.1093/neuonc/nou360.</cite> [<a href="https://doi.org/10.1093/neuonc/nou360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4483039/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25746091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro.%20Oncol.&amp;title=Polymeric%20Drug%20Delivery%20for%20the%20Treatment%20of%20Glioblastoma&amp;author=S.%20D.%20Wait&amp;author=R.%20S.%20Prabhu&amp;author=S.%20H.%20Burri&amp;author=T.%20G.%20Atkins&amp;author=A.%20L.%20Asher&amp;volume=17%20Suppl%202&amp;issue=Suppl%202&amp;publication_year=2015&amp;pages=ii9-ii23&amp;pmid=25746091&amp;doi=10.1093/neuonc/nou360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref34">
<cite>Brem H., Mahaley M. S. Jr., Vick N. A., Black K. L., Schold S. C. Jr., Burger P. C., Friedman A. H., Ciric I. S., Eller T. W., Cozzens J. W.. et al. Interstitial
Chemotherapy with Drug Polymer Implants for the Treatment of Recurrent
Gliomas. J. Neurosurg. 1991;74(3):441–446. doi: 10.3171/jns.1991.74.3.0441.</cite> [<a href="https://doi.org/10.3171/jns.1991.74.3.0441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1993909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurosurg&amp;title=Interstitial%20Chemotherapy%20with%20Drug%20Polymer%20Implants%20for%20the%20Treatment%20of%20Recurrent%20Gliomas&amp;author=H.%20Brem&amp;author=M.%20S.%20Mahaley&amp;author=N.%20A.%20Vick&amp;author=K.%20L.%20Black&amp;author=S.%20C.%20Schold&amp;volume=74&amp;issue=3&amp;publication_year=1991&amp;pages=441-446&amp;pmid=1993909&amp;doi=10.3171/jns.1991.74.3.0441&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref35">
<cite>Brem H., Piantadosi S., Burger P. C., Walker M., Selker R., Vick N. A., Black K., Sisti M., Brem S., Mohr G.. et al. Placebo-Controlled Trial of Safety and Efficacy of
Intraoperative Controlled Delivery by Biodegradable Polymers of Chemotherapy
for Recurrent Gliomas. The Polymer-Brain Tumor Treatment Group. Lancet. 1995;345(8956):1008–1012. doi: 10.1016/S0140-6736(95)90755-6.</cite> [<a href="https://doi.org/10.1016/S0140-6736(95)90755-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7723496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Placebo-Controlled%20Trial%20of%20Safety%20and%20Efficacy%20of%20Intraoperative%20Controlled%20Delivery%20by%20Biodegradable%20Polymers%20of%20Chemotherapy%20for%20Recurrent%20Gliomas.%20The%20Polymer-Brain%20Tumor%20Treatment%20Group&amp;author=H.%20Brem&amp;author=S.%20Piantadosi&amp;author=P.%20C.%20Burger&amp;author=M.%20Walker&amp;author=R.%20Selker&amp;volume=345&amp;issue=8956&amp;publication_year=1995&amp;pages=1008-1012&amp;pmid=7723496&amp;doi=10.1016/S0140-6736(95)90755-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref36">
<cite>Sipos E. P., Tyler B., Piantadosi S., Burger P. C., Brem H.. Optimizing
Interstitial Delivery of BCNU from Controlled Release Polymers for
the Treatment of Brain Tumors. Cancer Chemother
Pharmacol. 1997;39(5):383–389. doi: 10.1007/s002800050588.</cite> [<a href="https://doi.org/10.1007/s002800050588" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9054951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Chemother%20Pharmacol&amp;title=Optimizing%20Interstitial%20Delivery%20of%20BCNU%20from%20Controlled%20Release%20Polymers%20for%20the%20Treatment%20of%20Brain%20Tumors&amp;author=E.%20P.%20Sipos&amp;author=B.%20Tyler&amp;author=S.%20Piantadosi&amp;author=P.%20C.%20Burger&amp;author=H.%20Brem&amp;volume=39&amp;issue=5&amp;publication_year=1997&amp;pages=383-389&amp;pmid=9054951&amp;doi=10.1007/s002800050588&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref37">
<cite>Olivi A., Grossman S. A., Tatter S., Barker F., Judy K., Olsen J., Bruce J., Hilt D., Fisher J., Piantadosi S.. Dose Escalation of Carmustine in Surgically Implanted
Polymers in Patients with Recurrent Malignant Glioma: A New Approaches
to Brain Tumor Therapy CNS Consortium Trial. J. Clin Oncol. 2003;21(9):1845–1849. doi: 10.1200/JCO.2003.09.041.</cite> [<a href="https://doi.org/10.1200/JCO.2003.09.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12721262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin%20Oncol&amp;title=Dose%20Escalation%20of%20Carmustine%20in%20Surgically%20Implanted%20Polymers%20in%20Patients%20with%20Recurrent%20Malignant%20Glioma:%20A%20New%20Approaches%20to%20Brain%20Tumor%20Therapy%20CNS%20Consortium%20Trial&amp;author=A.%20Olivi&amp;author=S.%20A.%20Grossman&amp;author=S.%20Tatter&amp;author=F.%20Barker&amp;author=K.%20Judy&amp;volume=21&amp;issue=9&amp;publication_year=2003&amp;pages=1845-1849&amp;pmid=12721262&amp;doi=10.1200/JCO.2003.09.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref38">
<cite>Stupp R., Mason W. P., van den Bent M. J., Weller M., Fisher B., Taphoorn M. J. B., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O.. Radiotherapy plus Concomitant and
Adjuvant Temozolomide for Glioblastoma. N Engl
J. Med. 2005;352(10):987–996. doi: 10.1056/NEJMoa043330.</cite> [<a href="https://doi.org/10.1056/NEJMoa043330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15758009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J.%20Med.&amp;title=Radiotherapy%20plus%20Concomitant%20and%20Adjuvant%20Temozolomide%20for%20Glioblastoma&amp;author=R.%20Stupp&amp;author=W.%20P.%20Mason&amp;author=M.%20J.%20van%20den%20Bent&amp;author=M.%20Weller&amp;author=B.%20Fisher&amp;volume=352&amp;issue=10&amp;publication_year=2005&amp;pages=987-996&amp;pmid=15758009&amp;doi=10.1056/NEJMoa043330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref39">
<cite>Brem S., Tyler B., Li K., Pradilla G., Legnani F., Caplan J., Brem H.. Local Delivery of Temozolomide by
Biodegradable Polymers Is Superior to Oral Administration in a Rodent
Glioma Model. Cancer Chemother Pharmacol. 2007;60(5):643–650. doi: 10.1007/s00280-006-0407-2.</cite> [<a href="https://doi.org/10.1007/s00280-006-0407-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17256133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Chemother%20Pharmacol&amp;title=Local%20Delivery%20of%20Temozolomide%20by%20Biodegradable%20Polymers%20Is%20Superior%20to%20Oral%20Administration%20in%20a%20Rodent%20Glioma%20Model&amp;author=S.%20Brem&amp;author=B.%20Tyler&amp;author=K.%20Li&amp;author=G.%20Pradilla&amp;author=F.%20Legnani&amp;volume=60&amp;issue=5&amp;publication_year=2007&amp;pages=643-650&amp;pmid=17256133&amp;doi=10.1007/s00280-006-0407-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref40">
<cite>Champeaux-Depond C., Jecko V., Weller J., Constantinou P., Tuppin P., Metellus P.. Newly Diagnosed High-Grade Glioma
Surgery with Carmustine Wafers Implantation. A Long-Term Nationwide
Retrospective Study. World Neurosurg. 2023;173:e778–e786. doi: 10.1016/j.wneu.2023.03.015.</cite> [<a href="https://doi.org/10.1016/j.wneu.2023.03.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36906091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20Neurosurg&amp;title=Newly%20Diagnosed%20High-Grade%20Glioma%20Surgery%20with%20Carmustine%20Wafers%20Implantation.%20A%20Long-Term%20Nationwide%20Retrospective%20Study&amp;author=C.%20Champeaux-Depond&amp;author=V.%20Jecko&amp;author=J.%20Weller&amp;author=P.%20Constantinou&amp;author=P.%20Tuppin&amp;volume=173&amp;publication_year=2023&amp;pages=e778-e786&amp;pmid=36906091&amp;doi=10.1016/j.wneu.2023.03.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref41">
<cite>Kadota T., Saito R., Kumabe T., Mizusawa J., Katayama H., Sumi M., Igaki H., Kinoshita M., Komori T., Ichimura K., Narita Y., Nishikawa R.. A Multicenter
Randomized Phase III Study for Newly Diagnosed Maximally Resected
Glioblastoma Comparing Carmustine Wafer Implantation Followed by Chemoradiotherapy
with Temozolomide with Chemoradiotherapy Alone; Japan Clinical Oncology
Group Study JCOG1703 (MACS Study) Jpn. J. Clin
Oncol. 2019;49(12):1172–1175. doi: 10.1093/jjco/hyz169.</cite> [<a href="https://doi.org/10.1093/jjco/hyz169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31804699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jpn.%20J.%20Clin%20Oncol&amp;title=A%20Multicenter%20Randomized%20Phase%20III%20Study%20for%20Newly%20Diagnosed%20Maximally%20Resected%20Glioblastoma%20Comparing%20Carmustine%20Wafer%20Implantation%20Followed%20by%20Chemoradiotherapy%20with%20Temozolomide%20with%20Chemoradiotherapy%20Alone;%20Japan%20Clinical%20Oncology%20Group%20Study%20JCOG1703%20(MACS%20Study)&amp;author=T.%20Kadota&amp;author=R.%20Saito&amp;author=T.%20Kumabe&amp;author=J.%20Mizusawa&amp;author=H.%20Katayama&amp;volume=49&amp;issue=12&amp;publication_year=2019&amp;pages=1172-1175&amp;pmid=31804699&amp;doi=10.1093/jjco/hyz169&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref42">
<cite>Mangraviti A., Raghavan T., Volpin F., Skuli N., Gullotti D., Zhou J., Asnaghi L., Sankey E., Liu A., Wang Y., Lee D.-H., Gorelick N., Serra R., Peters M., Schriefer D., Delaspre F., Rodriguez F. J., Eberhart C. G., Brem H., Olivi A., Tyler B.. HIF-1α-
Targeting Acriflavine Provides Long Term Survival and Radiological
Tumor Response in Brain Cancer Therapy. Sci.
Rep. 2017;7(1):14978. doi: 10.1038/s41598-017-14990-w.</cite> [<a href="https://doi.org/10.1038/s41598-017-14990-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5668269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29097800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep&amp;title=HIF-1%CE%B1-%20Targeting%20Acriflavine%20Provides%20Long%20Term%20Survival%20and%20Radiological%20Tumor%20Response%20in%20Brain%20Cancer%20Therapy&amp;author=A.%20Mangraviti&amp;author=T.%20Raghavan&amp;author=F.%20Volpin&amp;author=N.%20Skuli&amp;author=D.%20Gullotti&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=14978&amp;pmid=29097800&amp;doi=10.1038/s41598-017-14990-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref43">
<cite>Shikani A. H., Domb A. J.. Polymer Chemotherapy
for Head and Neck Cancer. Laryngoscope. 2000;110(6):907–917. doi: 10.1097/00005537-200006000-00004.</cite> [<a href="https://doi.org/10.1097/00005537-200006000-00004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10852503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Laryngoscope&amp;title=Polymer%20Chemotherapy%20for%20Head%20and%20Neck%20Cancer&amp;author=A.%20H.%20Shikani&amp;author=A.%20J.%20Domb&amp;volume=110&amp;issue=6&amp;publication_year=2000&amp;pages=907-917&amp;pmid=10852503&amp;doi=10.1097/00005537-200006000-00004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref44">
<cite>Bastiancich C., Malfanti A., Preat V., Rahman R.. Rationally Designed
Drug Delivery Systems for the Local Treatment of Resected Glioblastoma. Adv. Drug Deliv Rev. 2021;177:113951.  doi: 10.1016/j.addr.2021.113951.</cite> [<a href="https://doi.org/10.1016/j.addr.2021.113951" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34461201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Drug%20Deliv%20Rev.&amp;title=Rationally%20Designed%20Drug%20Delivery%20Systems%20for%20the%20Local%20Treatment%20of%20Resected%20Glioblastoma&amp;author=C.%20Bastiancich&amp;author=A.%20Malfanti&amp;author=V.%20Preat&amp;author=R.%20Rahman&amp;volume=177&amp;publication_year=2021&amp;pages=113951&amp;pmid=34461201&amp;doi=10.1016/j.addr.2021.113951&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref45">
<cite>Pena E. S., Graham-Gurysh E. G., Bachelder E. M., Ainslie K. M.. Design of Biopolymer-Based
Interstitial Therapies for the Treatment of Glioblastoma. Int. J. Mol. Sci. 2021;22(23):13160. doi: 10.3390/ijms222313160.</cite> [<a href="https://doi.org/10.3390/ijms222313160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8658694/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34884965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Design%20of%20Biopolymer-Based%20Interstitial%20Therapies%20for%20the%20Treatment%20of%20Glioblastoma&amp;author=E.%20S.%20Pena&amp;author=E.%20G.%20Graham-Gurysh&amp;author=E.%20M.%20Bachelder&amp;author=K.%20M.%20Ainslie&amp;volume=22&amp;issue=23&amp;publication_year=2021&amp;pages=13160&amp;pmid=34884965&amp;doi=10.3390/ijms222313160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref46">
<cite>Norouzi M., Firouzi J., Sodeifi N., Ebrahimi M., Miller D. W.. Salinomycin-Loaded
Injectable Thermosensitive Hydrogels for Glioblastoma Therapy. Int. J. Pharm. 2021;598:120316.  doi: 10.1016/j.ijpharm.2021.120316.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2021.120316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33540001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Pharm.&amp;title=Salinomycin-Loaded%20Injectable%20Thermosensitive%20Hydrogels%20for%20Glioblastoma%20Therapy&amp;author=M.%20Norouzi&amp;author=J.%20Firouzi&amp;author=N.%20Sodeifi&amp;author=M.%20Ebrahimi&amp;author=D.%20W.%20Miller&amp;volume=598&amp;publication_year=2021&amp;pages=120316&amp;pmid=33540001&amp;doi=10.1016/j.ijpharm.2021.120316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref47">
<cite>Han D., Serra R., Gorelick N., Fatima U., Eberhart C. G., Brem H., Tyler B., Steckl A. J.. Multi-Layered Core-Sheath
Fiber Membranes for Controlled Drug Release in the Local Treatment
of Brain Tumor. Sci. Rep. 2019;9(1):17936. doi: 10.1038/s41598-019-54283-y.</cite> [<a href="https://doi.org/10.1038/s41598-019-54283-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6884550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31784666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep&amp;title=Multi-Layered%20Core-Sheath%20Fiber%20Membranes%20for%20Controlled%20Drug%20Release%20in%20the%20Local%20Treatment%20of%20Brain%20Tumor&amp;author=D.%20Han&amp;author=R.%20Serra&amp;author=N.%20Gorelick&amp;author=U.%20Fatima&amp;author=C.%20G.%20Eberhart&amp;volume=9&amp;issue=1&amp;publication_year=2019&amp;pages=17936&amp;pmid=31784666&amp;doi=10.1038/s41598-019-54283-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref48">
<cite>Tyler B., Fowers K. D., Li K. W., Recinos V. R., Caplan J. M., Hdeib A., Grossman R., Basaldella L., Bekelis K., Pradilla G., Legnani F., Brem H.. A Thermal
Gel Depot for Local Delivery of Paclitaxel to Treat Experimental Brain
Tumors in Rats. J. Neurosurg. 2010;113(2):210–217. doi: 10.3171/2009.11.JNS08162.</cite> [<a href="https://doi.org/10.3171/2009.11.JNS08162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20001591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurosurg&amp;title=A%20Thermal%20Gel%20Depot%20for%20Local%20Delivery%20of%20Paclitaxel%20to%20Treat%20Experimental%20Brain%20Tumors%20in%20Rats&amp;author=B.%20Tyler&amp;author=K.%20D.%20Fowers&amp;author=K.%20W.%20Li&amp;author=V.%20R.%20Recinos&amp;author=J.%20M.%20Caplan&amp;volume=113&amp;issue=2&amp;publication_year=2010&amp;pages=210-217&amp;pmid=20001591&amp;doi=10.3171/2009.11.JNS08162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref49">
<cite>Mathieu M., Martin-Jaular L., Lavieu G., Théry C.. Specificities
of Secretion and Uptake of Exosomes and Other Extracellular Vesicles
for Cell-to-Cell Communication. Nat. Cell Biol. 2019;21(1):9–17. doi: 10.1038/s41556-018-0250-9.</cite> [<a href="https://doi.org/10.1038/s41556-018-0250-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30602770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Cell%20Biol.&amp;title=Specificities%20of%20Secretion%20and%20Uptake%20of%20Exosomes%20and%20Other%20Extracellular%20Vesicles%20for%20Cell-to-Cell%20Communication&amp;author=M.%20Mathieu&amp;author=L.%20Martin-Jaular&amp;author=G.%20Lavieu&amp;author=C.%20Th%C3%A9ry&amp;volume=21&amp;issue=1&amp;publication_year=2019&amp;pages=9-17&amp;pmid=30602770&amp;doi=10.1038/s41556-018-0250-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref50">
<cite>Saka O. M., Dora D. D., Kibar G., Tevlek A.. Expanding the Role
of Exosomes in Drug, Biomolecule, and Nanoparticle Delivery. Life Sci. 2025;368:123499.  doi: 10.1016/j.lfs.2025.123499.</cite> [<a href="https://doi.org/10.1016/j.lfs.2025.123499" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39993468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sci.&amp;title=Expanding%20the%20Role%20of%20Exosomes%20in%20Drug,%20Biomolecule,%20and%20Nanoparticle%20Delivery&amp;author=O.%20M.%20Saka&amp;author=D.%20D.%20Dora&amp;author=G.%20Kibar&amp;author=A.%20Tevlek&amp;volume=368&amp;publication_year=2025&amp;pages=123499&amp;pmid=39993468&amp;doi=10.1016/j.lfs.2025.123499&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref51">
<cite>Vahab S. A., V V. K., Kumar V. S.. Exosome-Based Drug
Delivery Systems
for Enhanced Neurological Therapeutics. Drug
Deliv Transl Res. 2025;15(4):1121–1138. doi: 10.1007/s13346-024-01710-x.</cite> [<a href="https://doi.org/10.1007/s13346-024-01710-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39325272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Deliv%20Transl%20Res.&amp;title=Exosome-Based%20Drug%20Delivery%20Systems%20for%20Enhanced%20Neurological%20Therapeutics&amp;author=S.%20A.%20Vahab&amp;author=V.%20K.%20V&amp;author=V.%20S.%20Kumar&amp;volume=15&amp;issue=4&amp;publication_year=2025&amp;pages=1121-1138&amp;pmid=39325272&amp;doi=10.1007/s13346-024-01710-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref52">
<cite>Cui G.-H., Guo H.-D., Li H., Zhai Y., Gong Z.-B., Wu J., Liu J.-S., Dong Y.-R., Hou S.-X., Liu J.-R.. RVG-Modified
Exosomes Derived from Mesenchymal Stem Cells Rescue Memory Deficits
by Regulating Inflammatory Responses in a Mouse Model of Alzheimer’s
Disease. Immun Ageing. 2019;16:10. doi: 10.1186/s12979-019-0150-2.</cite> [<a href="https://doi.org/10.1186/s12979-019-0150-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6515654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31114624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immun%20Ageing&amp;title=RVG-Modified%20Exosomes%20Derived%20from%20Mesenchymal%20Stem%20Cells%20Rescue%20Memory%20Deficits%20by%20Regulating%20Inflammatory%20Responses%20in%20a%20Mouse%20Model%20of%20Alzheimer%E2%80%99s%20Disease&amp;author=G.-H.%20Cui&amp;author=H.-D.%20Guo&amp;author=H.%20Li&amp;author=Y.%20Zhai&amp;author=Z.-B.%20Gong&amp;volume=16&amp;publication_year=2019&amp;pages=10&amp;pmid=31114624&amp;doi=10.1186/s12979-019-0150-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref53">
<cite>Wang H., Sui H., Zheng Y., Jiang Y., Shi Y., Liang J., Zhao L.. Curcumin-Primed Exosomes Potently
Ameliorate Cognitive Function in
AD Mice by Inhibiting Hyperphosphorylation of the Tau Protein through
the AKT/GSK-3β Pathway. Nanoscale. 2019;11(15):7481–7496. doi: 10.1039/C9NR01255A.</cite> [<a href="https://doi.org/10.1039/C9NR01255A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30942233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Curcumin-Primed%20Exosomes%20Potently%20Ameliorate%20Cognitive%20Function%20in%20AD%20Mice%20by%20Inhibiting%20Hyperphosphorylation%20of%20the%20Tau%20Protein%20through%20the%20AKT/GSK-3%CE%B2%20Pathway&amp;author=H.%20Wang&amp;author=H.%20Sui&amp;author=Y.%20Zheng&amp;author=Y.%20Jiang&amp;author=Y.%20Shi&amp;volume=11&amp;issue=15&amp;publication_year=2019&amp;pages=7481-7496&amp;pmid=30942233&amp;doi=10.1039/C9NR01255A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref54">
<cite>Tang B., Zeng W., Song L. L., Wang H. M., Qu L. Q., Lo H. H., Yu L., Wu A. G., Wong V. K. W., Law B. Y. K.. Extracellular
Vesicle Delivery of Neferine for the
Attenuation of Neurodegenerative Disease Proteins and Motor Deficit
in an Alzheimer’s Disease Mouse Model. Pharmaceuticals (Basel) 2022;15(1):83. doi: 10.3390/ph15010083.</cite> [<a href="https://doi.org/10.3390/ph15010083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8779383/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35056140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Extracellular%20Vesicle%20Delivery%20of%20Neferine%20for%20the%20Attenuation%20of%20Neurodegenerative%20Disease%20Proteins%20and%20Motor%20Deficit%20in%20an%20Alzheimer%E2%80%99s%20Disease%20Mouse%20Model&amp;author=B.%20Tang&amp;author=W.%20Zeng&amp;author=L.%20L.%20Song&amp;author=H.%20M.%20Wang&amp;author=L.%20Q.%20Qu&amp;volume=15&amp;issue=1&amp;publication_year=2022&amp;pages=83&amp;pmid=35056140&amp;doi=10.3390/ph15010083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref55">
<cite>Perets N., Betzer O., Shapira R., Brenstein S., Angel A., Sadan T., Ashery U., Popovtzer R., Offen D.. Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative
and Neurodevelopmental Disorders. Nano Lett. 2019;19(6):3422–3431. doi: 10.1021/acs.nanolett.8b04148.</cite> [<a href="https://doi.org/10.1021/acs.nanolett.8b04148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30761901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett.&amp;title=Golden%20Exosomes%20Selectively%20Target%20Brain%20Pathologies%20in%20Neurodegenerative%20and%20Neurodevelopmental%20Disorders&amp;author=N.%20Perets&amp;author=O.%20Betzer&amp;author=R.%20Shapira&amp;author=S.%20Brenstein&amp;author=A.%20Angel&amp;volume=19&amp;issue=6&amp;publication_year=2019&amp;pages=3422-3431&amp;pmid=30761901&amp;doi=10.1021/acs.nanolett.8b04148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref56">
<cite>Guo M., Wang J., Zhao Y., Feng Y., Han S., Dong Q., Cui M., Tieu K.. Microglial Exosomes
Facilitate α-Synuclein Transmission in Parkinson’s Disease. Brain. 2020;143(5):1476–1497. doi: 10.1093/brain/awaa090.</cite> [<a href="https://doi.org/10.1093/brain/awaa090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7241957/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32355963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Microglial%20Exosomes%20Facilitate%20%CE%B1-Synuclein%20Transmission%20in%20Parkinson%E2%80%99s%20Disease&amp;author=M.%20Guo&amp;author=J.%20Wang&amp;author=Y.%20Zhao&amp;author=Y.%20Feng&amp;author=S.%20Han&amp;volume=143&amp;issue=5&amp;publication_year=2020&amp;pages=1476-1497&amp;pmid=32355963&amp;doi=10.1093/brain/awaa090&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref57">
<cite>Izco M., Blesa J., Schleef M., Schmeer M., Porcari R., Al-Shawi R., Ellmerich S., de Toro M., Gardiner C., Seow Y., Reinares-Sebastian A., Forcen R., Simons J. P., Bellotti V., Cooper J. M., Alvarez-Erviti L.. Systemic Exosomal
Delivery of ShRNA Minicircles Prevents Parkinsonian Pathology. Mol. Ther. 2019;27(12):2111–2122. doi: 10.1016/j.ymthe.2019.08.010.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2019.08.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6904801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31501034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Ther&amp;title=Systemic%20Exosomal%20Delivery%20of%20ShRNA%20Minicircles%20Prevents%20Parkinsonian%20Pathology&amp;author=M.%20Izco&amp;author=J.%20Blesa&amp;author=M.%20Schleef&amp;author=M.%20Schmeer&amp;author=R.%20Porcari&amp;volume=27&amp;issue=12&amp;publication_year=2019&amp;pages=2111-2122&amp;pmid=31501034&amp;doi=10.1016/j.ymthe.2019.08.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref58">
<cite>Ren X., Zhao Y., Xue F., Zheng Y., Huang H., Wang W., Chang Y., Yang H., Zhang J.. Exosomal DNA
Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological
Deficits in a Mouse Parkinson’s Disease Model. Mol. Ther Nucleic Acids. 2019;17:726–740. doi: 10.1016/j.omtn.2019.07.008.</cite> [<a href="https://doi.org/10.1016/j.omtn.2019.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6709346/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31437653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Ther%20Nucleic%20Acids&amp;title=Exosomal%20DNA%20Aptamer%20Targeting%20%CE%B1-Synuclein%20Aggregates%20Reduced%20Neuropathological%20Deficits%20in%20a%20Mouse%20Parkinson%E2%80%99s%20Disease%20Model&amp;author=X.%20Ren&amp;author=Y.%20Zhao&amp;author=F.%20Xue&amp;author=Y.%20Zheng&amp;author=H.%20Huang&amp;volume=17&amp;publication_year=2019&amp;pages=726-740&amp;pmid=31437653&amp;doi=10.1016/j.omtn.2019.07.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref59">
<cite>Wu X.-Y., Liao B.-Y., Xiao D., Wu W.-C., Xiao Y., Alexander T., Song S.-J., Zhao Z.-H., Zhang Y., Wang Z.-H., Wang L.-B., Li X.. Encapsulation
of Bryostatin-1
by Targeted Exosomes Enhances Remyelination and Neuroprotection Effects
in the Cuprizone-Induced Demyelinating Animal Model of Multiple Sclerosis. Biomater Sci. 2022;10(3):714–727. doi: 10.1039/D1BM01142A.</cite> [<a href="https://doi.org/10.1039/D1BM01142A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34928285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater%20Sci.&amp;title=Encapsulation%20of%20Bryostatin-1%20by%20Targeted%20Exosomes%20Enhances%20Remyelination%20and%20Neuroprotection%20Effects%20in%20the%20Cuprizone-Induced%20Demyelinating%20Animal%20Model%20of%20Multiple%20Sclerosis&amp;author=X.-Y.%20Wu&amp;author=B.-Y.%20Liao&amp;author=D.%20Xiao&amp;author=W.-C.%20Wu&amp;author=Y.%20Xiao&amp;volume=10&amp;issue=3&amp;publication_year=2022&amp;pages=714-727&amp;pmid=34928285&amp;doi=10.1039/D1BM01142A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref60">
<cite>Zhang J., Buller B. A., Zhang Z. G., Zhang Y., Lu M., Rosene D. L., Medalla M., Moore T. L., Chopp M.. Exosomes Derived
from Bone Marrow Mesenchymal Stromal Cells Promote Remyelination and
Reduce Neuroinflammation in the Demyelinating Central Nervous System. Exp. Neurol. 2022;347:113895.  doi: 10.1016/j.expneurol.2021.113895.</cite> [<a href="https://doi.org/10.1016/j.expneurol.2021.113895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12050987/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34653510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp.%20Neurol.&amp;title=Exosomes%20Derived%20from%20Bone%20Marrow%20Mesenchymal%20Stromal%20Cells%20Promote%20Remyelination%20and%20Reduce%20Neuroinflammation%20in%20the%20Demyelinating%20Central%20Nervous%20System&amp;author=J.%20Zhang&amp;author=B.%20A.%20Buller&amp;author=Z.%20G.%20Zhang&amp;author=Y.%20Zhang&amp;author=M.%20Lu&amp;volume=347&amp;publication_year=2022&amp;pages=113895&amp;pmid=34653510&amp;doi=10.1016/j.expneurol.2021.113895&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref61">
<cite>Huang L.-Y., Song J.-X., Cai H., Wang P.-P., Yin Q.-L., Zhang Y.-D., Chen J., Li M., Song J.-J., Wang Y.-L., Luo L., Wang W., Qi S.-H.. Healthy
Serum-Derived Exosomes Improve Neurological Outcomes and Protect Blood-Brain
Barrier by Inhibiting Endothelial Cell Apoptosis and Reversing Autophagy-Mediated
Tight Junction Protein Reduction in Rat Stroke Model. Front Cell Neurosci. 2022;16:841544.  doi: 10.3389/fncel.2022.841544.</cite> [<a href="https://doi.org/10.3389/fncel.2022.841544" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8927286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35308117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Neurosci&amp;title=Healthy%20Serum-Derived%20Exosomes%20Improve%20Neurological%20Outcomes%20and%20Protect%20Blood-Brain%20Barrier%20by%20Inhibiting%20Endothelial%20Cell%20Apoptosis%20and%20Reversing%20Autophagy-Mediated%20Tight%20Junction%20Protein%20Reduction%20in%20Rat%20Stroke%20Model&amp;author=L.-Y.%20Huang&amp;author=J.-X.%20Song&amp;author=H.%20Cai&amp;author=P.-P.%20Wang&amp;author=Q.-L.%20Yin&amp;volume=16&amp;publication_year=2022&amp;pages=841544&amp;pmid=35308117&amp;doi=10.3389/fncel.2022.841544&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref62">
<cite>Hu Y., Zhao M., Wang H., Guo Y., Cheng X., Zhao T., Wang H., Zhang Y., Ma Y., Tao W.. Exosome-Sheathed ROS-Responsive Nanogel to Improve Targeted Therapy
in Perimenopausal Depression. J. Nanobiotechnology. 2023;21(1):261. doi: 10.1186/s12951-023-02005-y.</cite> [<a href="https://doi.org/10.1186/s12951-023-02005-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10408189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37553718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nanobiotechnology&amp;title=Exosome-Sheathed%20ROS-Responsive%20Nanogel%20to%20Improve%20Targeted%20Therapy%20in%20Perimenopausal%20Depression&amp;author=Y.%20Hu&amp;author=M.%20Zhao&amp;author=H.%20Wang&amp;author=Y.%20Guo&amp;author=X.%20Cheng&amp;volume=21&amp;issue=1&amp;publication_year=2023&amp;pages=261&amp;pmid=37553718&amp;doi=10.1186/s12951-023-02005-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref63">
<cite>Li H., Ding Y., Huang J., Zhao Y., Chen W., Tang Q., An Y., Chen R., Hu C.. Angiopep-2
Modified Exosomes Load Rifampicin with Potential for Treating Central
Nervous System Tuberculosis. Int. J. Nanomedicine. 2023;18:489–503. doi: 10.2147/IJN.S395246.</cite> [<a href="https://doi.org/10.2147/IJN.S395246" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9888470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36733407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomedicine&amp;title=Angiopep-2%20Modified%20Exosomes%20Load%20Rifampicin%20with%20Potential%20for%20Treating%20Central%20Nervous%20System%20Tuberculosis&amp;author=H.%20Li&amp;author=Y.%20Ding&amp;author=J.%20Huang&amp;author=Y.%20Zhao&amp;author=W.%20Chen&amp;volume=18&amp;publication_year=2023&amp;pages=489-503&amp;pmid=36733407&amp;doi=10.2147/IJN.S395246&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref64">
<cite>Lee Y., Kim M., Ha J., Lee M.. Brain-Targeted Exosome-Mimetic Cell
Membrane Nanovesicles with Therapeutic Oligonucleotides Elicit Anti-Tumor
Effects in Glioblastoma Animal Models. Bioeng
Transl Med. 2023;8(2):e10426.  doi: 10.1002/btm2.10426.</cite> [<a href="https://doi.org/10.1002/btm2.10426" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10013800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36925699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioeng%20Transl%20Med.&amp;title=Brain-Targeted%20Exosome-Mimetic%20Cell%20Membrane%20Nanovesicles%20with%20Therapeutic%20Oligonucleotides%20Elicit%20Anti-Tumor%20Effects%20in%20Glioblastoma%20Animal%20Models&amp;author=Y.%20Lee&amp;author=M.%20Kim&amp;author=J.%20Ha&amp;author=M.%20Lee&amp;volume=8&amp;issue=2&amp;publication_year=2023&amp;pages=e10426&amp;pmid=36925699&amp;doi=10.1002/btm2.10426&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref65">
<cite>Wu J.-Y., Li Y.-J., Wang J., Hu X.-B., Huang S., Luo S., Xiang D.-X.. Multifunctional Exosome-Mimetics for Targeted Anti-Glioblastoma
Therapy by Manipulating Protein Corona. J. Nanobiotechnology. 2021;19(1):405. doi: 10.1186/s12951-021-01153-3.</cite> [<a href="https://doi.org/10.1186/s12951-021-01153-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8647369/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34872569/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nanobiotechnology&amp;title=Multifunctional%20Exosome-Mimetics%20for%20Targeted%20Anti-Glioblastoma%20Therapy%20by%20Manipulating%20Protein%20Corona&amp;author=J.-Y.%20Wu&amp;author=Y.-J.%20Li&amp;author=J.%20Wang&amp;author=X.-B.%20Hu&amp;author=S.%20Huang&amp;volume=19&amp;issue=1&amp;publication_year=2021&amp;pages=405&amp;pmid=34872569&amp;doi=10.1186/s12951-021-01153-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref66">
<cite>Liu X., Cao Z., Liu N., Gao G., Du M., Wang Y., Cheng B., Zhu M., Jia B., Pan L., Zhang W., Jiang Y., He W., Xu L., Zhang W., An Q., Guo Q., Gu J.. Kill Two Birds
with One Stone: Engineered Exosome-Mediated Delivery of Cholesterol
Modified YY1-SiRNA Enhances Chemoradiotherapy Sensitivity of Glioblastoma. Front Pharmacol. 2022;13:975291.  doi: 10.3389/fphar.2022.975291.</cite> [<a href="https://doi.org/10.3389/fphar.2022.975291" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9438942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36059990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Kill%20Two%20Birds%20with%20One%20Stone:%20Engineered%20Exosome-Mediated%20Delivery%20of%20Cholesterol%20Modified%20YY1-SiRNA%20Enhances%20Chemoradiotherapy%20Sensitivity%20of%20Glioblastoma&amp;author=X.%20Liu&amp;author=Z.%20Cao&amp;author=N.%20Liu&amp;author=G.%20Gao&amp;author=M.%20Du&amp;volume=13&amp;publication_year=2022&amp;pages=975291&amp;pmid=36059990&amp;doi=10.3389/fphar.2022.975291&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref67">
<cite>Liang S., Xu H., Ye B.-C.. Membrane-Decorated
Exosomes for Combination Drug Delivery
and Improved Glioma Therapy. Langmuir. 2022;38(1):299–308. doi: 10.1021/acs.langmuir.1c02500.</cite> [<a href="https://doi.org/10.1021/acs.langmuir.1c02500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34936368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Langmuir&amp;title=Membrane-Decorated%20Exosomes%20for%20Combination%20Drug%20Delivery%20and%20Improved%20Glioma%20Therapy&amp;author=S.%20Liang&amp;author=H.%20Xu&amp;author=B.-C.%20Ye&amp;volume=38&amp;issue=1&amp;publication_year=2022&amp;pages=299-308&amp;pmid=34936368&amp;doi=10.1021/acs.langmuir.1c02500&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref68">
<cite>Li B., Chen X., Qiu W., Zhao R., Duan J., Zhang S., Pan Z., Zhao S., Guo Q., Qi Y., Wang W., Deng L., Ni S., Sang Y., Xue H., Liu H., Li G.. Synchronous Disintegration of Ferroptosis
Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles
for Glioblastoma Therapy. Adv. Sci. (Weinh) 2022;9(17):e2105451.  doi: 10.1002/advs.202105451.</cite> [<a href="https://doi.org/10.1002/advs.202105451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9189685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35508804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Sci.%20(Weinh)&amp;title=Synchronous%20Disintegration%20of%20Ferroptosis%20Defense%20Axis%20via%20Engineered%20Exosome-Conjugated%20Magnetic%20Nanoparticles%20for%20Glioblastoma%20Therapy&amp;author=B.%20Li&amp;author=X.%20Chen&amp;author=W.%20Qiu&amp;author=R.%20Zhao&amp;author=J.%20Duan&amp;volume=9&amp;issue=17&amp;publication_year=2022&amp;pages=e2105451&amp;pmid=35508804&amp;doi=10.1002/advs.202105451&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref69">
<cite>Jia G., Han Y., An Y., Ding Y., He C., Wang X., Tang Q.. NRP-1 Targeted and Cargo-Loaded Exosomes Facilitate Simultaneous
Imaging and Therapy of Glioma in Vitro and in Vivo. Biomaterials. 2018;178:302–316. doi: 10.1016/j.biomaterials.2018.06.029.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2018.06.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29982104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=NRP-1%20Targeted%20and%20Cargo-Loaded%20Exosomes%20Facilitate%20Simultaneous%20Imaging%20and%20Therapy%20of%20Glioma%20in%20Vitro%20and%20in%20Vivo&amp;author=G.%20Jia&amp;author=Y.%20Han&amp;author=Y.%20An&amp;author=Y.%20Ding&amp;author=C.%20He&amp;volume=178&amp;publication_year=2018&amp;pages=302-316&amp;pmid=29982104&amp;doi=10.1016/j.biomaterials.2018.06.029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref70">
<cite>Rehman F. U., Liu Y., Yang Q., Yang H., Liu R., Zhang D., Muhammad P., Liu Y., Hanif S., Ismail M., Zheng M., Shi B.. Heme Oxygenase-1
Targeting Exosomes
for Temozolomide Resistant Glioblastoma Synergistic Therapy. J. Controlled Release. 2022;345:696–708. doi: 10.1016/j.jconrel.2022.03.036.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2022.03.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35341901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Heme%20Oxygenase-1%20Targeting%20Exosomes%20for%20Temozolomide%20Resistant%20Glioblastoma%20Synergistic%20Therapy&amp;author=F.%20U.%20Rehman&amp;author=Y.%20Liu&amp;author=Q.%20Yang&amp;author=H.%20Yang&amp;author=R.%20Liu&amp;volume=345&amp;publication_year=2022&amp;pages=696-708&amp;pmid=35341901&amp;doi=10.1016/j.jconrel.2022.03.036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref71">
<cite>Cui J., Wang X., Li J., Zhu A., Du Y., Zeng W., Guo Y., Di L., Wang R.. Immune Exosomes
Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier
for Chemo-Immunotherapy against Glioblastoma. ACS Nano. 2023;17:1464. doi: 10.1021/acsnano.2c10219.</cite> [<a href="https://doi.org/10.1021/acsnano.2c10219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36626296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Immune%20Exosomes%20Loading%20Self-Assembled%20Nanomicelles%20Traverse%20the%20Blood-Brain%20Barrier%20for%20Chemo-Immunotherapy%20against%20Glioblastoma&amp;author=J.%20Cui&amp;author=X.%20Wang&amp;author=J.%20Li&amp;author=A.%20Zhu&amp;author=Y.%20Du&amp;volume=17&amp;publication_year=2023&amp;pages=1464&amp;pmid=36626296&amp;doi=10.1021/acsnano.2c10219&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref72">
<cite>Lundstrom K.. Viral Vectors
in Gene Therapy. Diseases. 2018;6(2):42. doi: 10.3390/diseases6020042.</cite> [<a href="https://doi.org/10.3390/diseases6020042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6023384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29883422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diseases&amp;title=Viral%20Vectors%20in%20Gene%20Therapy&amp;author=K.%20Lundstrom&amp;volume=6&amp;issue=2&amp;publication_year=2018&amp;pages=42&amp;pmid=29883422&amp;doi=10.3390/diseases6020042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref73">
<cite>Kay M. A.. State-of-the-Art
Gene-Based Therapies: The Road Ahead. Nat. Rev.
Genet. 2011;12(5):316–328. doi: 10.1038/nrg2971.</cite> [<a href="https://doi.org/10.1038/nrg2971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21468099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Genet&amp;title=State-of-the-Art%20Gene-Based%20Therapies:%20The%20Road%20Ahead&amp;author=M.%20A.%20Kay&amp;volume=12&amp;issue=5&amp;publication_year=2011&amp;pages=316-328&amp;pmid=21468099&amp;doi=10.1038/nrg2971&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref74">
<cite>Song R., Pekrun K., Khan T. A., Zhang F., Paşca S. P., Kay M. A.. Selection of RAAV Vectors That Cross the Human Blood-Brain
Barrier and Target the Central Nervous System Using a Transwell Model. Mol. Ther Methods Clin Dev. 2022;27:73–88. doi: 10.1016/j.omtm.2022.09.002.</cite> [<a href="https://doi.org/10.1016/j.omtm.2022.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9494039/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36186955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Ther%20Methods%20Clin%20Dev&amp;title=Selection%20of%20RAAV%20Vectors%20That%20Cross%20the%20Human%20Blood-Brain%20Barrier%20and%20Target%20the%20Central%20Nervous%20System%20Using%20a%20Transwell%20Model&amp;author=R.%20Song&amp;author=K.%20Pekrun&amp;author=T.%20A.%20Khan&amp;author=F.%20Zhang&amp;author=S.%20P.%20Pa%C5%9Fca&amp;volume=27&amp;publication_year=2022&amp;pages=73-88&amp;pmid=36186955&amp;doi=10.1016/j.omtm.2022.09.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref75">
<cite>Rodrigues J. P., Prajapati N., DeCoster M. A., Poh S., Murray T. A.. Efficient
LRP1-Mediated Uptake and Low Cytotoxicity of Peptide L57 In Vitro
Shows Its Promise as CNS Drug Delivery Vector. J. Pharm. Sci. 2021;110(2):824–832. doi: 10.1016/j.xphs.2020.09.019.</cite> [<a href="https://doi.org/10.1016/j.xphs.2020.09.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7855644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33065129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharm.%20Sci.&amp;title=Efficient%20LRP1-Mediated%20Uptake%20and%20Low%20Cytotoxicity%20of%20Peptide%20L57%20In%20Vitro%20Shows%20Its%20Promise%20as%20CNS%20Drug%20Delivery%20Vector&amp;author=J.%20P.%20Rodrigues&amp;author=N.%20Prajapati&amp;author=M.%20A.%20DeCoster&amp;author=S.%20Poh&amp;author=T.%20A.%20Murray&amp;volume=110&amp;issue=2&amp;publication_year=2021&amp;pages=824-832&amp;pmid=33065129&amp;doi=10.1016/j.xphs.2020.09.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref76">
<cite>Haberman R. P., McCown T. J., Samulski R. J.. Novel Transcriptional
Regulatory
Signals in the Adeno-Associated Virus Terminal Repeat A/D Junction
Element. J. Virol. 2000;74(18):8732–8739. doi: 10.1128/JVI.74.18.8732-8739.2000.</cite> [<a href="https://doi.org/10.1128/JVI.74.18.8732-8739.2000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC116385/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10954575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Virol&amp;title=Novel%20Transcriptional%20Regulatory%20Signals%20in%20the%20Adeno-Associated%20Virus%20Terminal%20Repeat%20A/D%20Junction%20Element&amp;author=R.%20P.%20Haberman&amp;author=T.%20J.%20McCown&amp;author=R.%20J.%20Samulski&amp;volume=74&amp;issue=18&amp;publication_year=2000&amp;pages=8732-8739&amp;pmid=10954575&amp;doi=10.1128/JVI.74.18.8732-8739.2000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref77">
<cite>Zhang H., Yang B., Mu X., Ahmed S. S., Su Q., He R., Wang H., Mueller C., Sena-Esteves M., Brown R., Xu Z., Gao G.. Several RAAV Vectors
Efficiently Cross the Blood-Brain Barrier and Transduce Neurons and
Astrocytes in the Neonatal Mouse Central Nervous System. Mol. Ther. 2011;19(8):1440–1448. doi: 10.1038/mt.2011.98.</cite> [<a href="https://doi.org/10.1038/mt.2011.98" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3149178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21610699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Ther&amp;title=Several%20RAAV%20Vectors%20Efficiently%20Cross%20the%20Blood-Brain%20Barrier%20and%20Transduce%20Neurons%20and%20Astrocytes%20in%20the%20Neonatal%20Mouse%20Central%20Nervous%20System&amp;author=H.%20Zhang&amp;author=B.%20Yang&amp;author=X.%20Mu&amp;author=S.%20S.%20Ahmed&amp;author=Q.%20Su&amp;volume=19&amp;issue=8&amp;publication_year=2011&amp;pages=1440-1448&amp;pmid=21610699&amp;doi=10.1038/mt.2011.98&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref78">
<cite>Cearley C. N., Vandenberghe L. H., Parente M. K., Carnish E. R., Wilson J. M., Wolfe J. H.. Expanded
Repertoire of AAV Vector Serotypes Mediate
Unique Patterns of Transduction in Mouse Brain. Mol. Ther. 2008;16(10):1710–1718. doi: 10.1038/mt.2008.166.</cite> [<a href="https://doi.org/10.1038/mt.2008.166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3056207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18714307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Ther&amp;title=Expanded%20Repertoire%20of%20AAV%20Vector%20Serotypes%20Mediate%20Unique%20Patterns%20of%20Transduction%20in%20Mouse%20Brain&amp;author=C.%20N.%20Cearley&amp;author=L.%20H.%20Vandenberghe&amp;author=M.%20K.%20Parente&amp;author=E.%20R.%20Carnish&amp;author=J.%20M.%20Wilson&amp;volume=16&amp;issue=10&amp;publication_year=2008&amp;pages=1710-1718&amp;pmid=18714307&amp;doi=10.1038/mt.2008.166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref79">
<cite>Cearley C. N., Wolfe J. H.. Transduction Characteristics of Adeno-Associated Virus
Vectors Expressing Cap Serotypes 7, 8, 9, and Rh10 in the Mouse Brain. Mol. Ther. 2006;13(3):528–537. doi: 10.1016/j.ymthe.2005.11.015.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2005.11.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16413228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Ther&amp;title=Transduction%20Characteristics%20of%20Adeno-Associated%20Virus%20Vectors%20Expressing%20Cap%20Serotypes%207,%208,%209,%20and%20Rh10%20in%20the%20Mouse%20Brain&amp;author=C.%20N.%20Cearley&amp;author=J.%20H.%20Wolfe&amp;volume=13&amp;issue=3&amp;publication_year=2006&amp;pages=528-537&amp;pmid=16413228&amp;doi=10.1016/j.ymthe.2005.11.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref80">
<cite>Albright B. H., Storey C. M., Murlidharan G., Castellanos Rivera R. M., Berry G. E., Madigan V. J., Asokan A.. Mapping the Structural
Determinants Required for AAVrh.10 Transport across the Blood-Brain
Barrier. Mol. Ther. 2018;26(2):510–523. doi: 10.1016/j.ymthe.2017.10.017.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2017.10.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5835146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29175157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Ther&amp;title=Mapping%20the%20Structural%20Determinants%20Required%20for%20AAVrh.10%20Transport%20across%20the%20Blood-Brain%20Barrier&amp;author=B.%20H.%20Albright&amp;author=C.%20M.%20Storey&amp;author=G.%20Murlidharan&amp;author=R.%20M.%20Castellanos%20Rivera&amp;author=G.%20E.%20Berry&amp;volume=26&amp;issue=2&amp;publication_year=2018&amp;pages=510-523&amp;pmid=29175157&amp;doi=10.1016/j.ymthe.2017.10.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref81">
<cite>Chuapoco M. R., Flytzanis N. C., Goeden N., Christopher Octeau J., Roxas K. M., Chan K. Y., Scherrer J., Winchester J., Blackburn R. J., Campos L. J., Man K. N. M., Sun J., Chen X., Lefevre A., Singh V. P., Arokiaraj C. M., Shay T. F., Vendemiatti J., Jang M. J., Mich J. K., Bishaw Y., Gore B. B., Omstead V., Taskin N., Weed N., Levi B. P., Ting J. T., Miller C. T., Deverman B. E., Pickel J., Tian L., Fox A. S., Gradinaru V.. Adeno-Associated Viral Vectors for Functional Intravenous
Gene Transfer throughout the Non-Human Primate Brain. Nat. Nanotechnol. 2023;18:1241. doi: 10.1038/s41565-023-01419-x.</cite> [<a href="https://doi.org/10.1038/s41565-023-01419-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10575780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37430038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Nanotechnol&amp;title=Adeno-Associated%20Viral%20Vectors%20for%20Functional%20Intravenous%20Gene%20Transfer%20throughout%20the%20Non-Human%20Primate%20Brain&amp;author=M.%20R.%20Chuapoco&amp;author=N.%20C.%20Flytzanis&amp;author=N.%20Goeden&amp;author=J.%20Christopher%20Octeau&amp;author=K.%20M.%20Roxas&amp;volume=18&amp;publication_year=2023&amp;pages=1241&amp;pmid=37430038&amp;doi=10.1038/s41565-023-01419-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref82">
<cite>Israel L. L., Galstyan A., Cox A., Shatalova E. S., Sun T., Rashid M.-H., Grodzinski Z., Chiechi A., Fuchs D.-T., Patil R., Koronyo-Hamaoui M., Black K. L., Ljubimova J. Y., Holler E.. Signature Effects of Vector-Guided Systemic Nano Bioconjugate
Delivery Across Blood-Brain Barrier of Normal, Alzheimer’s,
and Tumor Mouse Models. ACS Nano. 2022;16(8):11815–11832. doi: 10.1021/acsnano.1c10034.</cite> [<a href="https://doi.org/10.1021/acsnano.1c10034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9413444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35961653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Signature%20Effects%20of%20Vector-Guided%20Systemic%20Nano%20Bioconjugate%20Delivery%20Across%20Blood-Brain%20Barrier%20of%20Normal,%20Alzheimer%E2%80%99s,%20and%20Tumor%20Mouse%20Models&amp;author=L.%20L.%20Israel&amp;author=A.%20Galstyan&amp;author=A.%20Cox&amp;author=E.%20S.%20Shatalova&amp;author=T.%20Sun&amp;volume=16&amp;issue=8&amp;publication_year=2022&amp;pages=11815-11832&amp;pmid=35961653&amp;doi=10.1021/acsnano.1c10034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref83">
<cite>Israel L. L., Sun T., Braubach O., Cox A., Shatalova E. S., Rashid H.-M., Galstyan A., Grodzinski Z., Song X. Y., Chepurna O., Ljubimov V. A., Chiechi A., Sharma S., Phebus C., Wang Y., Ljubimova J. Y., Black K. L., Holler E.. β-Amyloid Targeting Nanodrug
for Neuron-Specific Delivery of Nucleic Acids in Alzheimer’s
Disease Mouse Models. J. Controlled Release. 2023;361:636–658. doi: 10.1016/j.jconrel.2023.08.001.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2023.08.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37544515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=%CE%B2-Amyloid%20Targeting%20Nanodrug%20for%20Neuron-Specific%20Delivery%20of%20Nucleic%20Acids%20in%20Alzheimer%E2%80%99s%20Disease%20Mouse%20Models&amp;author=L.%20L.%20Israel&amp;author=T.%20Sun&amp;author=O.%20Braubach&amp;author=A.%20Cox&amp;author=E.%20S.%20Shatalova&amp;volume=361&amp;publication_year=2023&amp;pages=636-658&amp;pmid=37544515&amp;doi=10.1016/j.jconrel.2023.08.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref84">
<cite>Marino M., Zhou L., Rincon M. Y., Callaerts-Vegh Z., Verhaert J., Wahis J., Creemers E., Yshii L., Wierda K., Saito T., Marneffe C., Voytyuk I., Wouters Y., Dewilde M., Duqué S. I., Vincke C., Levites Y., Golde T. E., Saido T. C., Muyldermans S., Liston A., De Strooper B., Holt M. G.. AAV-Mediated Delivery of an Anti-BACE1 VHH Alleviates
Pathology in an Alzheimer’s Disease Model. EMBO Mol. Med. 2022;14(4):e09824.  doi: 10.15252/emmm.201809824.</cite> [<a href="https://doi.org/10.15252/emmm.201809824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8988209/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35352880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Mol.%20Med.&amp;title=AAV-Mediated%20Delivery%20of%20an%20Anti-BACE1%20VHH%20Alleviates%20Pathology%20in%20an%20Alzheimer%E2%80%99s%20Disease%20Model&amp;author=M.%20Marino&amp;author=L.%20Zhou&amp;author=M.%20Y.%20Rincon&amp;author=Z.%20Callaerts-Vegh&amp;author=J.%20Verhaert&amp;volume=14&amp;issue=4&amp;publication_year=2022&amp;pages=e09824&amp;pmid=35352880&amp;doi=10.15252/emmm.201809824&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref85">
<cite>Neves A. R., Albuquerque T., Faria R., Gonçalves A. M., Santos C., Vivès E., Boisguérin P., Passarinha L. A., Sousa Â., Costa D.. Development of WRAP5
Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma
Therapy. Pharmaceutics. 2022;14(10):2213. doi: 10.3390/pharmaceutics14102213.</cite> [<a href="https://doi.org/10.3390/pharmaceutics14102213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9607428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36297647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Development%20of%20WRAP5%20Peptide%20Complexes%20for%20Targeted%20Drug/Gene%20Co-Delivery%20toward%20Glioblastoma%20Therapy&amp;author=A.%20R.%20Neves&amp;author=T.%20Albuquerque&amp;author=R.%20Faria&amp;author=A.%20M.%20Gon%C3%A7alves&amp;author=C.%20Santos&amp;volume=14&amp;issue=10&amp;publication_year=2022&amp;pages=2213&amp;pmid=36297647&amp;doi=10.3390/pharmaceutics14102213&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref86">
<cite>Zhang H., Wang T., Qiu W., Han Y., Sun Q., Zeng J., Yan F., Zheng H., Li Z., Gao M.. Monitoring the Opening and Recovery of the Blood-Brain
Barrier with
Noninvasive Molecular Imaging by Biodegradable Ultrasmall Cu­(2- x)­Se
Nanoparticles. Nano Lett. 2018;18(8):4985–4992. doi: 10.1021/acs.nanolett.8b01818.</cite> [<a href="https://doi.org/10.1021/acs.nanolett.8b01818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29995426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett.&amp;title=Monitoring%20the%20Opening%20and%20Recovery%20of%20the%20Blood-Brain%20Barrier%20with%20Noninvasive%20Molecular%20Imaging%20by%20Biodegradable%20Ultrasmall%20Cu%C2%AD(2-%20x)%C2%ADSe%20Nanoparticles&amp;author=H.%20Zhang&amp;author=T.%20Wang&amp;author=W.%20Qiu&amp;author=Y.%20Han&amp;author=Q.%20Sun&amp;volume=18&amp;issue=8&amp;publication_year=2018&amp;pages=4985-4992&amp;pmid=29995426&amp;doi=10.1021/acs.nanolett.8b01818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref87">
<cite>Ohta S., Kikuchi E., Ishijima A., Azuma T., Sakuma I., Ito T.. Investigating the Optimum
Size of Nanoparticles for Their Delivery
into the Brain Assisted by Focused Ultrasound-Induced Blood-Brain
Barrier Opening. Sci. Rep. 2020;10(1):18220. doi: 10.1038/s41598-020-75253-9.</cite> [<a href="https://doi.org/10.1038/s41598-020-75253-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7588485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33106562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep&amp;title=Investigating%20the%20Optimum%20Size%20of%20Nanoparticles%20for%20Their%20Delivery%20into%20the%20Brain%20Assisted%20by%20Focused%20Ultrasound-Induced%20Blood-Brain%20Barrier%20Opening&amp;author=S.%20Ohta&amp;author=E.%20Kikuchi&amp;author=A.%20Ishijima&amp;author=T.%20Azuma&amp;author=I.%20Sakuma&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=18220&amp;pmid=33106562&amp;doi=10.1038/s41598-020-75253-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref88">
<cite>Li X., Vemireddy V., Cai Q., Xiong H., Kang P., Li X., Giannotta M., Hayenga H. N., Pan E., Sirsi S. R., Mateo C., Kleinfeld D., Greene C., Campbell M., Dejana E., Bachoo R., Qin Z.. Reversibly Modulating
the Blood-Brain Barrier by Laser Stimulation of Molecular-Targeted
Nanoparticles. Nano Lett. 2021;21(22):9805–9815. doi: 10.1021/acs.nanolett.1c02996.</cite> [<a href="https://doi.org/10.1021/acs.nanolett.1c02996" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8616836/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34516144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett.&amp;title=Reversibly%20Modulating%20the%20Blood-Brain%20Barrier%20by%20Laser%20Stimulation%20of%20Molecular-Targeted%20Nanoparticles&amp;author=X.%20Li&amp;author=V.%20Vemireddy&amp;author=Q.%20Cai&amp;author=H.%20Xiong&amp;author=P.%20Kang&amp;volume=21&amp;issue=22&amp;publication_year=2021&amp;pages=9805-9815&amp;pmid=34516144&amp;doi=10.1021/acs.nanolett.1c02996&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref89">
<cite>Lilius T. O., Mortensen K. N., Deville C., Lohela T. J., Stæger F. F., Sigurdsson B., Fiordaliso E. M., Rosenholm M., Kamphuis C., Beekman F. J., Jensen A. I., Nedergaard M.. Glymphatic-Assisted
Perivascular Brain Delivery of Intrathecal Small Gold Nanoparticles. J. Controlled Release. 2023;355:135–148. doi: 10.1016/j.jconrel.2023.01.054.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2023.01.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36731802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Glymphatic-Assisted%20Perivascular%20Brain%20Delivery%20of%20Intrathecal%20Small%20Gold%20Nanoparticles&amp;author=T.%20O.%20Lilius&amp;author=K.%20N.%20Mortensen&amp;author=C.%20Deville&amp;author=T.%20J.%20Lohela&amp;author=F.%20F.%20St%C3%A6ger&amp;volume=355&amp;publication_year=2023&amp;pages=135-148&amp;pmid=36731802&amp;doi=10.1016/j.jconrel.2023.01.054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref187">
<cite>Wünsch A., Mulac D., Langer K.. Lecithin coating
binds
ApoE and mediates non-lysosomal uptake leading to transcytosis over
the blood-brain barrier. Int. J. Pharm. 2020;589:119821. doi: 10.1016/j.ijpharm.2020.119821.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2020.119821" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32861770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Pharm.&amp;title=Lecithin%20coating%20binds%20ApoE%20and%20mediates%20non-lysosomal%20uptake%20leading%20to%20transcytosis%20over%20the%20blood-brain%20barrier&amp;author=A.%20W%C3%BCnsch&amp;author=D.%20Mulac&amp;author=K.%20Langer&amp;volume=589&amp;publication_year=2020&amp;pages=119821&amp;pmid=32861770&amp;doi=10.1016/j.ijpharm.2020.119821&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref90">
<cite>Rabanel J.-M., Piec P.-A., Landri S., Patten S. A., Ramassamy C.. Transport
of PEGylated-PLA Nanoparticles across a Blood Brain Barrier Model,
Entry into Neuronal Cells and in Vivo Brain Bioavailability. J. Controlled Release. 2020;328:679–695. doi: 10.1016/j.jconrel.2020.09.042.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2020.09.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32979453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Transport%20of%20PEGylated-PLA%20Nanoparticles%20across%20a%20Blood%20Brain%20Barrier%20Model,%20Entry%20into%20Neuronal%20Cells%20and%20in%20Vivo%20Brain%20Bioavailability&amp;author=J.-M.%20Rabanel&amp;author=P.-A.%20Piec&amp;author=S.%20Landri&amp;author=S.%20A.%20Patten&amp;author=C.%20Ramassamy&amp;volume=328&amp;publication_year=2020&amp;pages=679-695&amp;pmid=32979453&amp;doi=10.1016/j.jconrel.2020.09.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref91">
<cite>Bharadwaj V. N., Rowe R. K., Harrison J., Wu C., Anderson T. R., Lifshitz J., Adelson P. D., Kodibagkar V. D., Stabenfeldt S. E.. Blood-Brainbarrier Disruption Dictates Nanoparticle
Accumulation Following Experimental Brain Injury. Nanomedicine. 2018;14(7):2155–2166. doi: 10.1016/j.nano.2018.06.004.</cite> [<a href="https://doi.org/10.1016/j.nano.2018.06.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6177306/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29933022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Blood-Brainbarrier%20Disruption%20Dictates%20Nanoparticle%20Accumulation%20Following%20Experimental%20Brain%20Injury&amp;author=V.%20N.%20Bharadwaj&amp;author=R.%20K.%20Rowe&amp;author=J.%20Harrison&amp;author=C.%20Wu&amp;author=T.%20R.%20Anderson&amp;volume=14&amp;issue=7&amp;publication_year=2018&amp;pages=2155-2166&amp;pmid=29933022&amp;doi=10.1016/j.nano.2018.06.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref92">
<cite>Han Z., Han Y., Huang X., Ma H., Zhang X., Song J., Dong J., Li S., Yu R., Liu H.. A Novel Targeted
Nanoparticle for Traumatic Brain Injury Treatment: Combined Effect
of ROS Depletion and Calcium Overload Inhibition. Adv. Healthc Mater. 2022;11(11):e2102256.  doi: 10.1002/adhm.202102256.</cite> [<a href="https://doi.org/10.1002/adhm.202102256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35118827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Healthc%20Mater.&amp;title=A%20Novel%20Targeted%20Nanoparticle%20for%20Traumatic%20Brain%20Injury%20Treatment:%20Combined%20Effect%20of%20ROS%20Depletion%20and%20Calcium%20Overload%20Inhibition&amp;author=Z.%20Han&amp;author=Y.%20Han&amp;author=X.%20Huang&amp;author=H.%20Ma&amp;author=X.%20Zhang&amp;volume=11&amp;issue=11&amp;publication_year=2022&amp;pages=e2102256&amp;pmid=35118827&amp;doi=10.1002/adhm.202102256&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref93">
<cite>Violatto M. B., Pasetto L., Casarin E., Tondello C., Schiavon E., Talamini L., Marchini G., Cagnotto A., Morelli A., Lanno A., Passoni A., Bigini P., Morpurgo M., Bonetto V.. Development of a Nanoparticle-Based
Approach for the
Blood-Brain Barrier Passage in a Murine Model of Amyotrophic Lateral
Sclerosis. Cells. 2022;11(24):4003. doi: 10.3390/cells11244003.</cite> [<a href="https://doi.org/10.3390/cells11244003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9776960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36552768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Development%20of%20a%20Nanoparticle-Based%20Approach%20for%20the%20Blood-Brain%20Barrier%20Passage%20in%20a%20Murine%20Model%20of%20Amyotrophic%20Lateral%20Sclerosis&amp;author=M.%20B.%20Violatto&amp;author=L.%20Pasetto&amp;author=E.%20Casarin&amp;author=C.%20Tondello&amp;author=E.%20Schiavon&amp;volume=11&amp;issue=24&amp;publication_year=2022&amp;pages=4003&amp;pmid=36552768&amp;doi=10.3390/cells11244003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref94">
<cite>Liang J., Gao C., Zhu Y., Ling C., Wang Q., Huang Y., Qin J., Wang J., Lu W., Wang J.. Natural Brain Penetration
Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery. ACS Appl. Mater. Interfaces. 2018;10(36):30201–30213. doi: 10.1021/acsami.8b11782.</cite> [<a href="https://doi.org/10.1021/acsami.8b11782" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30113810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Mater.%20Interfaces&amp;title=Natural%20Brain%20Penetration%20Enhancer-Modified%20Albumin%20Nanoparticles%20for%20Glioma%20Targeting%20Delivery&amp;author=J.%20Liang&amp;author=C.%20Gao&amp;author=Y.%20Zhu&amp;author=C.%20Ling&amp;author=Q.%20Wang&amp;volume=10&amp;issue=36&amp;publication_year=2018&amp;pages=30201-30213&amp;pmid=30113810&amp;doi=10.1021/acsami.8b11782&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref95">
<cite>Ha S.-W., Hwang K., Jin J., Cho A.-S., Kim T. Y., Hwang S. Il, Lee H. J., Kim C.-Y.. Ultrasound-Sensitizing
Nanoparticle Complex for Overcoming the Blood-Brain Barrier: An Effective
Drug Delivery System. Int. J. Nanomedicine. 2019;14:3743–3752. doi: 10.2147/IJN.S193258.</cite> [<a href="https://doi.org/10.2147/IJN.S193258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6539164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31213800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomedicine&amp;title=Ultrasound-Sensitizing%20Nanoparticle%20Complex%20for%20Overcoming%20the%20Blood-Brain%20Barrier:%20An%20Effective%20Drug%20Delivery%20System&amp;author=S.-W.%20Ha&amp;author=K.%20Hwang&amp;author=J.%20Jin&amp;author=A.-S.%20Cho&amp;author=T.%20Y.%20Kim&amp;volume=14&amp;publication_year=2019&amp;pages=3743-3752&amp;pmid=31213800&amp;doi=10.2147/IJN.S193258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref96">
<cite>Rizzuto M. A., Dal Magro R., Barbieri L., Pandolfi L., Sguazzini-Viscontini A., Truffi M., Salvioni L., Corsi F., Colombo M., Re F., Prosperi D.. H-Ferritin Nanoparticle-Mediated Delivery of Antibodies
across a BBB in Vitro Model for Treatment of Brain Malignancies. Biomater Sci. 2021;9(6):2032–2042. doi: 10.1039/D0BM01726D.</cite> [<a href="https://doi.org/10.1039/D0BM01726D" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33544109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater%20Sci.&amp;title=H-Ferritin%20Nanoparticle-Mediated%20Delivery%20of%20Antibodies%20across%20a%20BBB%20in%20Vitro%20Model%20for%20Treatment%20of%20Brain%20Malignancies&amp;author=M.%20A.%20Rizzuto&amp;author=R.%20Dal%20Magro&amp;author=L.%20Barbieri&amp;author=L.%20Pandolfi&amp;author=A.%20Sguazzini-Viscontini&amp;volume=9&amp;issue=6&amp;publication_year=2021&amp;pages=2032-2042&amp;pmid=33544109&amp;doi=10.1039/D0BM01726D&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref97">
<cite>Wu Y., Qian Y., Peng W., Qi X.. Functionalized Nanoparticles
Crossing the Brain-Blood Barrier to Target Glioma Cells. PeerJ. 2023;11:e15571.  doi: 10.7717/peerj.15571.</cite> [<a href="https://doi.org/10.7717/peerj.15571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10327649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37426416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PeerJ.&amp;title=Functionalized%20Nanoparticles%20Crossing%20the%20Brain-Blood%20Barrier%20to%20Target%20Glioma%20Cells&amp;author=Y.%20Wu&amp;author=Y.%20Qian&amp;author=W.%20Peng&amp;author=X.%20Qi&amp;volume=11&amp;publication_year=2023&amp;pages=e15571&amp;pmid=37426416&amp;doi=10.7717/peerj.15571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref188">
<cite>He H., Yao J., Zhang Y., Chen Y., Wang K., Lee R. J., Yu B., Zhang X.. Solid lipid nanoparticles
as a drug delivery system to across the blood-brain barrier. Biochem. Biophys. Res. Commun. 2019;519(2):385–390. doi: 10.1016/j.bbrc.2019.09.017.</cite> [<a href="https://doi.org/10.1016/j.bbrc.2019.09.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31519326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;title=Solid%20lipid%20nanoparticles%20as%20a%20drug%20delivery%20system%20to%20across%20the%20blood-brain%20barrier&amp;author=H.%20He&amp;author=J.%20Yao&amp;author=Y.%20Zhang&amp;author=Y.%20Chen&amp;author=K.%20Wang&amp;volume=519&amp;issue=2&amp;publication_year=2019&amp;pages=385-390&amp;pmid=31519326&amp;doi=10.1016/j.bbrc.2019.09.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref98">
<cite>Gkountas A. A., Polychronopoulos N. D., Sofiadis G. N., Karvelas E. G., Spyrou L. A., Sarris I. E.. Simulation of Magnetic Nanoparticles
Crossing through
a Simplified Blood-Brain Barrier Model for Glioblastoma Multiforme
Treatment. Comput. Methods Programs Biomed. 2021;212:106477.  doi: 10.1016/j.cmpb.2021.106477.</cite> [<a href="https://doi.org/10.1016/j.cmpb.2021.106477" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34736172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Comput.%20Methods%20Programs%20Biomed&amp;title=Simulation%20of%20Magnetic%20Nanoparticles%20Crossing%20through%20a%20Simplified%20Blood-Brain%20Barrier%20Model%20for%20Glioblastoma%20Multiforme%20Treatment&amp;author=A.%20A.%20Gkountas&amp;author=N.%20D.%20Polychronopoulos&amp;author=G.%20N.%20Sofiadis&amp;author=E.%20G.%20Karvelas&amp;author=L.%20A.%20Spyrou&amp;volume=212&amp;publication_year=2021&amp;pages=106477&amp;pmid=34736172&amp;doi=10.1016/j.cmpb.2021.106477&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref99">
<cite>Gareev K., Tagaeva R., Bobkov D., Yudintceva N., Goncharova D., Combs S. E., Ten A., Samochernych K., Shevtsov M.. Passing of Nanocarriers across the
Histohematic Barriers:
Current Approaches for Tumor Theranostics. Nanomaterials. 2023;13(7):1140. doi: 10.3390/nano13071140.</cite> [<a href="https://doi.org/10.3390/nano13071140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10096980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37049234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomaterials&amp;title=Passing%20of%20Nanocarriers%20across%20the%20Histohematic%20Barriers:%20Current%20Approaches%20for%20Tumor%20Theranostics&amp;author=K.%20Gareev&amp;author=R.%20Tagaeva&amp;author=D.%20Bobkov&amp;author=N.%20Yudintceva&amp;author=D.%20Goncharova&amp;volume=13&amp;issue=7&amp;publication_year=2023&amp;pages=1140&amp;pmid=37049234&amp;doi=10.3390/nano13071140&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref100">
<cite>Meng Y., Hynynen K., Lipsman N.. Applications
of Focused
Ultrasound in the Brain: From Thermoablation to Drug Delivery. Nat. Rev. Neurol. 2021;17(1):7–22. doi: 10.1038/s41582-020-00418-z.</cite> [<a href="https://doi.org/10.1038/s41582-020-00418-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33106619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Neurol&amp;title=Applications%20of%20Focused%20Ultrasound%20in%20the%20Brain:%20From%20Thermoablation%20to%20Drug%20Delivery&amp;author=Y.%20Meng&amp;author=K.%20Hynynen&amp;author=N.%20Lipsman&amp;volume=17&amp;issue=1&amp;publication_year=2021&amp;pages=7-22&amp;pmid=33106619&amp;doi=10.1038/s41582-020-00418-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref101">
<cite>MEYERS R., FRY W. J., FRY F. J., DREYER L. L., SCHULTZ D. F., NOYES R. F.. Early Experiences
with Ultrasonic
Irradiation of the Pallidofugal and Nigral Complexes in Hyperkinetic
and Hypertonic Disorders. J. Neurosurg. 1959;16(1):32–54. doi: 10.3171/jns.1959.16.1.0032.</cite> [<a href="https://doi.org/10.3171/jns.1959.16.1.0032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/13621264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurosurg&amp;title=Early%20Experiences%20with%20Ultrasonic%20Irradiation%20of%20the%20Pallidofugal%20and%20Nigral%20Complexes%20in%20Hyperkinetic%20and%20Hypertonic%20Disorders&amp;author=R.%20MEYERS&amp;author=W.%20J.%20FRY&amp;author=F.%20J.%20FRY&amp;author=L.%20L.%20DREYER&amp;author=D.%20F.%20SCHULTZ&amp;volume=16&amp;issue=1&amp;publication_year=1959&amp;pages=32-54&amp;pmid=13621264&amp;doi=10.3171/jns.1959.16.1.0032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref102">
<cite>NELSON E., LINDSTROM P. A., HAYMAKER W.. Pathological Effects
of Ultrasound on the Human Brain. A Study of 25 Cases in Which Ultrasonic
Irradiation Was Used as a Lobotomy Procedure. J. Neuropathol Exp Neurol. 1959;18:489–508. doi: 10.1097/00005072-195910000-00001.</cite> [<a href="https://doi.org/10.1097/00005072-195910000-00001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14426446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neuropathol%20Exp%20Neurol&amp;title=Pathological%20Effects%20of%20Ultrasound%20on%20the%20Human%20Brain.%20A%20Study%20of%2025%20Cases%20in%20Which%20Ultrasonic%20Irradiation%20Was%20Used%20as%20a%20Lobotomy%20Procedure&amp;author=E.%20NELSON&amp;author=P.%20A.%20LINDSTROM&amp;author=W.%20HAYMAKER&amp;volume=18&amp;publication_year=1959&amp;pages=489-508&amp;pmid=14426446&amp;doi=10.1097/00005072-195910000-00001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref103">
<cite>Leksell L.. Echo-Encephalography. I. Detection
of Intracranial
Complications Following Head Injury. Acta Chir
Scand. 1956;110(4):301–315.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/13292078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Chir%20Scand&amp;title=Echo-Encephalography.%20I.%20Detection%20of%20Intracranial%20Complications%20Following%20Head%20Injury&amp;author=L.%20Leksell&amp;volume=110&amp;issue=4&amp;publication_year=1956&amp;pages=301-315&amp;pmid=13292078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref104">
<cite>Kwak G., Grewal A., Slika H., Mess G., Li H., Kwatra M., Poulopoulos A., Woodworth G. F., Eberhart C. G., Ko H. S., Manbachi A., Caplan J., Price R. J., Tyler B., Suk J. S.. Brain Nucleic Acid
Delivery and Genome Editing via Focused Ultrasound-Mediated Blood–Brain
Barrier Opening and Long-Circulating Nanoparticles. ACS Nano. 2024;18(35):24139–24153. doi: 10.1021/acsnano.4c05270.</cite> [<a href="https://doi.org/10.1021/acsnano.4c05270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11792178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39172436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Brain%20Nucleic%20Acid%20Delivery%20and%20Genome%20Editing%20via%20Focused%20Ultrasound-Mediated%20Blood%E2%80%93Brain%20Barrier%20Opening%20and%20Long-Circulating%20Nanoparticles&amp;author=G.%20Kwak&amp;author=A.%20Grewal&amp;author=H.%20Slika&amp;author=G.%20Mess&amp;author=H.%20Li&amp;volume=18&amp;issue=35&amp;publication_year=2024&amp;pages=24139-24153&amp;pmid=39172436&amp;doi=10.1021/acsnano.4c05270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref105">
<cite>Shin J., Kong C., Lee J., Choi B. Y., Sim J., Koh C. S., Park M., Na Y. C., Suh S. W., Chang W. S., Chang J. W.. Focused
Ultrasound-Induced Blood-Brain
Barrier Opening Improves Adult Hippocampal Neurogenesis and Cognitive
Function in a Cholinergic Degeneration Dementia Rat Model. Alzheimers Res. Ther. 2019;11(1):110. doi: 10.1186/s13195-019-0569-x.</cite> [<a href="https://doi.org/10.1186/s13195-019-0569-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6933667/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31881998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Res.%20Ther&amp;title=Focused%20Ultrasound-Induced%20Blood-Brain%20Barrier%20Opening%20Improves%20Adult%20Hippocampal%20Neurogenesis%20and%20Cognitive%20Function%20in%20a%20Cholinergic%20Degeneration%20Dementia%20Rat%20Model&amp;author=J.%20Shin&amp;author=C.%20Kong&amp;author=J.%20Lee&amp;author=B.%20Y.%20Choi&amp;author=J.%20Sim&amp;volume=11&amp;issue=1&amp;publication_year=2019&amp;pages=110&amp;pmid=31881998&amp;doi=10.1186/s13195-019-0569-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref106">
<cite>Xhima K., Markham-Coultes K., Nedev H., Heinen S., Saragovi H. U., Hynynen K., Aubert I.. Focused Ultrasound
Delivery of a Selective TrkA Agonist Rescues Cholinergic Function
in a Mouse Model of Alzheimer’s Disease. Sci. Adv. 2020;6(4):eaax6646. doi: 10.1126/sciadv.aax6646.</cite> [<a href="https://doi.org/10.1126/sciadv.aax6646" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6976301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32010781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Adv.&amp;title=Focused%20Ultrasound%20Delivery%20of%20a%20Selective%20TrkA%20Agonist%20Rescues%20Cholinergic%20Function%20in%20a%20Mouse%20Model%20of%20Alzheimer%E2%80%99s%20Disease&amp;author=K.%20Xhima&amp;author=K.%20Markham-Coultes&amp;author=H.%20Nedev&amp;author=S.%20Heinen&amp;author=H.%20U.%20Saragovi&amp;volume=6&amp;issue=4&amp;publication_year=2020&amp;pages=eaax6646&amp;pmid=32010781&amp;doi=10.1126/sciadv.aax6646&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref107">
<cite>Liu Y., Gong Y., Xie W., Huang A., Yuan X., Zhou H., Zhu X., Chen X., Liu J., Liu J., Qin X.. Microbubbles in Combination with Focused Ultrasound
for the Delivery of Quercetin-Modified Sulfur Nanoparticles through
the Blood Brain Barrier into the Brain Parenchyma and Relief of Endoplasmic
Reticulum Stress to Treat Alzheimer’s Disease. Nanoscale. 2020;12(11):6498–6511. doi: 10.1039/C9NR09713A.</cite> [<a href="https://doi.org/10.1039/C9NR09713A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32154811/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Microbubbles%20in%20Combination%20with%20Focused%20Ultrasound%20for%20the%20Delivery%20of%20Quercetin-Modified%20Sulfur%20Nanoparticles%20through%20the%20Blood%20Brain%20Barrier%20into%20the%20Brain%20Parenchyma%20and%20Relief%20of%20Endoplasmic%20Reticulum%20Stress%20to%20Treat%20Alzheimer%E2%80%99s%20Disease&amp;author=Y.%20Liu&amp;author=Y.%20Gong&amp;author=W.%20Xie&amp;author=A.%20Huang&amp;author=X.%20Yuan&amp;volume=12&amp;issue=11&amp;publication_year=2020&amp;pages=6498-6511&amp;pmid=32154811&amp;doi=10.1039/C9NR09713A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref108">
<cite>Kong C., Ahn J. W., Kim S., Park J. Y., Na Y. C., Chang J. W., Chung S., Chang W. S.. Long-Lasting
Restoration of Memory Function and Hippocampal Synaptic Plasticity
by Focused Ultrasound in Alzheimer’s Disease. Brain Stimul. 2023;16(3):857–866. doi: 10.1016/j.brs.2023.05.014.</cite> [<a href="https://doi.org/10.1016/j.brs.2023.05.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37211337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Stimul&amp;title=Long-Lasting%20Restoration%20of%20Memory%20Function%20and%20Hippocampal%20Synaptic%20Plasticity%20by%20Focused%20Ultrasound%20in%20Alzheimer%E2%80%99s%20Disease&amp;author=C.%20Kong&amp;author=J.%20W.%20Ahn&amp;author=S.%20Kim&amp;author=J.%20Y.%20Park&amp;author=Y.%20C.%20Na&amp;volume=16&amp;issue=3&amp;publication_year=2023&amp;pages=857-866&amp;pmid=37211337&amp;doi=10.1016/j.brs.2023.05.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref109">
<cite>Antoniou A., Stavrou M., Evripidou N., Georgiou E., Kousiappa I., Koupparis A., Papacostas S. S., Kleopa K. A., Damianou C.. FUS-Mediated Blood-Brain
Barrier Disruption for Delivering Anti-Aβ Antibodies in 5XFAD
Alzheimer’s Disease Mice. J. Ultrasound. 2024;27:251. doi: 10.1007/s40477-023-00805-4.</cite> [<a href="https://doi.org/10.1007/s40477-023-00805-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11178731/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37516718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Ultrasound&amp;title=FUS-Mediated%20Blood-Brain%20Barrier%20Disruption%20for%20Delivering%20Anti-A%CE%B2%20Antibodies%20in%205XFAD%20Alzheimer%E2%80%99s%20Disease%20Mice&amp;author=A.%20Antoniou&amp;author=M.%20Stavrou&amp;author=N.%20Evripidou&amp;author=E.%20Georgiou&amp;author=I.%20Kousiappa&amp;volume=27&amp;publication_year=2024&amp;pages=251&amp;pmid=37516718&amp;doi=10.1007/s40477-023-00805-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref110">
<cite>Lipsman N., Meng Y., Bethune A. J., Huang Y., Lam B., Masellis M., Herrmann N., Heyn C., Aubert I., Boutet A., Smith G. S., Hynynen K., Black S. E.. Blood-Brain
Barrier Opening in Alzheimer’s Disease Using MR-Guided Focused
Ultrasound. Nat. Commun. 2018;9(1):2336. doi: 10.1038/s41467-018-04529-6.</cite> [<a href="https://doi.org/10.1038/s41467-018-04529-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6060168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30046032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Blood-Brain%20Barrier%20Opening%20in%20Alzheimer%E2%80%99s%20Disease%20Using%20MR-Guided%20Focused%20Ultrasound&amp;author=N.%20Lipsman&amp;author=Y.%20Meng&amp;author=A.%20J.%20Bethune&amp;author=Y.%20Huang&amp;author=B.%20Lam&amp;volume=9&amp;issue=1&amp;publication_year=2018&amp;pages=2336&amp;pmid=30046032&amp;doi=10.1038/s41467-018-04529-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref111">
<cite>Rezai A. R., Ranjan M., D’Haese P.-F., Haut M. W., Carpenter J., Najib U., Mehta R. I., Chazen J. L., Zibly Z., Yates J. R., Hodder S. L., Kaplitt M.. Noninvasive Hippocampal Blood-Brain Barrier Opening
in Alzheimer’s Disease with Focused Ultrasound. Proc. Natl. Acad. Sci. U. S. A. 2020;117(17):9180–9182. doi: 10.1073/pnas.2002571117.</cite> [<a href="https://doi.org/10.1073/pnas.2002571117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7196825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32284421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.%20S.%20A.&amp;title=Noninvasive%20Hippocampal%20Blood-Brain%20Barrier%20Opening%20in%20Alzheimer%E2%80%99s%20Disease%20with%20Focused%20Ultrasound&amp;author=A.%20R.%20Rezai&amp;author=M.%20Ranjan&amp;author=P.-F.%20D%E2%80%99Haese&amp;author=M.%20W.%20Haut&amp;author=J.%20Carpenter&amp;volume=117&amp;issue=17&amp;publication_year=2020&amp;pages=9180-9182&amp;pmid=32284421&amp;doi=10.1073/pnas.2002571117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref112">
<cite>Mehta R. I., Carpenter J. S., Mehta R. I., Haut M. W., Ranjan M., Najib U., Lockman P., Wang P., D’haese P.-F., Rezai A. R.. Blood-Brain Barrier Opening with
MRI-Guided Focused Ultrasound Elicits Meningeal Venous Permeability
in Humans with Early Alzheimer Disease. Radiology. 2021;298(3):654–662. doi: 10.1148/radiol.2021200643.</cite> [<a href="https://doi.org/10.1148/radiol.2021200643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7924515/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33399511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Blood-Brain%20Barrier%20Opening%20with%20MRI-Guided%20Focused%20Ultrasound%20Elicits%20Meningeal%20Venous%20Permeability%20in%20Humans%20with%20Early%20Alzheimer%20Disease&amp;author=R.%20I.%20Mehta&amp;author=J.%20S.%20Carpenter&amp;author=R.%20I.%20Mehta&amp;author=M.%20W.%20Haut&amp;author=M.%20Ranjan&amp;volume=298&amp;issue=3&amp;publication_year=2021&amp;pages=654-662&amp;pmid=33399511&amp;doi=10.1148/radiol.2021200643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref113">
<cite>Park S. H., Baik K., Jeon S., Chang W. S., Ye B. S., Chang J. W.. Extensive Frontal Focused Ultrasound
Mediated Blood-Brain Barrier Opening for the Treatment of Alzheimer’s
Disease: A Proof-of-Concept Study. Transl Neurodegener. 2021;10(1):44. doi: 10.1186/s40035-021-00269-8.</cite> [<a href="https://doi.org/10.1186/s40035-021-00269-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8570037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34740367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Neurodegener&amp;title=Extensive%20Frontal%20Focused%20Ultrasound%20Mediated%20Blood-Brain%20Barrier%20Opening%20for%20the%20Treatment%20of%20Alzheimer%E2%80%99s%20Disease:%20A%20Proof-of-Concept%20Study&amp;author=S.%20H.%20Park&amp;author=K.%20Baik&amp;author=S.%20Jeon&amp;author=W.%20S.%20Chang&amp;author=B.%20S.%20Ye&amp;volume=10&amp;issue=1&amp;publication_year=2021&amp;pages=44&amp;pmid=34740367&amp;doi=10.1186/s40035-021-00269-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref114">
<cite>Rezai A. R., Ranjan M., Haut M. W., Carpenter J., D’Haese P. F., Mehta R. I., Najib U., Wang P., Claassen D. O., Chazen J. L., Krishna V., Deib G., Zibly Z., Hodder S. L., Wilhelmsen K. C., Finomore V., Konrad P. E., Kaplitt M.. Focused Ultrasound-Mediated
Blood-Brain Barrier Opening in Alzheimer’s Disease: Long-Term
Safety, Imaging, and Cognitive Outcomes. J.
Neurosurg. 2023;139(1):275–283. doi: 10.3171/2022.9.JNS221565.</cite> [<a href="https://doi.org/10.3171/2022.9.JNS221565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36334289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurosurg&amp;title=Focused%20Ultrasound-Mediated%20Blood-Brain%20Barrier%20Opening%20in%20Alzheimer%E2%80%99s%20Disease:%20Long-Term%20Safety,%20Imaging,%20and%20Cognitive%20Outcomes&amp;author=A.%20R.%20Rezai&amp;author=M.%20Ranjan&amp;author=M.%20W.%20Haut&amp;author=J.%20Carpenter&amp;author=P.%20F.%20D%E2%80%99Haese&amp;volume=139&amp;issue=1&amp;publication_year=2023&amp;pages=275-283&amp;pmid=36334289&amp;doi=10.3171/2022.9.JNS221565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref115">
<cite>Mehta R. I., Carpenter J. S., Mehta R. I., Haut M. W., Wang P., Ranjan M., Najib U., D’Haese P.-F., Rezai A. R.. Ultrasound-Mediated
Blood-Brain Barrier Opening Uncovers
an Intracerebral Perivenous Fluid Network in Persons with Alzheimer’s
Disease. Fluids Barriers CNS. 2023;20(1):46. doi: 10.1186/s12987-023-00447-y.</cite> [<a href="https://doi.org/10.1186/s12987-023-00447-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10276371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37328855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fluids%20Barriers%20CNS&amp;title=Ultrasound-Mediated%20Blood-Brain%20Barrier%20Opening%20Uncovers%20an%20Intracerebral%20Perivenous%20Fluid%20Network%20in%20Persons%20with%20Alzheimer%E2%80%99s%20Disease&amp;author=R.%20I.%20Mehta&amp;author=J.%20S.%20Carpenter&amp;author=R.%20I.%20Mehta&amp;author=M.%20W.%20Haut&amp;author=P.%20Wang&amp;volume=20&amp;issue=1&amp;publication_year=2023&amp;pages=46&amp;pmid=37328855&amp;doi=10.1186/s12987-023-00447-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref116">
<cite>Meng Y., Goubran M., Rabin J. S., McSweeney M., Ottoy J., Pople C. B., Huang Y., Storace A., Ozzoude M., Bethune A., Lam B., Swardfager W., Heyn C., Abrahao A., Davidson B., Hamani C., Aubert I., Zetterberg H., Ashton N. J., Karikari T. K., Blennow K., Black S. E., Hynynen K., Lipsman N.. Blood-Brain
Barrier Opening of the Default Mode Network in Alzheimer’s
Disease with Magnetic Resonance-Guided Focused Ultrasound. Brain. 2023;146(3):865–872. doi: 10.1093/brain/awac459.</cite> [<a href="https://doi.org/10.1093/brain/awac459" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10226733/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36694943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Blood-Brain%20Barrier%20Opening%20of%20the%20Default%20Mode%20Network%20in%20Alzheimer%E2%80%99s%20Disease%20with%20Magnetic%20Resonance-Guided%20Focused%20Ultrasound&amp;author=Y.%20Meng&amp;author=M.%20Goubran&amp;author=J.%20S.%20Rabin&amp;author=M.%20McSweeney&amp;author=J.%20Ottoy&amp;volume=146&amp;issue=3&amp;publication_year=2023&amp;pages=865-872&amp;pmid=36694943&amp;doi=10.1093/brain/awac459&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref117">
<cite>Trinh D., Nash J., Goertz D., Hynynen K., Bulner S., Iqbal U., Keenan J.. Microbubble Drug Conjugate
and Focused Ultrasound Blood Brain Barrier Delivery of AAV-2 SIRT-3. Drug Deliv. 2022;29(1):1176–1183. doi: 10.1080/10717544.2022.2035855.</cite> [<a href="https://doi.org/10.1080/10717544.2022.2035855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9004516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35393905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Deliv&amp;title=Microbubble%20Drug%20Conjugate%20and%20Focused%20Ultrasound%20Blood%20Brain%20Barrier%20Delivery%20of%20AAV-2%20SIRT-3&amp;author=D.%20Trinh&amp;author=J.%20Nash&amp;author=D.%20Goertz&amp;author=K.%20Hynynen&amp;author=S.%20Bulner&amp;volume=29&amp;issue=1&amp;publication_year=2022&amp;pages=1176-1183&amp;pmid=35393905&amp;doi=10.1080/10717544.2022.2035855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref118">
<cite>Aly A. E.-E., Sun T., Zhang Y., Li Z., Kyada M., Ma Q., Padegimas L., Sesenoglu-Laird O., Cooper M. J., McDannold N. J., Waszczak B. L.. Focused Ultrasound Enhances Transgene Expression of
Intranasal HGDNF DNA Nanoparticles in the Sonicated Brain Regions. J. Controlled Release. 2023;358:498–509. doi: 10.1016/j.jconrel.2023.04.041.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2023.04.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37127076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Focused%20Ultrasound%20Enhances%20Transgene%20Expression%20of%20Intranasal%20HGDNF%20DNA%20Nanoparticles%20in%20the%20Sonicated%20Brain%20Regions&amp;author=A.%20E.-E.%20Aly&amp;author=T.%20Sun&amp;author=Y.%20Zhang&amp;author=Z.%20Li&amp;author=M.%20Kyada&amp;volume=358&amp;publication_year=2023&amp;pages=498-509&amp;pmid=37127076&amp;doi=10.1016/j.jconrel.2023.04.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref119">
<cite>Gasca-Salas C., Fernández-Rodríguez B., Pineda-Pardo J. A., Rodríguez-Rojas R., Obeso I., Hernández-Fernández F., Del Álamo M., Mata D., Guida P., Ordás-Bandera C., Montero-Roblas J. I., Martínez-Fernández R., Foffani G., Rachmilevitch I., Obeso J. A.. Blood-Brain Barrier
Opening with Focused Ultrasound in Parkinson’s Disease Dementia. Nat. Commun. 2021;12(1):779. doi: 10.1038/s41467-021-21022-9.</cite> [<a href="https://doi.org/10.1038/s41467-021-21022-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7859400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33536430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Blood-Brain%20Barrier%20Opening%20with%20Focused%20Ultrasound%20in%20Parkinson%E2%80%99s%20Disease%20Dementia&amp;author=C.%20Gasca-Salas&amp;author=B.%20Fern%C3%A1ndez-Rodr%C3%ADguez&amp;author=J.%20A.%20Pineda-Pardo&amp;author=R.%20Rodr%C3%ADguez-Rojas&amp;author=I.%20Obeso&amp;volume=12&amp;issue=1&amp;publication_year=2021&amp;pages=779&amp;pmid=33536430&amp;doi=10.1038/s41467-021-21022-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref120">
<cite>Gallay M. N., Moser D., Magara A. E., Haufler F., Jeanmonod D.. Bilateral MR-Guided Focused Ultrasound Pallidothalamic
Tractotomy for Parkinson’s Disease With 1-Year Follow-Up. Front Neurol. 2021;12:601153.  doi: 10.3389/fneur.2021.601153.</cite> [<a href="https://doi.org/10.3389/fneur.2021.601153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7900542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33633664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Neurol&amp;title=Bilateral%20MR-Guided%20Focused%20Ultrasound%20Pallidothalamic%20Tractotomy%20for%20Parkinson%E2%80%99s%20Disease%20With%201-Year%20Follow-Up&amp;author=M.%20N.%20Gallay&amp;author=D.%20Moser&amp;author=A.%20E.%20Magara&amp;author=F.%20Haufler&amp;author=D.%20Jeanmonod&amp;volume=12&amp;publication_year=2021&amp;pages=601153&amp;pmid=33633664&amp;doi=10.3389/fneur.2021.601153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref121">
<cite>Yamamoto K., Ito H., Fukutake S., Odo T., Kamei T., Yamaguchi T., Taira T.. Focused Ultrasound
Thalamotomy for Tremor-Dominant Parkinson’s Disease: A Prospective
1-Year Follow-up Study. Neurol Med. Chir (Tokyo) 2021;61(7):414–421. doi: 10.2176/nmc.oa.2020-0370.</cite> [<a href="https://doi.org/10.2176/nmc.oa.2020-0370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8280323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33967176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurol%20Med.%20Chir%20(Tokyo)&amp;title=Focused%20Ultrasound%20Thalamotomy%20for%20Tremor-Dominant%20Parkinson%E2%80%99s%20Disease:%20A%20Prospective%201-Year%20Follow-up%20Study&amp;author=K.%20Yamamoto&amp;author=H.%20Ito&amp;author=S.%20Fukutake&amp;author=T.%20Odo&amp;author=T.%20Kamei&amp;volume=61&amp;issue=7&amp;publication_year=2021&amp;pages=414-421&amp;pmid=33967176&amp;doi=10.2176/nmc.oa.2020-0370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref122">
<cite>Huang Y., Meng Y., Pople C. B., Bethune A., Jones R. M., Abrahao A., Hamani C., Kalia S. K., Kalia L. V., Lipsman N., Hynynen K.. Cavitation Feedback
Control of Focused Ultrasound Blood-Brain Barrier Opening for Drug
Delivery in Patients with Parkinson’s Disease. Pharmaceutics. 2022;14(12):2607. doi: 10.3390/pharmaceutics14122607.</cite> [<a href="https://doi.org/10.3390/pharmaceutics14122607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9781334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36559101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Cavitation%20Feedback%20Control%20of%20Focused%20Ultrasound%20Blood-Brain%20Barrier%20Opening%20for%20Drug%20Delivery%20in%20Patients%20with%20Parkinson%E2%80%99s%20Disease&amp;author=Y.%20Huang&amp;author=Y.%20Meng&amp;author=C.%20B.%20Pople&amp;author=A.%20Bethune&amp;author=R.%20M.%20Jones&amp;volume=14&amp;issue=12&amp;publication_year=2022&amp;pages=2607&amp;pmid=36559101&amp;doi=10.3390/pharmaceutics14122607&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref123">
<cite>Pineda-Pardo J. A., Gasca-Salas C., Fernández-Rodríguez B., Rodríguez-Rojas R., del Álamo M., Obeso I., Hernández-Fernández F., Trompeta C., Martínez-Fernández R., Matarazzo M., Mata-Marín D., Guida P., Duque A., Albillo D., Plaza de las Heras I., Montero J. I., Foffani G., Toltsis G., Rachmilevitch I., Blesa J., Obeso J. A.. Striatal
Blood-Brain Barrier Opening in Parkinson’s Disease Dementia:
A Pilot Exploratory Study. Mov Disord. 2022;37(10):2057–2065. doi: 10.1002/mds.29134.</cite> [<a href="https://doi.org/10.1002/mds.29134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35765711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mov%20Disord&amp;title=Striatal%20Blood-Brain%20Barrier%20Opening%20in%20Parkinson%E2%80%99s%20Disease%20Dementia:%20A%20Pilot%20Exploratory%20Study&amp;author=J.%20A.%20Pineda-Pardo&amp;author=C.%20Gasca-Salas&amp;author=B.%20Fern%C3%A1ndez-Rodr%C3%ADguez&amp;author=R.%20Rodr%C3%ADguez-Rojas&amp;author=M.%20del%20%C3%81lamo&amp;volume=37&amp;issue=10&amp;publication_year=2022&amp;pages=2057-2065&amp;pmid=35765711&amp;doi=10.1002/mds.29134&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref124">
<cite>Meng Y., Pople C. B., Huang Y., Jones R. M., Ottoy J., Goubran M., Oliveira L. M., Davidson B., Lawrence L. S. P., Lau A. Z., Bethune A., Maralani P., Abrahao A., Hamani C., Hynynen K., Kalia S. K., Lipsman N., Kalia L. V.. Putaminal Recombinant
Glucocerebrosidase
Delivery with Magnetic Resonance-Guided Focused Ultrasound in Parkinson’s
Disease: A Phase I Study. Mov Disord. 2022;37(10):2134–2139. doi: 10.1002/mds.29190.</cite> [<a href="https://doi.org/10.1002/mds.29190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36089809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mov%20Disord&amp;title=Putaminal%20Recombinant%20Glucocerebrosidase%20Delivery%20with%20Magnetic%20Resonance-Guided%20Focused%20Ultrasound%20in%20Parkinson%E2%80%99s%20Disease:%20A%20Phase%20I%20Study&amp;author=Y.%20Meng&amp;author=C.%20B.%20Pople&amp;author=Y.%20Huang&amp;author=R.%20M.%20Jones&amp;author=J.%20Ottoy&amp;volume=37&amp;issue=10&amp;publication_year=2022&amp;pages=2134-2139&amp;pmid=36089809&amp;doi=10.1002/mds.29190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref125">
<cite>Shen Y., Zhang J., Xu Y., Sun S., Chen K., Chen S., Yang X., Chen X.. Ultrasound-Enhanced
Brain Delivery of Edaravone Provides Additive Amelioration on Disease
Progression in an ALS Mouse Model. Brain Stimul. 2023;16(2):628–641. doi: 10.1016/j.brs.2023.03.006.</cite> [<a href="https://doi.org/10.1016/j.brs.2023.03.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36931463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Stimul&amp;title=Ultrasound-Enhanced%20Brain%20Delivery%20of%20Edaravone%20Provides%20Additive%20Amelioration%20on%20Disease%20Progression%20in%20an%20ALS%20Mouse%20Model&amp;author=Y.%20Shen&amp;author=J.%20Zhang&amp;author=Y.%20Xu&amp;author=S.%20Sun&amp;author=K.%20Chen&amp;volume=16&amp;issue=2&amp;publication_year=2023&amp;pages=628-641&amp;pmid=36931463&amp;doi=10.1016/j.brs.2023.03.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref189">
<cite>Abrahao A., Meng Y., Llinas M., Huang Y., Hamani C., Mainprize T., Aubert I., Heyn C., Black S. E., Hynynen K., Lipsman N., Zinman L.. First-in-human
trial of blood-brain barrier opening in amyotrophic lateral sclerosis
using MR-guided focused ultrasound. Nat. Commun. 2019;10(1):4373. doi: 10.1038/s41467-019-12426-9.</cite> [<a href="https://doi.org/10.1038/s41467-019-12426-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6763482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31558719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=First-in-human%20trial%20of%20blood-brain%20barrier%20opening%20in%20amyotrophic%20lateral%20sclerosis%20using%20MR-guided%20focused%20ultrasound&amp;author=A.%20Abrahao&amp;author=Y.%20Meng&amp;author=M.%20Llinas&amp;author=Y.%20Huang&amp;author=C.%20Hamani&amp;volume=10&amp;issue=1&amp;publication_year=2019&amp;pages=4373&amp;pmid=31558719&amp;doi=10.1038/s41467-019-12426-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref126">
<cite>Dong Q., He L., Chen L., Deng Q.. Opening the
Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments
of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble
Contrast Agent. Biomed Res. Int. 2018;2018:1. doi: 10.1155/2018/6501508.</cite> [<a href="https://doi.org/10.1155/2018/6501508" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6252217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30534564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Res.%20Int.&amp;title=Opening%20the%20Blood-Brain%20Barrier%20and%20Improving%20the%20Efficacy%20of%20Temozolomide%20Treatments%20of%20Glioblastoma%20Using%20Pulsed,%20Focused%20Ultrasound%20with%20a%20Microbubble%20Contrast%20Agent&amp;author=Q.%20Dong&amp;author=L.%20He&amp;author=L.%20Chen&amp;author=Q.%20Deng&amp;volume=2018&amp;publication_year=2018&amp;pages=1&amp;pmid=30534564&amp;doi=10.1155/2018/6501508&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref127">
<cite>Wei H.-J., Upadhyayula P. S., Pouliopoulos A. N., Englander Z. K., Zhang X., Jan C.-I., Guo J., Mela A., Zhang Z., Wang T. J. C., Bruce J. N., Canoll P. D., Feldstein N. A., Zacharoulis S., Konofagou E. E., Wu C.-C.. Focused Ultrasound-Mediated Blood-Brain
Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma
Treatment. Int. J. Radiat Oncol Biol. Phys. 2021;110(2):539–550. doi: 10.1016/j.ijrobp.2020.12.019.</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2020.12.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8553628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33346092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Radiat%20Oncol%20Biol.%20Phys.&amp;title=Focused%20Ultrasound-Mediated%20Blood-Brain%20Barrier%20Opening%20Increases%20Delivery%20and%20Efficacy%20of%20Etoposide%20for%20Glioblastoma%20Treatment&amp;author=H.-J.%20Wei&amp;author=P.%20S.%20Upadhyayula&amp;author=A.%20N.%20Pouliopoulos&amp;author=Z.%20K.%20Englander&amp;author=X.%20Zhang&amp;volume=110&amp;issue=2&amp;publication_year=2021&amp;pages=539-550&amp;pmid=33346092&amp;doi=10.1016/j.ijrobp.2020.12.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref128">
<cite>Moon H., Hwang K., Nam K. M., Kim Y.-S., Ko M. J., Kim H. R., Lee H. J., Kim M. J., Kim T. H., Kang K.-S., Kim N. G., Choi S. W., Kim C.-Y.. Enhanced
Delivery to Brain Using Sonosensitive Liposome
and Microbubble with Focused Ultrasound. Biomaterials
advances. 2022;141:213102.  doi: 10.1016/j.bioadv.2022.213102.</cite> [<a href="https://doi.org/10.1016/j.bioadv.2022.213102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36103796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials%20advances&amp;title=Enhanced%20Delivery%20to%20Brain%20Using%20Sonosensitive%20Liposome%20and%20Microbubble%20with%20Focused%20Ultrasound&amp;author=H.%20Moon&amp;author=K.%20Hwang&amp;author=K.%20M.%20Nam&amp;author=Y.-S.%20Kim&amp;author=M.%20J.%20Ko&amp;volume=141&amp;publication_year=2022&amp;pages=213102&amp;pmid=36103796&amp;doi=10.1016/j.bioadv.2022.213102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref129">
<cite>Wang F., Dong L., Liang S., Wei X., Wang Y., Chang L., Guo K., Wu H., Chang Y., Yin Y., Wang L., Shi Y., Yan F., Li N.. Ultrasound-Triggered
Drug Delivery for Glioma Therapy
through Gambogic Acid-Loaded Nanobubble-Microbubble Complexes. Biomed Pharmacother. 2022;150:113042.  doi: 10.1016/j.biopha.2022.113042.</cite> [<a href="https://doi.org/10.1016/j.biopha.2022.113042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35658212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Pharmacother&amp;title=Ultrasound-Triggered%20Drug%20Delivery%20for%20Glioma%20Therapy%20through%20Gambogic%20Acid-Loaded%20Nanobubble-Microbubble%20Complexes&amp;author=F.%20Wang&amp;author=L.%20Dong&amp;author=S.%20Liang&amp;author=X.%20Wei&amp;author=Y.%20Wang&amp;volume=150&amp;publication_year=2022&amp;pages=113042&amp;pmid=35658212&amp;doi=10.1016/j.biopha.2022.113042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref130">
<cite>Martinez P., Nault G., Steiner J., Wempe M. F., Pierce A., Brunt B., Slade M., Mongin A., Song J., Song K.-H., Ellens N., Serkova N., Green A., Borden M.. MRI-Guided Focused Ultrasound Blood-Brain
Barrier Opening Increases Drug Delivery and Efficacy in a Diffuse
Midline Glioma Mouse Model. bioRxiv. 2023 doi: 10.1101/2023.04.05.534448.</cite> [<a href="https://doi.org/10.1101/2023.04.05.534448" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10547466/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37795179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=bioRxiv&amp;title=MRI-Guided%20Focused%20Ultrasound%20Blood-Brain%20Barrier%20Opening%20Increases%20Drug%20Delivery%20and%20Efficacy%20in%20a%20Diffuse%20Midline%20Glioma%20Mouse%20Model&amp;author=P.%20Martinez&amp;author=G.%20Nault&amp;author=J.%20Steiner&amp;author=M.%20F.%20Wempe&amp;author=A.%20Pierce&amp;publication_year=2023&amp;pmid=37795179&amp;doi=10.1101/2023.04.05.534448&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref131">
<cite>Park S. H., Kim M. J., Jung H. H., Chang W. S., Choi H. S., Rachmilevitch I., Zadicario E., Chang J. W.. One-Year Outcome of Multiple Blood-Brain
Barrier Disruptions
With Temozolomide for the Treatment of Glioblastoma. Front Oncol. 2020;10:1663. doi: 10.3389/fonc.2020.01663.</cite> [<a href="https://doi.org/10.3389/fonc.2020.01663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7511634/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33014832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=One-Year%20Outcome%20of%20Multiple%20Blood-Brain%20Barrier%20Disruptions%20With%20Temozolomide%20for%20the%20Treatment%20of%20Glioblastoma&amp;author=S.%20H.%20Park&amp;author=M.%20J.%20Kim&amp;author=H.%20H.%20Jung&amp;author=W.%20S.%20Chang&amp;author=H.%20S.%20Choi&amp;volume=10&amp;publication_year=2020&amp;pages=1663&amp;pmid=33014832&amp;doi=10.3389/fonc.2020.01663&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref132">
<cite>Park S. H., Kim M. J., Jung H. H., Chang W. S., Choi H. S., Rachmilevitch I., Zadicario E., Chang J. W.. Safety and Feasibility of Multiple
Blood-Brain Barrier
Disruptions for the Treatment of Glioblastoma in Patients Undergoing
Standard Adjuvant Chemotherapy. J. Neurosurg. 2021;134(2):475–483. doi: 10.3171/2019.10.JNS192206.</cite> [<a href="https://doi.org/10.3171/2019.10.JNS192206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31899873/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurosurg&amp;title=Safety%20and%20Feasibility%20of%20Multiple%20Blood-Brain%20Barrier%20Disruptions%20for%20the%20Treatment%20of%20Glioblastoma%20in%20Patients%20Undergoing%20Standard%20Adjuvant%20Chemotherapy&amp;author=S.%20H.%20Park&amp;author=M.%20J.%20Kim&amp;author=H.%20H.%20Jung&amp;author=W.%20S.%20Chang&amp;author=H.%20S.%20Choi&amp;volume=134&amp;issue=2&amp;publication_year=2021&amp;pages=475-483&amp;pmid=31899873&amp;doi=10.3171/2019.10.JNS192206&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref133">
<cite>Anastasiadis P., Gandhi D., Guo Y., Ahmed A.-K., Bentzen S. M., Arvanitis C., Woodworth G. F.. Localized
Blood-Brain Barrier Opening in Infiltrating Gliomas with MRI-Guided
Acoustic Emissions-Controlled Focused Ultrasound. Proc. Natl. Acad. Sci. U. S. A. 2021;118(37):e2103280118.  doi: 10.1073/pnas.2103280118.</cite> [<a href="https://doi.org/10.1073/pnas.2103280118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8449371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34504017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.%20S.%20A.&amp;title=Localized%20Blood-Brain%20Barrier%20Opening%20in%20Infiltrating%20Gliomas%20with%20MRI-Guided%20Acoustic%20Emissions-Controlled%20Focused%20Ultrasound&amp;author=P.%20Anastasiadis&amp;author=D.%20Gandhi&amp;author=Y.%20Guo&amp;author=A.-K.%20Ahmed&amp;author=S.%20M.%20Bentzen&amp;volume=118&amp;issue=37&amp;publication_year=2021&amp;pages=e2103280118&amp;pmid=34504017&amp;doi=10.1073/pnas.2103280118&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref134">
<cite>Sonabend A. M., Gould A., Amidei C., Ward R., Schmidt K. A., Zhang D. Y., Gomez C., Bebawy J. F., Liu B. P., Bouchoux G., Desseaux C., Helenowski I. B., Lukas R. V., Dixit K., Kumthekar P., Arrieta V. A., Lesniak M. S., Carpentier A., Zhang H., Muzzio M., Canney M., Stupp R.. Repeated Blood-Brain
Barrier Opening with an Implantable Ultrasound Device for Delivery
of Albumin-Bound Paclitaxel in Patients with Recurrent Glioblastoma:
A Phase 1 Trial. Lancet Oncol. 2023;24(5):509–522. doi: 10.1016/S1470-2045(23)00112-2.</cite> [<a href="https://doi.org/10.1016/S1470-2045(23)00112-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10256454/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37142373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Repeated%20Blood-Brain%20Barrier%20Opening%20with%20an%20Implantable%20Ultrasound%20Device%20for%20Delivery%20of%20Albumin-Bound%20Paclitaxel%20in%20Patients%20with%20Recurrent%20Glioblastoma:%20A%20Phase%201%20Trial&amp;author=A.%20M.%20Sonabend&amp;author=A.%20Gould&amp;author=C.%20Amidei&amp;author=R.%20Ward&amp;author=K.%20A.%20Schmidt&amp;volume=24&amp;issue=5&amp;publication_year=2023&amp;pages=509-522&amp;pmid=37142373&amp;doi=10.1016/S1470-2045(23)00112-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref135">
<cite>Erdő F., Bors L. A., Farkas D., Bajza Á., Gizurarson S.. Evaluation of Intranasal Delivery
Route of Drug Administration
for Brain Targeting. Brain Res. Bull. 2018;143:155–170. doi: 10.1016/j.brainresbull.2018.10.009.</cite> [<a href="https://doi.org/10.1016/j.brainresbull.2018.10.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30449731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Res.%20Bull.&amp;title=Evaluation%20of%20Intranasal%20Delivery%20Route%20of%20Drug%20Administration%20for%20Brain%20Targeting&amp;author=F.%20Erd%C5%91&amp;author=L.%20A.%20Bors&amp;author=D.%20Farkas&amp;author=%C3%81.%20Bajza&amp;author=S.%20Gizurarson&amp;volume=143&amp;publication_year=2018&amp;pages=155-170&amp;pmid=30449731&amp;doi=10.1016/j.brainresbull.2018.10.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref136">
<cite>Crowe T. P., Greenlee M. H. W., Kanthasamy A. G., Hsu W. H.. Mechanism of Intranasal Drug Delivery Directly to the
Brain. Life Sci. 2018;195:44–52. doi: 10.1016/j.lfs.2017.12.025.</cite> [<a href="https://doi.org/10.1016/j.lfs.2017.12.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29277310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sci.&amp;title=Mechanism%20of%20Intranasal%20Drug%20Delivery%20Directly%20to%20the%20Brain&amp;author=T.%20P.%20Crowe&amp;author=M.%20H.%20W.%20Greenlee&amp;author=A.%20G.%20Kanthasamy&amp;author=W.%20H.%20Hsu&amp;volume=195&amp;publication_year=2018&amp;pages=44-52&amp;pmid=29277310&amp;doi=10.1016/j.lfs.2017.12.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref137">
<cite>Pardeshi C. V., Belgamwar V. S.. Direct
Nose to Brain Drug Delivery
via Integrated Nerve Pathways Bypassing the Blood-Brain Barrier: An
Excellent Platform for Brain Targeting. Expert
Opin Drug Deliv. 2013;10(7):957–972. doi: 10.1517/17425247.2013.790887.</cite> [<a href="https://doi.org/10.1517/17425247.2013.790887" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23586809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Drug%20Deliv&amp;title=Direct%20Nose%20to%20Brain%20Drug%20Delivery%20via%20Integrated%20Nerve%20Pathways%20Bypassing%20the%20Blood-Brain%20Barrier:%20An%20Excellent%20Platform%20for%20Brain%20Targeting&amp;author=C.%20V.%20Pardeshi&amp;author=V.%20S.%20Belgamwar&amp;volume=10&amp;issue=7&amp;publication_year=2013&amp;pages=957-972&amp;pmid=23586809&amp;doi=10.1517/17425247.2013.790887&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref138">
<cite>Sasaki K., Fukakusa S., Torikai Y., Suzuki C., Sonohata I., Kawahata T., Magata Y., Kawai K., Haruta S.. Effective Nose-to-Brain Drug Delivery Using a Combination
System Targeting the Olfactory Region in Monkeys. J. Controlled Release. 2023;359:384–399. doi: 10.1016/j.jconrel.2023.06.005.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2023.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37315691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Effective%20Nose-to-Brain%20Drug%20Delivery%20Using%20a%20Combination%20System%20Targeting%20the%20Olfactory%20Region%20in%20Monkeys&amp;author=K.%20Sasaki&amp;author=S.%20Fukakusa&amp;author=Y.%20Torikai&amp;author=C.%20Suzuki&amp;author=I.%20Sonohata&amp;volume=359&amp;publication_year=2023&amp;pages=384-399&amp;pmid=37315691&amp;doi=10.1016/j.jconrel.2023.06.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref139">
<cite>Cecchelli R., Berezowski V., Lundquist S., Culot M., Renftel M., Dehouck M.-P., Fenart L.. Modelling
of the Blood-Brain Barrier in Drug Discovery and Development. Nat. Rev. Drug Discov. 2007;6(8):650–661. doi: 10.1038/nrd2368.</cite> [<a href="https://doi.org/10.1038/nrd2368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17667956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Drug%20Discov&amp;title=Modelling%20of%20the%20Blood-Brain%20Barrier%20in%20Drug%20Discovery%20and%20Development&amp;author=R.%20Cecchelli&amp;author=V.%20Berezowski&amp;author=S.%20Lundquist&amp;author=M.%20Culot&amp;author=M.%20Renftel&amp;volume=6&amp;issue=8&amp;publication_year=2007&amp;pages=650-661&amp;pmid=17667956&amp;doi=10.1038/nrd2368&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref140">
<cite>Lindup W. E., Orme M. C.. Clinical Pharmacology:
Plasma Protein
Binding of Drugs. Br Med. J. (Clin Res. Ed) 1981;282(6259):212–214. doi: 10.1136/bmj.282.6259.212.</cite> [<a href="https://doi.org/10.1136/bmj.282.6259.212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1503970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6779954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20Med.%20J.%20(Clin%20Res.%20Ed)&amp;title=Clinical%20Pharmacology:%20Plasma%20Protein%20Binding%20of%20Drugs&amp;author=W.%20E.%20Lindup&amp;author=M.%20C.%20Orme&amp;volume=282&amp;issue=6259&amp;publication_year=1981&amp;pages=212-214&amp;pmid=6779954&amp;doi=10.1136/bmj.282.6259.212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref141">
<cite>Padmakumar S., Jones G., Pawar G., Khorkova O., Hsiao J., Kim J., Amiji M. M., Bleier B. S.. Minimally
Invasive Nasal Depot (MIND) Technique for Direct BDNF AntagoNAT Delivery
to the Brain. J. Controlled Release. 2021;331:176–186. doi: 10.1016/j.jconrel.2021.01.027.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2021.01.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7946770/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33484777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Minimally%20Invasive%20Nasal%20Depot%20(MIND)%20Technique%20for%20Direct%20BDNF%20AntagoNAT%20Delivery%20to%20the%20Brain&amp;author=S.%20Padmakumar&amp;author=G.%20Jones&amp;author=G.%20Pawar&amp;author=O.%20Khorkova&amp;author=J.%20Hsiao&amp;volume=331&amp;publication_year=2021&amp;pages=176-186&amp;pmid=33484777&amp;doi=10.1016/j.jconrel.2021.01.027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref142">
<cite>Gudis D., Zhao K., Cohen N. A.. Acquired
Cilia Dysfunction
in Chronic Rhinosinusitis. Am. J. Rhinol Allergy. 2012;26(1):1–6. doi: 10.2500/ajra.2012.26.3716.</cite> [<a href="https://doi.org/10.2500/ajra.2012.26.3716" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3906518/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22391065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Rhinol%20Allergy&amp;title=Acquired%20Cilia%20Dysfunction%20in%20Chronic%20Rhinosinusitis&amp;author=D.%20Gudis&amp;author=K.%20Zhao&amp;author=N.%20A.%20Cohen&amp;volume=26&amp;issue=1&amp;publication_year=2012&amp;pages=1-6&amp;pmid=22391065&amp;doi=10.2500/ajra.2012.26.3716&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref143">
<cite>Bahadur S., Sachan N., Harwansh R. K., Deshmukh R.. Nanoparticlized
System: Promising Approach for the Management of Alzheimer’s
Disease through Intranasal Delivery. Curr. Pharm.
Des. 2020;26(12):1331–1344. doi: 10.2174/1381612826666200311131658.</cite> [<a href="https://doi.org/10.2174/1381612826666200311131658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32160843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Pharm.%20Des&amp;title=Nanoparticlized%20System:%20Promising%20Approach%20for%20the%20Management%20of%20Alzheimer%E2%80%99s%20Disease%20through%20Intranasal%20Delivery&amp;author=S.%20Bahadur&amp;author=N.%20Sachan&amp;author=R.%20K.%20Harwansh&amp;author=R.%20Deshmukh&amp;volume=26&amp;issue=12&amp;publication_year=2020&amp;pages=1331-1344&amp;pmid=32160843&amp;doi=10.2174/1381612826666200311131658&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref144">
<cite>Yang X., Yang W., Xia X., Lei T., Yang Z., Jia W., Zhou Y., Cheng G., Gao H.. Intranasal Delivery of BACE1 SiRNA and Rapamycin by Dual Targets
Modified Nanoparticles for Alzheimer’s Disease Therapy. Small. 2022;18(30):e2203182.  doi: 10.1002/smll.202203182.</cite> [<a href="https://doi.org/10.1002/smll.202203182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35771092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Small&amp;title=Intranasal%20Delivery%20of%20BACE1%20SiRNA%20and%20Rapamycin%20by%20Dual%20Targets%20Modified%20Nanoparticles%20for%20Alzheimer%E2%80%99s%20Disease%20Therapy&amp;author=X.%20Yang&amp;author=W.%20Yang&amp;author=X.%20Xia&amp;author=T.%20Lei&amp;author=Z.%20Yang&amp;volume=18&amp;issue=30&amp;publication_year=2022&amp;pages=e2203182&amp;pmid=35771092&amp;doi=10.1002/smll.202203182&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref145">
<cite>Espinoza L. C., Guaya D., Calpena A. C., Perotti R. M., Halbaut L., Sosa L., Brito-Llera A., Mallandrich M.. Comparative Study of Donepezil-Loaded Formulations
for the Treatment of Alzheimer’s Disease by Nasal Administration. Gels. 2022;8(11):715. doi: 10.3390/gels8110715.</cite> [<a href="https://doi.org/10.3390/gels8110715" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9689763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36354623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gels&amp;title=Comparative%20Study%20of%20Donepezil-Loaded%20Formulations%20for%20the%20Treatment%20of%20Alzheimer%E2%80%99s%20Disease%20by%20Nasal%20Administration&amp;author=L.%20C.%20Espinoza&amp;author=D.%20Guaya&amp;author=A.%20C.%20Calpena&amp;author=R.%20M.%20Perotti&amp;author=L.%20Halbaut&amp;volume=8&amp;issue=11&amp;publication_year=2022&amp;pages=715&amp;pmid=36354623&amp;doi=10.3390/gels8110715&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref146">
<cite>Lin H., Xie L., Lv L., Chen J., Feng F., Liu W., Han L., Liu F.. Intranasally Administered Thermosensitive
Gel for Brain-Targeted Delivery of Rhynchophylline to Treat Parkinson’s
Disease. Colloids Surf. B Biointerfaces. 2023;222:113065.  doi: 10.1016/j.colsurfb.2022.113065.</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2022.113065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36473372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Colloids%20Surf.%20B%20Biointerfaces&amp;title=Intranasally%20Administered%20Thermosensitive%20Gel%20for%20Brain-Targeted%20Delivery%20of%20Rhynchophylline%20to%20Treat%20Parkinson%E2%80%99s%20Disease&amp;author=H.%20Lin&amp;author=L.%20Xie&amp;author=L.%20Lv&amp;author=J.%20Chen&amp;author=F.%20Feng&amp;volume=222&amp;publication_year=2023&amp;pages=113065&amp;pmid=36473372&amp;doi=10.1016/j.colsurfb.2022.113065&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref147">
<cite>Di Scala C., Armstrong N., Chahinian H., Chabrière E., Fantini J., Yahi N.. AmyP53, a
Therapeutic
Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s
Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to
Brain Delivery. Int. J. Mol. Sci. 2022;23(21):13383. doi: 10.3390/ijms232113383.</cite> [<a href="https://doi.org/10.3390/ijms232113383" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9654333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36362170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=AmyP53,%20a%20Therapeutic%20Peptide%20Candidate%20for%20the%20Treatment%20of%20Alzheimer%E2%80%99s%20and%20Parkinson%E2%80%99s%20Disease:%20Safety,%20Stability,%20Pharmacokinetics%20Parameters%20and%20Nose-to%20Brain%20Delivery&amp;author=C.%20Di%20Scala&amp;author=N.%20Armstrong&amp;author=H.%20Chahinian&amp;author=E.%20Chabri%C3%A8re&amp;author=J.%20Fantini&amp;volume=23&amp;issue=21&amp;publication_year=2022&amp;pages=13383&amp;pmid=36362170&amp;doi=10.3390/ijms232113383&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref148">
<cite>Fan N., Li Q., Liu Y., Ma B., Li M., Yin D.. Preparation of an HI-6-Loaded Brain-Targeted
Liposomes Based on the
Nasal Delivery Route and the Evaluation of Its Reactivation of Central
Toxic Acetylcholinesterase. Eur. J. Pharm. Sci. 2023;184:106406.  doi: 10.1016/j.ejps.2023.106406.</cite> [<a href="https://doi.org/10.1016/j.ejps.2023.106406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36805055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharm.%20Sci.&amp;title=Preparation%20of%20an%20HI-6-Loaded%20Brain-Targeted%20Liposomes%20Based%20on%20the%20Nasal%20Delivery%20Route%20and%20the%20Evaluation%20of%20Its%20Reactivation%20of%20Central%20Toxic%20Acetylcholinesterase&amp;author=N.%20Fan&amp;author=Q.%20Li&amp;author=Y.%20Liu&amp;author=B.%20Ma&amp;author=M.%20Li&amp;volume=184&amp;publication_year=2023&amp;pages=106406&amp;pmid=36805055&amp;doi=10.1016/j.ejps.2023.106406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref149">
<cite>Du W., Li H., Tian B., Sai S., Gao Y., Lan T., Meng Y., Ding C.. Development
of Nose-to-Brain Delivery
of Ketoconazole by Nanostructured Lipid Carriers against Cryptococcal
Meningoencephalitis in Mice. Colloids Surf.
B Biointerfaces. 2019;183:110446.  doi: 10.1016/j.colsurfb.2019.110446.</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2019.110446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31465938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Colloids%20Surf.%20B%20Biointerfaces&amp;title=Development%20of%20Nose-to-Brain%20Delivery%20of%20Ketoconazole%20by%20Nanostructured%20Lipid%20Carriers%20against%20Cryptococcal%20Meningoencephalitis%20in%20Mice&amp;author=W.%20Du&amp;author=H.%20Li&amp;author=B.%20Tian&amp;author=S.%20Sai&amp;author=Y.%20Gao&amp;volume=183&amp;publication_year=2019&amp;pages=110446&amp;pmid=31465938&amp;doi=10.1016/j.colsurfb.2019.110446&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref150">
<cite>Nair A. B., Chaudhary S., Jacob S., Patel D., Shinu P., Shah H., Chaudhary A., Aldhubiab B., Almuqbil R. M., Alnaim A. S., Alqattan F., Shah J.. Intranasal Administration of Dolutegravir-Loaded
Nanoemulsion-Based
In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting. Gels. 2023;9(2):130. doi: 10.3390/gels9020130.</cite> [<a href="https://doi.org/10.3390/gels9020130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9956165/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36826300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gels&amp;title=Intranasal%20Administration%20of%20Dolutegravir-Loaded%20Nanoemulsion-Based%20In%20Situ%20Gel%20for%20Enhanced%20Bioavailability%20and%20Direct%20Brain%20Targeting&amp;author=A.%20B.%20Nair&amp;author=S.%20Chaudhary&amp;author=S.%20Jacob&amp;author=D.%20Patel&amp;author=P.%20Shinu&amp;volume=9&amp;issue=2&amp;publication_year=2023&amp;pages=130&amp;pmid=36826300&amp;doi=10.3390/gels9020130&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref151">
<cite>Abo El-Enin H. A., Ahmed M. F., Naguib I. A., El-Far S. W., Ghoneim M. M., Alsalahat I., Abdel-Bar H. M.. Utilization
of Polymeric Micelles as a Lucrative Platform for Efficient Brain
Deposition of Olanzapine as an Antischizophrenic Drug via Intranasal
Delivery. Pharmaceuticals (Basel) 2022;15(2):249. doi: 10.3390/ph15020249.</cite> [<a href="https://doi.org/10.3390/ph15020249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8877317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35215361/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Utilization%20of%20Polymeric%20Micelles%20as%20a%20Lucrative%20Platform%20for%20Efficient%20Brain%20Deposition%20of%20Olanzapine%20as%20an%20Antischizophrenic%20Drug%20via%20Intranasal%20Delivery&amp;author=H.%20A.%20Abo%20El-Enin&amp;author=M.%20F.%20Ahmed&amp;author=I.%20A.%20Naguib&amp;author=S.%20W.%20El-Far&amp;author=M.%20M.%20Ghoneim&amp;volume=15&amp;issue=2&amp;publication_year=2022&amp;pages=249&amp;pmid=35215361&amp;doi=10.3390/ph15020249&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref152">
<cite>Thakkar H., Modi B., Patel B.. Intranasal
Spray of
Cubosomal Tizanidine Hydrochloride for Brain Targeting: In Vitro and
in Vivo Characterisation. J. Microencapsul. 2023;40(5):366–383. doi: 10.1080/02652048.2023.2209651.</cite> [<a href="https://doi.org/10.1080/02652048.2023.2209651" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37129532/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Microencapsul&amp;title=Intranasal%20Spray%20of%20Cubosomal%20Tizanidine%20Hydrochloride%20for%20Brain%20Targeting:%20In%20Vitro%20and%20in%20Vivo%20Characterisation&amp;author=H.%20Thakkar&amp;author=B.%20Modi&amp;author=B.%20Patel&amp;volume=40&amp;issue=5&amp;publication_year=2023&amp;pages=366-383&amp;pmid=37129532&amp;doi=10.1080/02652048.2023.2209651&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref153">
<cite>Bekhet M. A., Ali A. A., Kharshoum R. M., El-Ela F. I. A., Salem H. F.. Intranasal
Niosomal In Situ Gel As
A Novel Strategy for Improving Citicoline Efficacy and Brain Delivery
in Treatment of Epilepsy: In Vitro and Ex Vivo Characterization and
In Vivo Pharmacodynamics Investigation. J. Pharm.
Sci. 2022;111(8):2258–2269. doi: 10.1016/j.xphs.2022.02.012.</cite> [<a href="https://doi.org/10.1016/j.xphs.2022.02.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35235845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharm.%20Sci.&amp;title=Intranasal%20Niosomal%20In%20Situ%20Gel%20As%20A%20Novel%20Strategy%20for%20Improving%20Citicoline%20Efficacy%20and%20Brain%20Delivery%20in%20Treatment%20of%20Epilepsy:%20In%20Vitro%20and%20Ex%20Vivo%20Characterization%20and%20In%20Vivo%20Pharmacodynamics%20Investigation&amp;author=M.%20A.%20Bekhet&amp;author=A.%20A.%20Ali&amp;author=R.%20M.%20Kharshoum&amp;author=F.%20I.%20A.%20El-Ela&amp;author=H.%20F.%20Salem&amp;volume=111&amp;issue=8&amp;publication_year=2022&amp;pages=2258-2269&amp;pmid=35235845&amp;doi=10.1016/j.xphs.2022.02.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref154">
<cite>Guo M., Ge X., Wang C., Yin Z., Jia Z., Hu T., Li M., Wang D., Han Z., Wang L., Xiong X., Chen F., Lei P.. Intranasal
Delivery
of Gene-Edited Microglial Exosomes Improves Neurological Outcomes
after Intracerebral Hemorrhage by Regulating Neuroinflammation. Brain Sci. 2023;13(4):639. doi: 10.3390/brainsci13040639.</cite> [<a href="https://doi.org/10.3390/brainsci13040639" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10137037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37190604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Sci.&amp;title=Intranasal%20Delivery%20of%20Gene-Edited%20Microglial%20Exosomes%20Improves%20Neurological%20Outcomes%20after%20Intracerebral%20Hemorrhage%20by%20Regulating%20Neuroinflammation&amp;author=M.%20Guo&amp;author=X.%20Ge&amp;author=C.%20Wang&amp;author=Z.%20Yin&amp;author=Z.%20Jia&amp;volume=13&amp;issue=4&amp;publication_year=2023&amp;pages=639&amp;pmid=37190604&amp;doi=10.3390/brainsci13040639&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref155">
<cite>Alaayedi M. H., Maraie N. K.. Lomustine’s Nanoemulsion as
Nose-to-Brain Drug Delivery System for CNS Tumor Treatment. Saudi Pharm. J. 2023;31(8):101692.  doi: 10.1016/j.jsps.2023.06.025.</cite> [<a href="https://doi.org/10.1016/j.jsps.2023.06.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10344812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37457367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Saudi%20Pharm.%20J.&amp;title=Lomustine%E2%80%99s%20Nanoemulsion%20as%20Nose-to-Brain%20Drug%20Delivery%20System%20for%20CNS%20Tumor%20Treatment&amp;author=M.%20H.%20Alaayedi&amp;author=N.%20K.%20Maraie&amp;volume=31&amp;issue=8&amp;publication_year=2023&amp;pages=101692&amp;pmid=37457367&amp;doi=10.1016/j.jsps.2023.06.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref156">
<cite>Farheen M., Akhter M. H., Chitme H., Akhter M. S., Tabassum F., Jaremko M., Emwas A.-H.. Harnessing
Folate-Functionalized
Nasal Delivery of Dox-Erlo-Loaded Biopolymeric Nanoparticles in Cancer
Treatment: Development, Optimization, Characterization, and Biodistribution
Analysis. Pharmaceuticals (Basel) 2023;16(2):207. doi: 10.3390/ph16020207.</cite> [<a href="https://doi.org/10.3390/ph16020207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9959140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37259356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Harnessing%20Folate-Functionalized%20Nasal%20Delivery%20of%20Dox-Erlo-Loaded%20Biopolymeric%20Nanoparticles%20in%20Cancer%20Treatment:%20Development,%20Optimization,%20Characterization,%20and%20Biodistribution%20Analysis&amp;author=M.%20Farheen&amp;author=M.%20H.%20Akhter&amp;author=H.%20Chitme&amp;author=M.%20S.%20Akhter&amp;author=F.%20Tabassum&amp;volume=16&amp;issue=2&amp;publication_year=2023&amp;pages=207&amp;pmid=37259356&amp;doi=10.3390/ph16020207&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref157">
<cite>Sandbhor P., Goda J., Mohanty B., Gera P., Yadav S., Chekuri G., Chaudhari P., Dutt S., Banerjee R.. Targeted Nano-Delivery of Chemotherapy
via Intranasal Route Suppresses in Vivo Glioblastoma Growth and Prolongs
Survival in the Intracranial Mouse Model. Drug
Deliv Transl Res. 2023;13(2):608–626. doi: 10.1007/s13346-022-01220-8.</cite> [<a href="https://doi.org/10.1007/s13346-022-01220-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36245060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Deliv%20Transl%20Res.&amp;title=Targeted%20Nano-Delivery%20of%20Chemotherapy%20via%20Intranasal%20Route%20Suppresses%20in%20Vivo%20Glioblastoma%20Growth%20and%20Prolongs%20Survival%20in%20the%20Intracranial%20Mouse%20Model&amp;author=P.%20Sandbhor&amp;author=J.%20Goda&amp;author=B.%20Mohanty&amp;author=P.%20Gera&amp;author=S.%20Yadav&amp;volume=13&amp;issue=2&amp;publication_year=2023&amp;pages=608-626&amp;pmid=36245060&amp;doi=10.1007/s13346-022-01220-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref158">
<cite>Yang Y., Zhang X., Wu S., Zhang R., Zhou B., Zhang X., Tang L., Tian Y., Men K., Yang L.. Enhanced Nose-to-Brain Delivery of SiRNA Using Hyaluronan-Enveloped
Nanomicelles for Glioma Therapy. J. Controlled
Release. 2022;342:66–80. doi: 10.1016/j.jconrel.2021.12.034.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2021.12.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34973309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Enhanced%20Nose-to-Brain%20Delivery%20of%20SiRNA%20Using%20Hyaluronan-Enveloped%20Nanomicelles%20for%20Glioma%20Therapy&amp;author=Y.%20Yang&amp;author=X.%20Zhang&amp;author=S.%20Wu&amp;author=R.%20Zhang&amp;author=B.%20Zhou&amp;volume=342&amp;publication_year=2022&amp;pages=66-80&amp;pmid=34973309&amp;doi=10.1016/j.jconrel.2021.12.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref159">
<cite>Semyachkina-Glushkovskaya O., Shirokov A., Blokhina I., Telnova V., Vodovozova E., Alekseeva A., Boldyrev I., Fedosov I., Dubrovsky A., Khorovodov A., Terskov A., Evsukova A., Elovenko D., Adushkina V., Tzoy M., Agranovich I., Kurths J., Rafailov E.. Intranasal Delivery of Liposomes
to Glioblastoma by Photostimulation of the Lymphatic System. Pharmaceutics. 2023;15(1):36. doi: 10.3390/pharmaceutics15010036.</cite> [<a href="https://doi.org/10.3390/pharmaceutics15010036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9867158/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36678667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Intranasal%20Delivery%20of%20Liposomes%20to%20Glioblastoma%20by%20Photostimulation%20of%20the%20Lymphatic%20System&amp;author=O.%20Semyachkina-Glushkovskaya&amp;author=A.%20Shirokov&amp;author=I.%20Blokhina&amp;author=V.%20Telnova&amp;author=E.%20Vodovozova&amp;volume=15&amp;issue=1&amp;publication_year=2023&amp;pages=36&amp;pmid=36678667&amp;doi=10.3390/pharmaceutics15010036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref160">
<cite>Puris E., Fricker G., Gynther M.. Targeting Transporters
for Drug Delivery to the Brain: Can We Do Better? Pharm. Res. 2022;39(7):1415–1455. doi: 10.1007/s11095-022-03241-x.</cite> [<a href="https://doi.org/10.1007/s11095-022-03241-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9246765/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35359241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm.%20Res.&amp;title=Targeting%20Transporters%20for%20Drug%20Delivery%20to%20the%20Brain:%20Can%20We%20Do%20Better?&amp;author=E.%20Puris&amp;author=G.%20Fricker&amp;author=M.%20Gynther&amp;volume=39&amp;issue=7&amp;publication_year=2022&amp;pages=1415-1455&amp;pmid=35359241&amp;doi=10.1007/s11095-022-03241-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref161">
<cite>Anthony D. P., Hegde M., Shetty S. S., Rafic T., Mutalik S., Rao B. S. S.. Targeting Receptor-Ligand
Chemistry
for Drug Delivery across Blood-Brain Barrier in Brain Diseases. Life Sci. 2021;274:119326.  doi: 10.1016/j.lfs.2021.119326.</cite> [<a href="https://doi.org/10.1016/j.lfs.2021.119326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33711385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sci.&amp;title=Targeting%20Receptor-Ligand%20Chemistry%20for%20Drug%20Delivery%20across%20Blood-Brain%20Barrier%20in%20Brain%20Diseases&amp;author=D.%20P.%20Anthony&amp;author=M.%20Hegde&amp;author=S.%20S.%20Shetty&amp;author=T.%20Rafic&amp;author=S.%20Mutalik&amp;volume=274&amp;publication_year=2021&amp;pages=119326&amp;pmid=33711385&amp;doi=10.1016/j.lfs.2021.119326&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref162">
<cite>Pulgar V. M.. Transcytosis to Cross the Blood Brain Barrier, New
Advancements and Challenges. Front Neurosci. 2019;12:1019. doi: 10.3389/fnins.2018.01019.</cite> [<a href="https://doi.org/10.3389/fnins.2018.01019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6337067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30686985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Neurosci&amp;title=Transcytosis%20to%20Cross%20the%20Blood%20Brain%20Barrier,%20New%20Advancements%20and%20Challenges&amp;author=V.%20M.%20Pulgar&amp;volume=12&amp;publication_year=2019&amp;pages=1019&amp;pmid=30686985&amp;doi=10.3389/fnins.2018.01019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref163">
<cite>De Bock M., Van Haver V., Vandenbroucke R. E., Decrock E., Wang N., Leybaert L.. Into Rather
Unexplored
Terrain-Transcellular Transport across the Blood-Brain Barrier. Glia. 2016;64(7):1097–1123. doi: 10.1002/glia.22960.</cite> [<a href="https://doi.org/10.1002/glia.22960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26852907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Glia&amp;title=Into%20Rather%20Unexplored%20Terrain-Transcellular%20Transport%20across%20the%20Blood-Brain%20Barrier&amp;author=M.%20De%20Bock&amp;author=V.%20Van%20Haver&amp;author=R.%20E.%20Vandenbroucke&amp;author=E.%20Decrock&amp;author=N.%20Wang&amp;volume=64&amp;issue=7&amp;publication_year=2016&amp;pages=1097-1123&amp;pmid=26852907&amp;doi=10.1002/glia.22960&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref164">
<cite>Pandit R., Koh W. K., Sullivan R. K. P., Palliyaguru T., Parton R. G., Götz J.. Role for Caveolin-Mediated Transcytosis
in Facilitating Transport of Large Cargoes into the Brain via Ultrasound. J. Controlled Release. 2020;327:667–675. doi: 10.1016/j.jconrel.2020.09.015.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2020.09.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32918963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Role%20for%20Caveolin-Mediated%20Transcytosis%20in%20Facilitating%20Transport%20of%20Large%20Cargoes%20into%20the%20Brain%20via%20Ultrasound&amp;author=R.%20Pandit&amp;author=W.%20K.%20Koh&amp;author=R.%20K.%20P.%20Sullivan&amp;author=T.%20Palliyaguru&amp;author=R.%20G.%20Parton&amp;volume=327&amp;publication_year=2020&amp;pages=667-675&amp;pmid=32918963&amp;doi=10.1016/j.jconrel.2020.09.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref165">
<cite>Virgintino D., Robertson D., Errede M., Benagiano V., Tauer U., Roncali L., Bertossi M.. Expression of Caveolin-1
in Human Brain Microvessels. Neuroscience. 2002;115(1):145–152. doi: 10.1016/S0306-4522(02)00374-3.</cite> [<a href="https://doi.org/10.1016/S0306-4522(02)00374-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12401329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=Expression%20of%20Caveolin-1%20in%20Human%20Brain%20Microvessels&amp;author=D.%20Virgintino&amp;author=D.%20Robertson&amp;author=M.%20Errede&amp;author=V.%20Benagiano&amp;author=U.%20Tauer&amp;volume=115&amp;issue=1&amp;publication_year=2002&amp;pages=145-152&amp;pmid=12401329&amp;doi=10.1016/S0306-4522(02)00374-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref166">
<cite>Knowland D., Arac A., Sekiguchi K. J., Hsu M., Lutz S. E., Perrino J., Steinberg G. K., Barres B. A., Nimmerjahn A., Agalliu D.. Stepwise Recruitment
of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier
Breakdown in Stroke. Neuron. 2014;82(3):603–617. doi: 10.1016/j.neuron.2014.03.003.</cite> [<a href="https://doi.org/10.1016/j.neuron.2014.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4016169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24746419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Stepwise%20Recruitment%20of%20Transcellular%20and%20Paracellular%20Pathways%20Underlies%20Blood-Brain%20Barrier%20Breakdown%20in%20Stroke&amp;author=D.%20Knowland&amp;author=A.%20Arac&amp;author=K.%20J.%20Sekiguchi&amp;author=M.%20Hsu&amp;author=S.%20E.%20Lutz&amp;volume=82&amp;issue=3&amp;publication_year=2014&amp;pages=603-617&amp;pmid=24746419&amp;doi=10.1016/j.neuron.2014.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref167">
<cite>Andreone B. J., Chow B. W., Tata A., Lacoste B., Ben-Zvi A., Bullock K., Deik A. A., Ginty D. D., Clish C. B., Gu C.. Blood-Brain Barrier
Permeability
Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated
Transcytosis. Neuron. 2017;94(3):581–594. doi: 10.1016/j.neuron.2017.03.043.</cite> [<a href="https://doi.org/10.1016/j.neuron.2017.03.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5474951/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28416077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Blood-Brain%20Barrier%20Permeability%20Is%20Regulated%20by%20Lipid%20Transport-Dependent%20Suppression%20of%20Caveolae-Mediated%20Transcytosis&amp;author=B.%20J.%20Andreone&amp;author=B.%20W.%20Chow&amp;author=A.%20Tata&amp;author=B.%20Lacoste&amp;author=A.%20Ben-Zvi&amp;volume=94&amp;issue=3&amp;publication_year=2017&amp;pages=581-594&amp;pmid=28416077&amp;doi=10.1016/j.neuron.2017.03.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref168">
<cite>Deng J., Huang Q., Wang F., Liu Y., Wang Z., Wang Z., Zhang Q., Lei B., Cheng Y.. The Role of Caveolin-1 in Blood-Brain Barrier Disruption Induced
by Focused Ultrasound Combined with Microbubbles. J. Mol. Neurosci. 2012;46(3):677–687. doi: 10.1007/s12031-011-9629-9.</cite> [<a href="https://doi.org/10.1007/s12031-011-9629-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21861133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Neurosci&amp;title=The%20Role%20of%20Caveolin-1%20in%20Blood-Brain%20Barrier%20Disruption%20Induced%20by%20Focused%20Ultrasound%20Combined%20with%20Microbubbles&amp;author=J.%20Deng&amp;author=Q.%20Huang&amp;author=F.%20Wang&amp;author=Y.%20Liu&amp;author=Z.%20Wang&amp;volume=46&amp;issue=3&amp;publication_year=2012&amp;pages=677-687&amp;pmid=21861133&amp;doi=10.1007/s12031-011-9629-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref169">
<cite>Hashimoto Y., Campbell M., Tachibana K., Okada Y., Kondoh M.. Claudin-5: A Pharmacological Target
to Modify the Permeability of the Blood-Brain Barrier. Biol. Pharm. Bull. 2021;44(10):1380–1390. doi: 10.1248/bpb.b21-00408.</cite> [<a href="https://doi.org/10.1248/bpb.b21-00408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34602546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol.%20Pharm.%20Bull.&amp;title=Claudin-5:%20A%20Pharmacological%20Target%20to%20Modify%20the%20Permeability%20of%20the%20Blood-Brain%20Barrier&amp;author=Y.%20Hashimoto&amp;author=M.%20Campbell&amp;author=K.%20Tachibana&amp;author=Y.%20Okada&amp;author=M.%20Kondoh&amp;volume=44&amp;issue=10&amp;publication_year=2021&amp;pages=1380-1390&amp;pmid=34602546&amp;doi=10.1248/bpb.b21-00408&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref170">
<cite>Neuhaus W., Piontek A., Protze J., Eichner M., Mahringer A., Subileau E.-A., Lee I.-F. M., Schulzke J. D., Krause G., Piontek J.. Reversible Opening
of the Blood-Brain
Barrier by Claudin-5-Binding Variants of Clostridium Perfringens Enterotoxin’s
Claudin-Binding Domain. Biomaterials. 2018;161:129–143. doi: 10.1016/j.biomaterials.2018.01.028.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2018.01.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29421550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Reversible%20Opening%20of%20the%20Blood-Brain%20Barrier%20by%20Claudin-5-Binding%20Variants%20of%20Clostridium%20Perfringens%20Enterotoxin%E2%80%99s%20Claudin-Binding%20Domain&amp;author=W.%20Neuhaus&amp;author=A.%20Piontek&amp;author=J.%20Protze&amp;author=M.%20Eichner&amp;author=A.%20Mahringer&amp;volume=161&amp;publication_year=2018&amp;pages=129-143&amp;pmid=29421550&amp;doi=10.1016/j.biomaterials.2018.01.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref171">
<cite>Veshnyakova A., Piontek J., Protze J., Waziri N., Heise I., Krause G.. Mechanism of Clostridium
Perfringens
Enterotoxin Interaction with Claudin-3/-4 Protein Suggests Structural
Modifications of the Toxin to Target Specific Claudins. J. Biol. Chem. 2012;287(3):1698–1708. doi: 10.1074/jbc.M111.312165.</cite> [<a href="https://doi.org/10.1074/jbc.M111.312165" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3265853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22128179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Mechanism%20of%20Clostridium%20Perfringens%20Enterotoxin%20Interaction%20with%20Claudin-3/-4%20Protein%20Suggests%20Structural%20Modifications%20of%20the%20Toxin%20to%20Target%20Specific%20Claudins&amp;author=A.%20Veshnyakova&amp;author=J.%20Piontek&amp;author=J.%20Protze&amp;author=N.%20Waziri&amp;author=I.%20Heise&amp;volume=287&amp;issue=3&amp;publication_year=2012&amp;pages=1698-1708&amp;pmid=22128179&amp;doi=10.1074/jbc.M111.312165&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref172">
<cite>Chen L., Sutharsan R., Lee J. L., Cruz E., Asnicar B., Palliyaguru T., Wasielewska J. M., Gaudin A., Song J., Leinenga G., Götz J.. Claudin-5
Binder Enhances Focused Ultrasound-Mediated Opening in an in Vitro
Blood-Brain Barrier Model. Theranostics. 2022;12(5):1952–1970. doi: 10.7150/thno.65539.</cite> [<a href="https://doi.org/10.7150/thno.65539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8899584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35265192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Claudin-5%20Binder%20Enhances%20Focused%20Ultrasound-Mediated%20Opening%20in%20an%20in%20Vitro%20Blood-Brain%20Barrier%20Model&amp;author=L.%20Chen&amp;author=R.%20Sutharsan&amp;author=J.%20L.%20Lee&amp;author=E.%20Cruz&amp;author=B.%20Asnicar&amp;volume=12&amp;issue=5&amp;publication_year=2022&amp;pages=1952-1970&amp;pmid=35265192&amp;doi=10.7150/thno.65539&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref173">
<cite>Breitkreuz-Korff O., Tscheik C., Del Vecchio G., Dithmer S., Walther W., Orthmann A., Wolburg H., Haseloff R. F., Schröder L., Blasig I. E., Winkler L.. M01 as a Novel
Drug Enhancer for Specifically Targeting the Blood-Brain Barrier. J. Controlled Release. 2021;338:137–148. doi: 10.1016/j.jconrel.2021.08.014.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2021.08.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34384796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=M01%20as%20a%20Novel%20Drug%20Enhancer%20for%20Specifically%20Targeting%20the%20Blood-Brain%20Barrier&amp;author=O.%20Breitkreuz-Korff&amp;author=C.%20Tscheik&amp;author=G.%20Del%20Vecchio&amp;author=S.%20Dithmer&amp;author=W.%20Walther&amp;volume=338&amp;publication_year=2021&amp;pages=137-148&amp;pmid=34384796&amp;doi=10.1016/j.jconrel.2021.08.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref174">
<cite>Tachibana K., Hashimoto Y., Shirakura K., Okada Y., Hirayama R., Iwashita Y., Nishino I., Ago Y., Takeda H., Kuniyasu H., Kondoh M.. Safety and Efficacy
of an Anti-Claudin-5 Monoclonal Antibody to Increase Blood-Brain Barrier
Permeability for Drug Delivery to the Brain in a Non-Human Primate. J. Controlled Release. 2021;336:105–111. doi: 10.1016/j.jconrel.2021.06.009.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2021.06.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34118338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Safety%20and%20Efficacy%20of%20an%20Anti-Claudin-5%20Monoclonal%20Antibody%20to%20Increase%20Blood-Brain%20Barrier%20Permeability%20for%20Drug%20Delivery%20to%20the%20Brain%20in%20a%20Non-Human%20Primate&amp;author=K.%20Tachibana&amp;author=Y.%20Hashimoto&amp;author=K.%20Shirakura&amp;author=Y.%20Okada&amp;author=R.%20Hirayama&amp;volume=336&amp;publication_year=2021&amp;pages=105-111&amp;pmid=34118338&amp;doi=10.1016/j.jconrel.2021.06.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref175">
<cite>Sato S., Liu S., Goto A., Yoneyama T., Okita K., Yamamoto S., Hirabayashi H., Iwasaki S., Kusuhara H.. Advanced Translational PBPK Model
for Transferrin Receptor-Mediated Drug Delivery to the Brain. J. Controlled Release. 2023;357:379–393. doi: 10.1016/j.jconrel.2023.04.012.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2023.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37031741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Advanced%20Translational%20PBPK%20Model%20for%20Transferrin%20Receptor-Mediated%20Drug%20Delivery%20to%20the%20Brain&amp;author=S.%20Sato&amp;author=S.%20Liu&amp;author=A.%20Goto&amp;author=T.%20Yoneyama&amp;author=K.%20Okita&amp;volume=357&amp;publication_year=2023&amp;pages=379-393&amp;pmid=37031741&amp;doi=10.1016/j.jconrel.2023.04.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref176">
<cite>Jefferies W. A., Brandon M. R., Hunt S. V., Williams A. F., Gatter K. C., Mason D. Y.. Transferrin Receptor on Endothelium
of Brain Capillaries. Nature. 1984;312(5990):162–163. doi: 10.1038/312162a0.</cite> [<a href="https://doi.org/10.1038/312162a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6095085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Transferrin%20Receptor%20on%20Endothelium%20of%20Brain%20Capillaries&amp;author=W.%20A.%20Jefferies&amp;author=M.%20R.%20Brandon&amp;author=S.%20V.%20Hunt&amp;author=A.%20F.%20Williams&amp;author=K.%20C.%20Gatter&amp;volume=312&amp;issue=5990&amp;publication_year=1984&amp;pages=162-163&amp;pmid=6095085&amp;doi=10.1038/312162a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref177">
<cite>Johnsen K. B., Burkhart A., Thomsen L. B., Andresen T. L., Moos T.. Targeting the Transferrin Receptor
for Brain Drug Delivery. Prog. Neurobiol. 2019;181:101665.  doi: 10.1016/j.pneurobio.2019.101665.</cite> [<a href="https://doi.org/10.1016/j.pneurobio.2019.101665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31376426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prog.%20Neurobiol&amp;title=Targeting%20the%20Transferrin%20Receptor%20for%20Brain%20Drug%20Delivery&amp;author=K.%20B.%20Johnsen&amp;author=A.%20Burkhart&amp;author=L.%20B.%20Thomsen&amp;author=T.%20L.%20Andresen&amp;author=T.%20Moos&amp;volume=181&amp;publication_year=2019&amp;pages=101665&amp;pmid=31376426&amp;doi=10.1016/j.pneurobio.2019.101665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref178">
<cite>Nielsen S. S. E., Holst M. R., Langthaler K., Christensen S. C., Bruun E. H., Brodin B., Nielsen M. S.. Apicobasal
Transferrin Receptor Localization and Trafficking in Brain Capillary
Endothelial Cells. Fluids Barriers CNS. 2023;20(1):2. doi: 10.1186/s12987-022-00404-1.</cite> [<a href="https://doi.org/10.1186/s12987-022-00404-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9830855/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36624498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fluids%20Barriers%20CNS&amp;title=Apicobasal%20Transferrin%20Receptor%20Localization%20and%20Trafficking%20in%20Brain%20Capillary%20Endothelial%20Cells&amp;author=S.%20S.%20E.%20Nielsen&amp;author=M.%20R.%20Holst&amp;author=K.%20Langthaler&amp;author=S.%20C.%20Christensen&amp;author=E.%20H.%20Bruun&amp;volume=20&amp;issue=1&amp;publication_year=2023&amp;pages=2&amp;pmid=36624498&amp;doi=10.1186/s12987-022-00404-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref179">
<cite>Sweeney M. D., Sagare A. P., Zlokovic B. V.. Blood-Brain
Barrier
Breakdown in Alzheimer Disease and Other Neurodegenerative Disorders. Nat. Rev. Neurol. 2018;14(3):133–150. doi: 10.1038/nrneurol.2017.188.</cite> [<a href="https://doi.org/10.1038/nrneurol.2017.188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5829048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29377008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Neurol&amp;title=Blood-Brain%20Barrier%20Breakdown%20in%20Alzheimer%20Disease%20and%20Other%20Neurodegenerative%20Disorders&amp;author=M.%20D.%20Sweeney&amp;author=A.%20P.%20Sagare&amp;author=B.%20V.%20Zlokovic&amp;volume=14&amp;issue=3&amp;publication_year=2018&amp;pages=133-150&amp;pmid=29377008&amp;doi=10.1038/nrneurol.2017.188&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref180">
<cite>Bourassa P., Alata W., Tremblay C., Paris-Robidas S., Calon F.. Transferrin Receptor-Mediated Uptake
at the Blood-Brain Barrier Is
Not Impaired by Alzheimer’s Disease Neuropathology. Mol. Pharmaceutics. 2019;16(2):583–594. doi: 10.1021/acs.molpharmaceut.8b00870.</cite> [<a href="https://doi.org/10.1021/acs.molpharmaceut.8b00870" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30609376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmaceutics&amp;title=Transferrin%20Receptor-Mediated%20Uptake%20at%20the%20Blood-Brain%20Barrier%20Is%20Not%20Impaired%20by%20Alzheimer%E2%80%99s%20Disease%20Neuropathology&amp;author=P.%20Bourassa&amp;author=W.%20Alata&amp;author=C.%20Tremblay&amp;author=S.%20Paris-Robidas&amp;author=F.%20Calon&amp;volume=16&amp;issue=2&amp;publication_year=2019&amp;pages=583-594&amp;pmid=30609376&amp;doi=10.1021/acs.molpharmaceut.8b00870&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref181">
<cite>Yang X., Li X., Liu L., Chen Y.-H., You Y., Gao Y., Liu Y.-Y., Yang L., Tong K., Chen D.-S., Hao J.-R., Sun N., Zhao Z.-M., Gao C.. Transferrin-Pep63-Liposomes Accelerate
the Clearance of Aβ
and Rescue Impaired Synaptic Plasticity in Early Alzheimer’s
Disease Models. Cell Death Discov. 2021;7(1):256. doi: 10.1038/s41420-021-00639-1.</cite> [<a href="https://doi.org/10.1038/s41420-021-00639-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8455582/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34548476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Discov&amp;title=Transferrin-Pep63-Liposomes%20Accelerate%20the%20Clearance%20of%20A%CE%B2%20and%20Rescue%20Impaired%20Synaptic%20Plasticity%20in%20Early%20Alzheimer%E2%80%99s%20Disease%20Models&amp;author=X.%20Yang&amp;author=X.%20Li&amp;author=L.%20Liu&amp;author=Y.-H.%20Chen&amp;author=Y.%20You&amp;volume=7&amp;issue=1&amp;publication_year=2021&amp;pages=256&amp;pmid=34548476&amp;doi=10.1038/s41420-021-00639-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref182">
<cite>Sarkar G., Curran G. L., Mahlum E., Decklever T., Wengenack T. M., Blahnik A., Hoesley B., Lowe V. J., Poduslo J. F., Jenkins R. B.. A Carrier for Non-Covalent
Delivery
of Functional Beta-Galactosidase and Antibodies against Amyloid Plaques
and IgM to the Brain. PLoS One. 2011;6(12):e28881.  doi: 10.1371/journal.pone.0028881.</cite> [<a href="https://doi.org/10.1371/journal.pone.0028881" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3244419/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22216132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=A%20Carrier%20for%20Non-Covalent%20Delivery%20of%20Functional%20Beta-Galactosidase%20and%20Antibodies%20against%20Amyloid%20Plaques%20and%20IgM%20to%20the%20Brain&amp;author=G.%20Sarkar&amp;author=G.%20L.%20Curran&amp;author=E.%20Mahlum&amp;author=T.%20Decklever&amp;author=T.%20M.%20Wengenack&amp;volume=6&amp;issue=12&amp;publication_year=2011&amp;pages=e28881&amp;pmid=22216132&amp;doi=10.1371/journal.pone.0028881&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref183">
<cite>Zou Z., Shen Q., Pang Y., Li X., Chen Y., Wang X., Luo X., Wu Z., Bao Z., Zhang J., Liang J., Kong L., Yan L., Xiong L., Zhu T., Yuan S., Wang M., Cai K., Yao Y., Wu J., Jiang Y., Liu H., Liu J., Zhou Y., Dong Q., Wang W., Zhu K., Li L., Lou Y., Wang H., Li Y., Lin H.. The Synthesized
Transporter K16APoE Enabled the Therapeutic HAYED Peptide to Cross
the Blood-Brain Barrier and Remove Excess Iron and Radicals in the
Brain, Thus Easing Alzheimer’s Disease. Drug Deliv Transl Res. 2019;9(1):394–403. doi: 10.1007/s13346-018-0579-4.</cite> [<a href="https://doi.org/10.1007/s13346-018-0579-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30136122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Deliv%20Transl%20Res.&amp;title=The%20Synthesized%20Transporter%20K16APoE%20Enabled%20the%20Therapeutic%20HAYED%20Peptide%20to%20Cross%20the%20Blood-Brain%20Barrier%20and%20Remove%20Excess%20Iron%20and%20Radicals%20in%20the%20Brain,%20Thus%20Easing%20Alzheimer%E2%80%99s%20Disease&amp;author=Z.%20Zou&amp;author=Q.%20Shen&amp;author=Y.%20Pang&amp;author=X.%20Li&amp;author=Y.%20Chen&amp;volume=9&amp;issue=1&amp;publication_year=2019&amp;pages=394-403&amp;pmid=30136122&amp;doi=10.1007/s13346-018-0579-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref184">
<cite>Kang S., Duan W., Zhang S., Chen D., Feng J., Qi N.. Muscone/RI7217 Co-Modified
Upward
Messenger DTX Liposomes Enhanced Permeability of Blood-Brain Barrier
and Targeting Glioma. Theranostics. 2020;10(10):4308–4322. doi: 10.7150/thno.41322.</cite> [<a href="https://doi.org/10.7150/thno.41322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7150489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32292496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Muscone/RI7217%20Co-Modified%20Upward%20Messenger%20DTX%20Liposomes%20Enhanced%20Permeability%20of%20Blood-Brain%20Barrier%20and%20Targeting%20Glioma&amp;author=S.%20Kang&amp;author=W.%20Duan&amp;author=S.%20Zhang&amp;author=D.%20Chen&amp;author=J.%20Feng&amp;volume=10&amp;issue=10&amp;publication_year=2020&amp;pages=4308-4322&amp;pmid=32292496&amp;doi=10.7150/thno.41322&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref185">
<cite>Huang C.-W., Chuang C.-P., Chen Y.-J., Wang H.-Y., Lin J.-J., Huang C.-Y., Wei K.-C., Huang F.-T.. Integrin
α­(2)­β­(1)-Targeting Ferritin Nanocarrier Traverses the
Blood-Brain Barrier for Effective Glioma Chemotherapy. J. Nanobiotechnology. 2021;19(1):180. doi: 10.1186/s12951-021-00925-1.</cite> [<a href="https://doi.org/10.1186/s12951-021-00925-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8201891/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34120610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nanobiotechnology&amp;title=Integrin%20%CE%B1%C2%AD(2)%C2%AD%CE%B2%C2%AD(1)-Targeting%20Ferritin%20Nanocarrier%20Traverses%20the%20Blood-Brain%20Barrier%20for%20Effective%20Glioma%20Chemotherapy&amp;author=C.-W.%20Huang&amp;author=C.-P.%20Chuang&amp;author=Y.-J.%20Chen&amp;author=H.-Y.%20Wang&amp;author=J.-J.%20Lin&amp;volume=19&amp;issue=1&amp;publication_year=2021&amp;pages=180&amp;pmid=34120610&amp;doi=10.1186/s12951-021-00925-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref186">
<cite>Chang J.-H., Greene C., Frudd K., Araujo Dos
Santos L., Futter C., Nichols B. J., Campbell M., Turowski P.. Methamphetamine Enhances Caveolar Transport of Therapeutic
Agents across the Rodent Blood-Brain Barrier. Cell Rep. Med. 2022;3(1):100497.  doi: 10.1016/j.xcrm.2021.100497.</cite> [<a href="https://doi.org/10.1016/j.xcrm.2021.100497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8784794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35106509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Rep.%20Med.&amp;title=Methamphetamine%20Enhances%20Caveolar%20Transport%20of%20Therapeutic%20Agents%20across%20the%20Rodent%20Blood-Brain%20Barrier&amp;author=J.-H.%20Chang&amp;author=C.%20Greene&amp;author=K.%20Frudd&amp;author=L.%20Araujo%20Dos%20Santos&amp;author=C.%20Futter&amp;volume=3&amp;issue=1&amp;publication_year=2022&amp;pages=100497&amp;pmid=35106509&amp;doi=10.1016/j.xcrm.2021.100497&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from ACS Omega are provided here courtesy of <strong>American Chemical Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1021/acsomega.5c00364"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ao5c00364.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12332615/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12332615/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332615%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332615/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12332615/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12332615/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40787406/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12332615/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40787406/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12332615/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12332615/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="qKFuOPEvvYgNfVMnW5fh9Zf05d8jxKX2cD4S6NPiJEy1fy0kBm6yX3gqc2PWsy00">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
